STOCK TITAN

Trustmark to merge for 0.7463 Hancock Whitney shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
425

Rhea-AI Filing Summary

Trustmark Corporation entered into a merger agreement with Hancock Whitney Corporation on November 11, 2026; Trustmark is to merge into Hancock Whitney, which is to survive, subject to the agreement’s conditions. Each Trustmark common share eligible for conversion is to convert into a right to receive 0.7463 Hancock Whitney common shares, with cash instead of fractional shares. Immediately afterward, Trustmark Bank is to merge into Hancock Whitney Bank, which is to survive.

Completion requires approval by both companies’ shareholders, regulatory authorizations and other conditions, including effectiveness of a Form S-4 registration statement and listing authorization for the shares issued. 5 current Trustmark directors, including its CEO, are to be appointed to Hancock Whitney’s board through its nomination and vetting process; Hancock Whitney is also to establish an advisory board for the Jackson, Mississippi metropolitan area. A $110,000,000 termination fee may be payable by either party in certain circumstances, including those involving alternative business combination proposals.

Filing Explained

The merger agreement states that Trustmark common holders will have no appraisal or dissenters’ rights in the proposed merger.

Exchange ratio 0.7463 Hancock Whitney common shares per Trustmark common share Merger consideration at the Effective Time for shares eligible for conversion
Trustmark director appointments 5 directors Current Trustmark directors, including its CEO, are to be appointed to Hancock Whitney’s board through its nomination and vetting process
Termination fee $110,000,000 May be payable by either party in specified termination circumstances
Closing deadline No later than 3 business days After satisfaction or waiver of the latest closing condition, subject to applicable law and written agreement otherwise
Exchange Ratio technical
"0.7463 (the “Exchange Ratio”) shares"
The exchange ratio is the number used to decide how many shares of one company you get for each share you own in another company during a merger or acquisition. It’s like a recipe that tells you how to swap shares fairly, ensuring both companies’ values are balanced. This ratio matters because it determines how ownership divides between the companies' shareholders.
Bank Merger technical
"Trustmark Bank will merge with and into Hancock Whitney Bank (the “Bank Merger”)"
termination fee financial
"a termination fee of $110,000,000 will be payable by either Hancock Whitney or Trustmark"
A termination fee is a payment required if one party ends a contract before its agreed-upon end date. It acts like a penalty or compensation to the other party for canceling early, similar to a fee you might pay for breaking a lease or canceling a service contract. For investors, it matters because it can influence a company's decisions and financial obligations related to ending agreements prematurely.
Materially Burdensome Regulatory Condition regulatory
"absence of any “Materially Burdensome Regulatory Condition”"
Form S-4 regulatory
"registration statement on Form S-4"
A Form S-4 is a legal document that companies file with the government to announce and explain a major business move, such as a merger or acquisition. It provides detailed information to help investors understand how the deal might affect the company's value and future prospects, similar to a detailed blueprint that clarifies the impact of a significant change.
restricted stock unit award technical
"each restricted stock unit award in respect of Trustmark common stock"
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What will TRMK shareholders receive in the Hancock Whitney merger?

Under the agreement, each eligible Trustmark common share is to convert into a right to receive 0.7463 Hancock Whitney common shares, without interest. Holders are to receive cash in lieu of fractional shares.

What is the TRMK merger termination fee?

The agreement provides for a $110,000,000 termination fee payable by either Hancock Whitney or Trustmark, as applicable, in certain termination circumstances, including those involving alternative business combination proposals.

What vote does Trustmark need to approve the merger?

Approval requires the affirmative vote of holders of a majority of the votes cast by holders of outstanding Trustmark common stock at the Trustmark shareholder meeting.

How will Trustmark equity awards be treated in the merger?

Unvested service-based restricted stock unit awards are to convert into Hancock Whitney awards on the same terms, with the share amount adjusted using the exchange ratio. Unvested performance awards are based on actual results through the end of the calendar quarter ending on or before the Effective Time; vested and director awards are canceled for Hancock Whitney shares, less applicable tax withholding.

When will TRMK shareholders receive exchange instructions?

Hancock is to have the exchange agent mail transmittal letters and instructions as promptly as practicable after the Effective Time, and no later than 10 days afterward. Holders must surrender their Trustmark certificates with a completed transmittal letter to receive the consideration.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

November 11, 2026

Date of Report (Date of earliest event reported)

 

 

 

LOGO

TRUSTMARK CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Mississippi   000-03683   64-0471500

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

248 East Capitol Street, Jackson, Mississippi   39201
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (601) 208-5111

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☒

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered Pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, no par value   TRMK   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01.

Entry into a Material Definitive Agreement.

On November 11, 2026, Trustmark Corporation, a Mississippi corporation (“Trustmark”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Hancock Whitney Corporation, a Mississippi corporation (“Hancock Whitney”). The Merger Agreement provides that, upon the terms and subject to the conditions set forth therein, Trustmark will merge with and into Hancock Whitney, with Hancock Whitney surviving the merger (the “Merger”, and Hancock Whitney as the surviving corporation, the “Surviving Corporation”). Immediately following the effective time of the Merger (the “Effective Time”), Trustmark’s wholly owned banking subsidiary, Trustmark Bank, will merge with and into Hancock Whitney’s wholly owned banking subsidiary, Hancock Whitney Bank (the “Bank Merger”), with Hancock Whitney Bank continuing as the surviving bank in the Bank Merger. The Merger Agreement was approved by the board of directors of each of Hancock Whitney and Trustmark.

Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each share of common stock, no par value, of Trustmark (the “Trustmark common stock”) issued and outstanding immediately prior to the Effective Time will be converted into the right to receive, without interest, 0.7463 (the “Exchange Ratio”) shares of common stock, par value $3.33 per share, of Hancock Whitney (the “Hancock Whitney Common Stock”). Holders of Trustmark common stock will receive cash in lieu of fractional shares of Hancock Whitney Common Stock.

Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, (i) each restricted stock unit award in respect of Trustmark common stock that is unvested as of immediately prior to the Effective Time (and is not held by a Trustmark non-employee director) will be assumed and converted into a restricted stock unit award in respect of Hancock Whitney Common Stock, with the same terms and conditions as were applicable prior to the Effective Time (other than with respect to any performance-based vesting conditions, which will be measured based on the actual performance results of Trustmark through the end of the calendar quarter ending on or before the Effective Time), and relating to the number of shares of Hancock Whitney Common Stock equal to the product of the number of shares of Trustmark common stock subject to such Trustmark award (which for performance-based vesting awards will be the number of shares subject to the Trustmark award determined to be earned based on actual performance results as measured through the end of the calendar quarter ending on or before the Effective Time), multiplied by the Exchange Ratio (with any fractional shares rounded to the nearest whole share of Hancock Whitney Common Stock), and (ii) each restricted stock unit award in respect of Trustmark common stock that is held by a Trustmark non-employee director (or is otherwise vested but not settled prior to the Effective Time) will be cancelled and the holder thereof will receive a number of shares of Hancock Whitney Common Stock equal to the product of the number of shares of Trustmark common stock subject to such award, multiplied by the Exchange Ratio, less applicable tax withholdings, and with cash paid for any fractional share.

The Merger Agreement also provides, among other things, that Hancock Whitney will take all necessary and appropriate action so that, effective as of the Effective Time, five (5) current directors of Trustmark will be appointed to the Board of Directors of Hancock Whitney. The directors will be identified and selected by the Nominating and Corporate Governance Committee of the Board of Directors of Hancock Whitney, in accordance with Hancock Whitney’s standard director nomination, vetting and governance process (including satisfaction of applicable director independence, qualification and committee eligibility criteria), after considering the recommendations of the Chair of the Board of Directors of Trustmark and the Chief Executive Officer of Trustmark. The parties have agreed that one of the designated directors will be the Chief Executive Officer of Trustmark.


Additionally, the Merger Agreement provides that, effective as of the Effective Time, Hancock Whitney will establish an advisory board for the Jackson, Mississippi metropolitan area, which will have an advisory role and operate pursuant to a charter adopted by Hancock Whitney (the “Central Mississippi Advisory Board”). The members of the Central Mississippi Advisory Board will be appointed by Hancock Whitney after considering the recommendations of the Chair of the Board of Directors of Trustmark and the Chief Executive Officer of Trustmark.

The Merger Agreement contains customary representations and warranties from both Hancock Whitney, on the one hand, and Trustmark, on the other hand, and each party has agreed to customary covenants including, among others, covenants relating to (1) the conduct of its business during the interim period between the execution of the Merger Agreement and the Effective Time, (2) its obligation to call a meeting of its shareholders to approve the Merger Agreement and the Merger, and, subject to certain exceptions, to recommend that its shareholders approve the Merger Agreement and the Merger, and (3) its non-solicitation obligations relating to alternative business combination proposals.

The completion of the Merger is subject to customary conditions, including (1) approval of the Merger Agreement by the shareholders of Hancock Whitney and Trustmark; (2) authorization for listing on The Nasdaq Global Select Stock Market of the shares of Hancock Whitney Common Stock to be issued in the Merger, in each case subject to official notice of issuance; (3) the effectiveness of the registration statement on Form S-4 for the shares of Hancock Whitney Common Stock to be issued in the Merger; (4) the absence of any order, injunction, decree or other legal restraint preventing the completion of the Merger or the Bank Merger or making the completion of the Merger or the Bank Merger illegal; and (5) the receipt of regulatory authorizations, consents and approvals, including from the Board of Governors of the Federal Reserve System, the Federal Deposit Insurance Corporation, the Mississippi Department of Banking and Consumer Finance, and expiration of all applicable waiting periods in respect thereof as well as the absence of any “Materially Burdensome Regulatory Condition” (as such term is defined in the Merger Agreement). Each party’s obligation to complete the Merger is also subject to certain additional customary conditions, including (1) subject to certain materiality qualifications, the accuracy of the representations and warranties of the other party; (2) performance in all material respects by the other party of its obligations under the Merger Agreement; and (3) receipt by such party of an opinion from its respective counsel to the effect that the Merger will qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended.

The Merger Agreement provides certain customary termination rights for Hancock Whitney and Trustmark and further provides that a termination fee of $110,000,000 will be payable by either Hancock Whitney or Trustmark, as applicable, in the event of a termination of the Merger Agreement under certain circumstances, including those relating to alternative business combination proposals.

The representations, warranties and covenants of each party set forth in the Merger Agreement have been made only for the purposes of, and were and are solely for the benefit of the parties to, the Merger Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the parties that differ from those applicable to investors. Accordingly, the representations and warranties may not describe the actual state of affairs at the date they were made or at any other time, and investors should not rely on them as statements of fact. In addition, such representations and warranties (1) will not survive consummation of the Merger and (2) were made only as of the date of the Merger Agreement or such other date as is specified in the Merger Agreement. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the parties’ public disclosures. Accordingly, the Merger Agreement is included with this filing only to provide investors with information regarding the terms of the Merger Agreement, and not to


provide investors with any factual information regarding Hancock Whitney or Trustmark, their respective affiliates or their respective businesses. The Merger Agreement should not be read alone, but should instead be read in conjunction with the other information regarding Hancock Whitney, Trustmark, their respective affiliates or their respective businesses, the Merger Agreement and the Merger, that will be contained in, or incorporated by reference into, the registration statement on Form S-4, that will include a joint proxy statement of Hancock Whitney and Trustmark and also constitute a Prospectus of Hancock Whitney, as well as in the Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings that Hancock Whitney makes with the Securities and Exchange Commission (the “SEC”).

The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, which is attached hereto as Exhibit 2.1 and is incorporated herein by reference.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
Number

  

Description of Exhibits

2.1    Agreement and Plan of Merger, dated as of November 11, 2026, by and between Trustmark Corporation and Hancock Whitney Corporation.*
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*

Pursuant to Item 601(a)(5) of Regulation S-K, certain schedules and similar attachments have been omitted. The registrant hereby agrees to furnish a copy of any omitted schedule or similar attachment to the SEC upon request.

Important Cautionary Statement about Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include statements, including, but not limited to, certain plans, expectations, goals, projections, and statements about the benefits of the proposed transaction, the plans, objectives, expectations and intentions of Hancock Whitney and Trustmark, the expected timing of completion of the transaction, and other statements that are not historical facts. Any forward-looking statement made in this Current Report on Form 8-K is subject to the safe harbor protections set forth in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous assumptions, risks, estimates, uncertainties, and other important factors that change over time and could cause actual results to differ materially from any results, performance, or events expressed or implied by such forward-looking statements, including as a result of the factors referenced below. Statements that do not describe historical or current facts, including statements about beliefs and expectations, are forward-looking statements. These statements often include the words “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “forecast,” “goals,” “targets,” “initiatives,” “focus,” “potentially,” “probably,” “projects,” “outlook,” or similar expressions or future conditional verbs such as “may,” “will,” “should,” “would,” and “could.” Forward-looking statements are based upon the current beliefs and expectations of management and on information currently available to management. Our statements speak as of the date hereof, and we do not assume any obligation to update these statements or to update the reasons why actual results could differ from those contained in such statements in light of new information or future events.


Hancock Whitney and Trustmark caution that the forward-looking statements in this communication are not guarantees of future performance and involve a number of known and unknown risks, uncertainties and assumptions that are difficult to assess and are subject to change based on factors which are, in many instances, beyond Hancock Whitney’s and Trustmark’s control. While there is no assurance that any list of risks and uncertainties or risk factors is complete, below are certain factors which could cause actual results to differ materially from those contained or implied in the forward-looking statements or historical performance: the impact of current and future economic conditions, including the effects of declines in the real estate market, tariffs or trade wars (including reduced consumer spending, lower economic growth or recession, reduced demand for U.S. exports, disruptions to supply chains, and decreased demand for other banking products and services), high unemployment, inflationary pressures, increasing insurance costs, fluctuations in interest rates, including the impact of changes in interest rates on our financial projections, models and guidance and slowdowns in economic growth, as well as the financial stress on borrowers as a result of the foregoing, general economic and business conditions in our local markets, Federal Reserve action with respect to interest rates, the effects of war or other conflicts, acts of terrorism, climate change, the impact of natural or man-made disasters, the adequacy of our enterprise risk management framework, potential claims, damages, penalties, fines and reputational damage resulting from pending or future litigation, regulatory proceedings, assessments, and enforcement actions, as well as the impact of negative developments affecting the banking industry and the resulting media coverage; the timing, benefits, and potential impact of third-party business combinations in our footprint on our performance and financial condition, the effectiveness of derivative financial instruments and hedging activities to manage risks, projected tax rates, increased cybersecurity risks, including potential business disruptions or financial losses, and the impact of artificial intelligence on our business operations, the adequacy of our internal controls over financial and non-financial reporting, the impact of changes in U.S. laws or policies, including those related to credit card interest rates, the financial impact of regulatory requirements and tax reform legislation, deposit trends, credit quality trends, net interest margin trends, future expense levels, future profitability, supplemental disclosure items, improvements in expense to revenue (efficiency) ratio, purchase accounting impacts and expected returns; the occurrence of any event, change or other circumstance that could give rise to the right of one or both of the parties to terminate the merger agreement between Hancock Whitney and Trustmark; the outcome of any legal proceedings that may be instituted against Hancock Whitney or Trustmark; delays in completing the proposed transaction involving Hancock Whitney and Trustmark; the failure to obtain necessary regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the transaction); the failure to obtain Hancock Whitney shareholder approval or Trustmark shareholder approval or to satisfy any of the other conditions to the transaction on a timely basis or at all; the possibility that the anticipated benefits of the transaction are not realized when expected or at all, including as a result of the impact of, or problems arising from, the integration of the two companies or as a result of the strength of the economy and competitive factors in the areas where Hancock Whitney and Trustmark do business; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; the ability of Hancock Whitney and Trustmark to meet expectations regarding the timing, completion and accounting and tax treatment of the transaction; diversion of management’s attention from ongoing business operations and opportunities; potential adverse reactions or changes to business, customer or employee relationships, including those resulting from the announcement or completion of the transaction; the ability to complete the transaction and integration of Hancock Whitney and Trustmark successfully; the dilution caused by Hancock Whitney’s issuance of additional shares of its capital stock in connection with the transaction; and other factors that may affect the future results of Hancock Whitney and Trustmark. Investors are cautioned against placing undue reliance on such statements. Actual results may differ materially from those set forth in the forward-looking statements. Additional factors that could cause actual results to differ materially from those described in the forward-looking statements can be found in Part I, “Item 1A. Risk Factors” of Hancock Whitney’s Annual Report on Form 10-K for the year ended December 31, 2025, and in its subsequent Quarterly Reports on Form 10-Q, including for the quarter ended September 30, 2026, each of which is on file with the SEC and available on the “Investor Relations” section of Hancock Whitney’s website,


investors.hancockwhitney.com, and in other documents Hancock Whitney files with the SEC, and in Trustmark’s Annual Report on Form 10-K for the year ended December 31, 2025 and in its subsequent Quarterly Reports on Form 10-Q, including for the quarter ended September 30, 2026, each of which is available on Trustmark’s investor relations website, investorrelations.trustmark.com, and in other documents Trustmark files with the SEC.

Important Additional Information and Where to Find It

In connection with the proposed transaction, Hancock Whitney will file with the SEC a Registration Statement on Form S-4 (the “registration statement”), that will include a joint Proxy Statement of Hancock Whitney and Trustmark and a Prospectus of Hancock Whitney (the “joint proxy statement/prospectus”), as well as other relevant documents regarding the proposed transaction. The proposed transaction involving Hancock Whitney and Trustmark will be submitted to Hancock Whitney’s shareholders and Trustmark’s shareholders for their consideration. INVESTORS, SHAREHOLDERS OF HANCOCK WHITNEY AND SHAREHOLDERS OF TRUSTMARK ARE URGED TO READ THE REGISTRATION STATEMENT AND THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE TRANSACTION WHEN IT BECOMES AVAILABLE AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC AND THE FEDERAL RESERVE, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Shareholders will be able to obtain a free copy of the definitive joint proxy statement/prospectus, as well as other filings containing information about Hancock Whitney and Trustmark, without charge, from the SEC’s website (www.sec.gov), Hancock Whitney’s website at investors.hancockwhitney.com and Trustmark’s website at investorrelations.trustmark.com. Copies of the joint proxy statement/prospectus, when available, and the filings with the SEC that will be incorporated by reference in the joint proxy statement/prospectus can also be obtained, without charge, by directing a request to Hancock Whitney Investor Relations, Hancock Whitney Corporation, Hancock Whitney Plaza, 2510 14th Street, Gulfport, Mississippi 39501, Attention: Investor Relations, by calling 504.299.5706, or by sending an e-mail to investorrelations@hancockwhitney.com. Copies of the joint proxy statement/prospectus, when available, and the filings containing information about Trustmark may be obtained after their filing with the SEC, without charge, by directing a request to Trustmark Investor Relations, Trustmark Corporation, 248 East Capitol Street, Jackson, Mississippi 39201, by calling 601.208.6898, or by sending an e-mail to investorrelations@trustmark.com. References to Hancock Whitney’s and Trustmark’s websites do not constitute incorporation by reference of the information contained on those websites and such information is not, and should not be, deemed part of this filing.

Participants in the Solicitation

Hancock Whitney, Trustmark, and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of Hancock Whitney and shareholders of Trustmark in connection with the proposed transaction. Information regarding the interests of the directors and executive officers of Hancock Whitney and Trustmark and other persons who may be deemed to be participants in the solicitation of shareholders of Hancock Whitney and Trustmark in connection with the transaction and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the definitive joint proxy statement/prospectus related to the transaction, which will be filed by Hancock Whitney with the SEC. Information regarding Hancock Whitney’s directors and executive officers is available in its definitive proxy statement relating to its 2026 Annual Meeting of Shareholders, which was filed with the SEC on March 17, 2026, and other documents filed by Hancock Whitney with the SEC. Information regarding Trustmark’s directors and executive officers is available in its definitive proxy statement relating to its 2026 Annual Meeting of Shareholders, which was filed with the SEC on March 16, 2026, and other documents filed by Trustmark with the SEC. Other information regarding the participants in the proxy solicitation and a description of their direct and


indirect interests, by security holdings or otherwise, will be contained in the joint proxy statement/prospectus and other relevant materials filed with the SEC by Hancock Whitney and Trustmark. Free copies of these documents may be obtained as described above under “Important Additional Information and Where to Find It.”

No Offer or Solicitation

This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to subscribe for, buy or sell, or an invitation to subscribe for, buy or sell any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, invitation, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, and otherwise in accordance with applicable law.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TRUSTMARK CORPORATION
BY:  

/s/ Joseph E. Bond

  Joseph E. Bond
  Treasurer and Principal Financial Officer
DATE:   November 16, 2026


Exhibit 2.1

EXECUTION VERSION

AGREEMENT AND PLAN OF MERGER

by and between

HANCOCK WHITNEY CORPORATION

and

TRUSTMARK CORPORATION

 

 

Dated as of November 11, 2026


TABLE OF CONTENTS

 

         Page  

ARTICLE I

 

THE MERGER

 

1.1

  The Merger      1  

1.2

  Closing      1  

1.3

  Effective Time      2  

1.4

  Effects of the Merger      2  

1.5

  Conversion of Trustmark Common Stock      2  

1.6

  Hancock Common Stock      3  

1.7

  Treatment of Trustmark Equity Awards      3  

1.8

  Bylaws of Surviving Corporation      4  

1.9

  Tax Consequences      4  

1.10

  Bank Merger      5  

ARTICLE II

 

EXCHANGE OF SHARES

 

2.1

  Hancock to Make Consideration Available      5  

2.2

  Exchange of Shares      5  

2.3

  No Appraisal or Dissenters’ Rights      8  

ARTICLE III

 

REPRESENTATIONS AND WARRANTIES OF TRUSTMARK

 

3.1

  Corporate Organization      8  

3.2

  Capitalization      10  

3.3

  Authority; No Violation      11  

3.4

  Consents and Approvals      12  

3.5

  Reports      13  

3.6

  Financial Statements      14  

3.7

  Broker’s Fees      15  

3.8

  Absence of Certain Changes or Events      15  

3.9

  Legal Proceedings      16  

3.10

  Taxes and Tax Returns      16  

3.11

  Employees and Employee Benefit Plans      17  

3.12

  Compliance with Applicable Law      21  

3.13

  Certain Contracts      23  

3.14

  Agreements with Regulatory Agencies      25  

3.15

  Risk Management Instruments      25  

 

-i-


3.16

  Environmental Matters      26  

3.17

  Investment Securities      26  

3.18

  Real Property      26  

3.19

  Intellectual Property      27  

3.20

  Related Party Transactions      28  

3.21

  Takeover Restrictions      28  

3.22

  Reorganization      28  

3.23

  Opinion      28  

3.24

  Trustmark Information      29  

3.25

  Loan Portfolio      29  

3.26

  Insurance      30  

3.27

  No Investment Adviser or Broker-Dealer Subsidiary      31  

3.28

  No Other Representations or Warranties      31  

ARTICLE IV

 

REPRESENTATIONS AND WARRANTIES OF HANCOCK

 

4.1

  Corporate Organization      32  

4.2

  Capitalization      32  

4.3

  Authority; No Violation      34  

4.4

  Consents and Approvals      35  

4.5

  Reports      35  

4.6

  Financial Statements      36  

4.7

  Broker’s Fees      37  

4.8

  Absence of Certain Changes or Events      38  

4.9

  Legal Proceedings      38  

4.10

  Taxes and Tax Returns      38  

4.11

  Compliance with Applicable Law      39  

4.12

  Certain Contracts      40  

4.13

  Agreements with Regulatory Agencies      41  

4.14

  Information Technology      41  

4.15

  Related Party Transactions      41  

4.16

  Reorganization      42  

4.17

  Investment Securities      42  

4.18

  Risk Management Instruments      42  

4.19

  Opinion      42  

4.20

  Hancock Information      43  

4.21

  Loan Portfolio      43  

4.22

  Employee Benefit Plans      44  

4.23

  No Other Representations or Warranties      45  

ARTICLE V

 

COVENANTS RELATING TO CONDUCT OF BUSINESS

 

5.1

  Conduct of Business Prior to the Effective Time; Forbearances      45  

 

-ii-


5.2

  Hancock Forbearances      49  

ARTICLE VI

 

ADDITIONAL AGREEMENTS

 

6.1

  Regulatory Matters      50  

6.2

  Access to Information      52  

6.3

  Trustmark Shareholder Approval      53  

6.4

  Hancock Shareholder Approval      55  

6.5

  Legal Conditions to Merger      56  

6.6

  Stock Exchange Listing      56  

6.7

  Tax Treatment      56  

6.8

  Employee Matters      57  

6.9

  Indemnification; Directors’ and Officers’ Insurance      59  

6.10

  Additional Agreements      60  

6.11

  Advice of Changes      60  

6.12

  Dividends      61  

6.13

  Trustmark Director Appointments; Central Mississippi Advisory Board      61  

6.14

  Acquisition Proposals      61  

6.15

  Public Announcements      64  

6.16

  Change of Method      64  

6.17

  Restructuring Efforts      64  

6.18

  Takeover Restrictions      65  

6.19

  Exemption from Liability Under Section 16(b)      65  

6.20

  Litigation and Claims      65  

6.21

  Assumption of Trustmark Debt      66  

ARTICLE VII

 

CONDITIONS PRECEDENT

 

7.1

  Conditions to Each Party’s Obligation to Effect the Merger      66  

7.2

  Conditions to Obligations of Hancock      67  

7.3

  Conditions to Obligations of Trustmark      68  

ARTICLE VIII

 

TERMINATION AND AMENDMENT

 

8.1

  Termination      69  

8.2

  Effect of Termination      70  

ARTICLE IX

 

GENERAL PROVISIONS

 

9.1

  Nonsurvival of Representations, Warranties and Agreements      72  

 

-iii-


9.2

  Amendment      72  

9.3

  Extension; Waiver      72  

9.4

  Expenses      73  

9.5

  Notices      73  

9.6

  Interpretation      74  

9.7

  Confidential Supervisory Information      74  

9.8

  Counterparts      75  

9.9

  Entire Agreement      75  

9.10

  Governing Law; Jurisdiction.      75  

9.11

  Waiver of Jury Trial      75  

9.12

  Assignment; Third-Party Beneficiaries      76  

9.13

  Specific Performance      76  

9.14

  Severability      76  

9.15

  Delivery by Electronic Transmission      77  

 

Exhibit A - Form of Bank Merger Agreement

INDEX OF DEFINED TERMS

 

     Page  

Adjusted RSU Award

     3  

Affiliate

     68  

Agreement

     1  

Articles of Merger

     2  

Bank Merger

     5  

Bank Merger Agreement

     5  

Bank Merger Certificates

     6  

BHC Act

     9  

business day

     68  

Central Mississippi Advisory Board

     60  

Chosen Courts

     69  

Classified Loan

     29  

Closing

     1  

Closing Date

     1  

Code

     1  

Confidentiality Agreement

     51  

Continuing Employees

     53  

Effective Time

     2  

Enforceability Exceptions

     12  

Environmental Laws

     25  

ERISA

     18  

Exception Shares

     2  

Exchange Act

     13  

 

-iv-


Exchange Agent

     6  

Exchange Fund

     6  

Exchange Ratio

     2  

FDIC

     10  

Federal Reserve Board

     13  

GAAP

     10  

Governmental Entity

     13  

Hancock

     1  

Hancock 401(k) Plan

     54  

Hancock Acquisition Proposal

     60  

Hancock Adverse Recommendation Change

     53  

Hancock Articles

     31  

Hancock Benefit Plans

     42  

Hancock Board Recommendation

     53  

Hancock Bylaws

     31  

Hancock Common Stock

     2  

Hancock Contract

     40  

Hancock Deferred Stock Unit Awards

     32  

Hancock Disclosure Schedule

     30  

Hancock Equity Awards

     33  

Hancock ERISA Affiliate

     42  

Hancock Meeting

     53  

Hancock Preferred Stock

     31  

Hancock Regulatory Agreement

     40  

Hancock Reports

     35  

Hancock Representatives

     60  

Hancock Share Closing Price

     7  

Hancock Stock Plans

     32  

Hancock Subsidiary

     31  

Hancock Whitney Bank

     5  

Intellectual Property

     27  

IRS

     17  

knowledge

     68  

Liens

     12  

Loans

     28  

made available

     68  

Material Adverse Effect

     9  

Materially Burdensome Regulatory Condition

     49  

MBCA

     1  

Merger

     1  

Merger Consideration

     2  

Mississippi Department of Banking

     12  

Mississippi Secretary

     2  

Multiemployer Plan

     19  

Multiple Employer Plan

     19  

Nasdaq

     7  

 

-v-


New Certificates

     6  

New Plans

     53  

OCC

     13  

Old Certificate

     2  

PBGC

     20  

Permitted Encumbrances

     27  

person

     68  

Personal Data

     21  

Premium Cap

     56  

Proxy Statement

     13  

Regulatory Agencies

     14  

Requisite Hancock Vote

     33  

Requisite Regulatory Approvals

     62  

Requisite Trustmark Vote

     12  

S-4

     13  

Sarbanes-Oxley Act

     15  

SEC

     13  

Securities Act

     14  

Senior Employee

     20  

SRO

     13  

Subsidiary

     10  

Surviving Corporation

     1  

Takeover Restrictions

     28  

Tax

     18  

Taxes

     18  

Tax Return

     18  

Termination Date

     64  

Termination Fee

     66  

Trustmark

     1  

Trustmark 401(k) Plan

     54  

Trustmark Acquisition Proposal

     58  

Trustmark Adverse Recommendation Change

     52  

Trustmark Articles

     10  

Trustmark Bank

     5  

Trustmark Benefit Plans

     18  

Trustmark Board Recommendation

     51  

Trustmark Bylaws

     10  

Trustmark Common Stock

     2  

Trustmark Contract

     24  

Trustmark Director RSU Award

     4  

Trustmark Disclosure Schedule

     9  

Trustmark Equity Awards

     4  

Trustmark ERISA Affiliate

     18  

Trustmark Indemnified Parties

     55  

Trustmark Insiders

     60  

Trustmark Meeting

     51  

 

-vi-


Trustmark Owned Properties

     26  

Trustmark PSU Award

     4  

Trustmark Qualified Plans

     19  

Trustmark Real Property

     26  

Trustmark Regulatory Agreement

     25  

Trustmark Reports

     14  

Trustmark RSU Award

     5  

Trustmark Stock Plans

     5  

Trustmark Subsidiary

     10  

Trustmark Unvested RSU Award

     4  

Trustmark Vested RSU Award

     4  

Willful Breach

     65  

 

-vii-


AGREEMENT AND PLAN OF MERGER

AGREEMENT AND PLAN OF MERGER, dated as of November 11, 2026 (this “Agreement”), by and between Hancock Whitney Corporation, a Mississippi corporation (“Hancock”), and Trustmark Corporation, a Mississippi corporation (“Trustmark”).

W I T N E S S E T H:

WHEREAS, the Boards of Directors of Hancock and Trustmark have each (a) determined that it is in the best interests of their respective corporations and their shareholders to consummate the strategic business combination transaction provided for herein, pursuant to which Trustmark will, subject to the terms and conditions set forth herein, merge with and into Hancock (the “Merger”), so that Hancock is the surviving corporation (hereinafter sometimes referred to in such capacity as the “Surviving Corporation”), (b) adopted the Agreement, and (c) resolved to submit this Agreement to their respective shareholders and to recommend that such shareholders approve this Agreement and the Merger;

WHEREAS, for federal income tax purposes, it is intended that the Merger shall qualify as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”), and this Agreement is intended to be and is adopted as a plan of reorganization for purposes of Sections 354 and 361 of the Code and Treasury Regulations Section 1.368-2(g); and

WHEREAS, the parties desire to make certain representations, warranties and agreements in connection with the Merger and also to prescribe certain conditions to the Merger.

NOW, THEREFORE, in consideration of the mutual covenants, representations, warranties and agreements contained herein, and intending to be legally bound hereby, the parties agree as follows:

ARTICLE I

THE MERGER

1.1 The Merger. Subject to the terms and conditions of this Agreement, in accordance with the Mississippi Business Corporation Act, as amended (the “MBCA”), at the Effective Time, Trustmark shall merge with and into Hancock. Hancock shall be the Surviving Corporation of the Merger and shall continue its corporate existence under the laws of the State of Mississippi. Upon consummation of the Merger, the separate corporate existence of Trustmark shall terminate.

1.2 Closing. Subject to the terms and conditions of this Agreement, the closing of the Merger (the “Closing”) will take place at 10:00 a.m., Mississippi time, remotely via the electronic exchange of Closing deliveries, on a date which shall be no later than three business days after the satisfaction or waiver (subject to applicable law) of the latest to occur of the conditions set forth in Article VII hereof (other than those conditions that by their nature can only be satisfied at the Closing, but subject to the satisfaction or waiver thereof), unless another date, time or place is agreed to in writing by Hancock and Trustmark. The date on which the Closing occurs is referred to in this Agreement as the “Closing Date”.


1.3 Effective Time. Subject to the terms and conditions of this Agreement, on or before the Closing Date, the parties shall cause to be filed articles of merger (the “Articles of Merger”) as provided under the MBCA with the Secretary of State of the State of Mississippi (the “Mississippi Secretary”). The Merger shall become effective as of the date and time specified in the Articles of Merger in accordance with the relevant provisions of the MBCA, or at such other date and time as shall be provided by applicable law (such date and time, the “Effective Time”).

1.4 Effects of the Merger. At and after the Effective Time, the Merger shall have the effects set forth in the applicable provisions of the MBCA and this Agreement.

1.5 Conversion of Trustmark Common Stock. At the Effective Time, by virtue of the Merger and without any action on the part of Hancock, Trustmark, or the holder of any of the following securities:

(a) Subject to Section 2.2(e), each share of the common stock, no par value, of Trustmark issued and outstanding immediately prior to the Effective Time (“Trustmark Common Stock”), except for shares of Trustmark Common Stock owned by Trustmark or Hancock (in each case other than shares of Trustmark Common Stock (i) held in trust accounts, managed accounts, mutual funds and the like, or otherwise held in a fiduciary or agency capacity or (ii) held, directly or indirectly, in respect of debts previously contracted (collectively, the “Exception Shares”)) shall be converted, in accordance with the procedures set forth in this Agreement, into the right to receive, without interest, 0.7463 shares (the “Exchange Ratio” and such shares, the “Merger Consideration”) of the common stock, par value $3.33 per share, of Hancock (the “Hancock Common Stock”).

(b) All of the shares of Trustmark Common Stock converted into the right to receive the Merger Consideration pursuant to this Article I shall no longer be outstanding and shall automatically be cancelled and shall cease to exist as of the Effective Time, and each certificate (each, an “Old Certificate,” it being understood that any reference herein to “Old Certificate” shall be deemed to include both certificates and book-entry account statements relating to the ownership of shares of Trustmark Common Stock) previously representing any such shares of Trustmark Common Stock shall thereafter represent only the right to receive (i) the Merger Consideration, (ii) cash in lieu of a fractional share which the shares of Trustmark Common Stock represented by such Old Certificate have been converted into the right to receive pursuant to this Section 1.5 and Section 2.2(e), and (iii) any dividends or distributions which the holder thereof has the right to receive pursuant to Section 2.2, in each case without any interest thereon. Old Certificates previously representing shares of Trustmark Common Stock shall be exchanged for certificates or, at Hancock’s option, evidence of shares in book-entry form representing whole shares of Hancock Common Stock as set forth in Section 1.5(a) (together with any dividends or distributions with respect thereto and cash in lieu of fractional shares issued in consideration therefor) upon the surrender of such Old Certificates in accordance with Section 2.2, without any interest thereon. If, between the date of this Agreement and the Effective Time, the outstanding shares of Hancock Common Stock or Trustmark Common Stock

 

-2-


shall have been increased, decreased, changed into, or exchanged for a different number or kind of shares or securities, in any such case as a result of a reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split, or other similar change in capitalization, or there shall be any extraordinary dividend or extraordinary distribution, an appropriate and proportionate adjustment shall be made to the Exchange Ratio to give holders of Trustmark Common Stock the same economic effect as contemplated by this Agreement prior to such event; provided that nothing in this sentence shall be construed to permit Hancock or Trustmark to take any action with respect to its securities that is prohibited by the terms of this Agreement.

(c) Notwithstanding anything in this Agreement to the contrary, at the Effective Time, all shares of Trustmark Common Stock that are owned by Trustmark or Hancock (in each case other than the Exception Shares) immediately prior to the Effective Time shall be cancelled and shall cease to exist, and neither the Merger Consideration nor any other consideration shall be delivered in exchange therefor.

1.6 Hancock Common Stock. At and after the Effective Time, each share of Hancock Common Stock issued and outstanding immediately prior to the Effective Time shall remain issued and outstanding and shall not be affected by the Merger.

1.7 Treatment of Trustmark Equity Awards.

(a) At the Effective Time, each restricted stock unit award in respect of Trustmark Common Stock that vests solely based on service (a “Trustmark RSU Award”) and is unvested as of immediately prior to the Effective Time and is not a Trustmark Vested RSU Award or a Trustmark Director RSU Award (as defined below) (each, a “Trustmark Unvested RSU Award”) shall be assumed and converted into a restricted stock unit award in respect of Hancock Common Stock (an “Adjusted RSU Award”) with the same terms and conditions as were applicable under such Trustmark Unvested RSU Award immediately prior to the Effective Time (including vesting terms and termination protections) and relating to the number of shares of Hancock Common Stock equal to the product of (i) the number of shares of Trustmark Common Stock subject to such Trustmark Unvested RSU Award immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded to the nearest whole share of Hancock Common Stock.

(b) At the Effective Time, each Trustmark RSU Award that is (i) vested but remains outstanding (i.e., has not yet settled), or (ii) held by a non-employee director of Trustmark (each, a “Trustmark Director RSU Award”) and is outstanding as of immediately prior to the Effective Time (each through (i)-(ii), a “Trustmark Vested RSU Award”), shall be cancelled by virtue of the Merger and without any action on the part of the holder thereof, and in exchange therefor, the holder of such cancelled Trustmark Vested RSU Award will be entitled to receive (without interest), in consideration of the cancellation of such Trustmark Vested RSU Award, a number of shares of Hancock Common Stock equal to the product of (i) the number of shares of Trustmark Common Stock subject to such Trustmark Vested RSU Award immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, less applicable Tax withholdings pursuant to Section 2.2 required to be withheld with respect to such Trustmark Vested RSU Award, with cash paid in lieu of any fractional share, and the shares of Hancock

 

-3-


Common Stock and any cash in respect of such Trustmark Vested RSU Awards to be issued or paid by the Surviving Corporation on the first regular payroll date that covers a full payroll period commencing on or after the Closing Date; provided that the shares of Hancock Common Stock and any cash in respect of Trustmark Director RSU Awards will be issued or paid by the Surviving Corporation as soon as reasonably practicable, and in any event no later than, ten days after the Closing Date. Notwithstanding the foregoing, any payments contemplated by this Section 1.7(b) that constitute nonqualified deferred compensation subject to Section 409A of the Code and that are not permitted to be paid or settled in accordance with the timing set forth in the preceding sentence without triggering a Tax or penalty under Section 409A of the Code shall be made at the earliest time permitted under the terms of such award that will not trigger a Tax or penalty under Section 409A of the Code.

(c) At the Effective Time, each restricted stock unit award in respect of Trustmark Common Stock that is unvested and subject to performance-based vesting conditions as of immediately prior to the Effective Time (each, a “Trustmark PSU Award”) shall be assumed and converted into an Adjusted RSU Award with the same terms and conditions as were applicable under such Trustmark Unvested RSU Award immediately prior to the Effective Time (including vesting terms and termination protections, but excluding performance-based vesting conditions) and relating to the number of shares of Hancock Common Stock equal to the product of (i) the number of shares of Trustmark Common Stock subject to such Trustmark Unvested RSU Award immediately prior to the Effective Time based on the actual performance results through the end of the calendar quarter ending on or before the Effective Time determined by the Compensation Committee of the Board of Directors of Trustmark in good faith consultation with Hancock, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded to the nearest whole share of Hancock Common Stock.

(d) Promptly following the Effective Time, Hancock shall file a post-effective amendment to the S-4 or an effective registration statement on Form S-8 with respect to the Hancock Common Stock subject to the applicable Adjusted RSU Awards, as required.

(e) At or prior to the Effective Time, Trustmark, the Board of Directors of Trustmark and its Compensation Committee, as applicable, shall adopt any resolutions and take any actions that are necessary, for the treatment of the Trustmark RSU Awards and Trustmark PSU Awards (collectively, “Trustmark Equity Awards”) and to effectuate the provisions of this Section 1.7. As used herein, “Trustmark Stock Plan” means the Trustmark Stock and Incentive Compensation Plan, as amended and restated effective April 23, 2024.

1.8 Bylaws of Surviving Corporation. At the Effective Time, the bylaws of Hancock, as in effect immediately prior to the Effective Time, shall be the bylaws of the Surviving Corporation until thereafter amended in accordance with applicable law.

1.9 Tax Consequences. It is intended that each of the Merger and the Bank Merger shall qualify as a “reorganization” within the meaning of Section 368(a) of the Code, and that this Agreement is intended to be and is adopted as a plan of reorganization for purposes of Sections 354 and 361 of the Code and Treasury Regulations Section 1.368-2(g).

 

-4-


1.10 Bank Merger. Immediately following the Merger, Trustmark Bank, a Mississippi state-chartered bank and a wholly owned Subsidiary of Trustmark (“Trustmark Bank”), will merge (the “Bank Merger”) with and into Hancock Whitney Bank, a Mississippi state-chartered bank and a wholly owned Subsidiary of Hancock (“Hancock Whitney Bank”). Hancock Whitney Bank shall be the surviving entity in the Bank Merger and, following the Bank Merger, the separate corporate existence of Trustmark Bank shall cease. Promptly after the date of this Agreement, Hancock Whitney Bank and Trustmark Bank shall enter into an agreement and plan of merger in substantially the form attached hereto as Exhibit A (the “Bank Merger Agreement”). Each of Hancock and Trustmark shall approve the Bank Merger Agreement and the Bank Merger as the sole shareholder of Hancock Whitney Bank and Trustmark Bank, respectively. Prior to the Effective Time, Trustmark shall cause Trustmark Bank, and Hancock shall cause Hancock Whitney Bank, to execute such certificates or articles of merger and such other documents and certificates as are necessary to effectuate the Bank Merger (“Bank Merger Certificates”).

ARTICLE II

EXCHANGE OF SHARES

2.1 Hancock to Make Consideration Available. At or prior to the Effective Time, Hancock shall deposit, or shall cause to be deposited, with a bank or trust company designated by Hancock (the “Exchange Agent”), for the benefit of the holders of Old Certificates, (a) certificates or, at Hancock’s option, evidence in book-entry form, representing shares of Hancock Common Stock to be issued pursuant to Section 1.5 and exchanged pursuant to Section 2.2(a) in exchange for outstanding shares of Trustmark Common Stock (“New Certificates”), and (b) cash in an amount sufficient to pay cash in lieu of any fractional shares (such New Certificates and cash described in the foregoing clauses (a) and (b), together with any dividends or distributions with respect thereto payable in accordance with Section 2.2(b), being hereinafter referred to as the “Exchange Fund”).

2.2 Exchange of Shares.

(a) As promptly as practicable after the Effective Time, but in no event later than ten days thereafter, Hancock shall cause the Exchange Agent to mail to each holder of record of one or more Old Certificates representing shares of Trustmark Common Stock immediately prior to the Effective Time that have been converted at the Effective Time into the right to receive the Merger Consideration pursuant to Article I, a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title to the Old Certificates shall pass, only upon proper delivery of the Old Certificates to the Exchange Agent) and instructions for use in effecting the surrender of the Old Certificates in exchange for certificates representing the number of whole shares of Hancock Common Stock and any cash in lieu of fractional shares which the shares of Trustmark Common Stock represented by such Old Certificate or Old Certificates shall have been converted into the right to receive pursuant to this Agreement as well as any dividends or distributions to be paid pursuant to Section 2.2(b). From and after the Effective Time, upon proper surrender of an Old Certificate or Old Certificates for exchange and cancellation to the Exchange Agent, together with such properly completed letter of transmittal, duly executed, the holder of such Old Certificate or Old Certificates shall be entitled to receive in

 

-5-


exchange therefor, as applicable, (i) a New Certificate representing that number of whole shares of Hancock Common Stock to which such holder of Trustmark Common Stock shall have become entitled pursuant to the provisions of Article I and (ii) a check representing the amount of (A) any cash in lieu of a fractional share which such holder has the right to receive in respect of the Old Certificate or Old Certificates surrendered pursuant to the provisions of this Article II, and (B) any dividends or distributions which the holder thereof has the right to receive pursuant to this Section 2.2. No interest will be paid or accrued on the Hancock Common Stock or any cash in lieu of fractional shares or dividends or distributions payable to holders of Old Certificates. Until surrendered as contemplated by this Section 2.2, each Old Certificate shall be deemed at any time after the Effective Time to represent only the right to receive, upon surrender, the number of whole shares of Hancock Common Stock which the shares of Trustmark Common Stock represented by such Old Certificate have been converted into the right to receive and any cash in lieu of fractional shares or in respect of dividends or distributions as contemplated by this Section 2.2.

(b) No dividends or other distributions declared with respect to Hancock Common Stock shall be paid to the holder of any unsurrendered Old Certificate until the holder thereof shall surrender such Old Certificate in accordance with this Article II. After the surrender of an Old Certificate in accordance with this Article II, the record holder thereof shall be entitled to receive any such dividends or other distributions, without any interest thereon, which theretofore had become payable with respect to the whole shares of Hancock Common Stock which the shares of Trustmark Common Stock represented by such Old Certificate have been converted into the right to receive (after giving effect to Section 6.12).

(c) If any New Certificate representing shares of Hancock Common Stock is to be issued in a name other than that in which the Old Certificate or Old Certificates surrendered in exchange therefor is or are registered, it shall be a condition of the issuance thereof that the Old Certificate or Old Certificates so surrendered shall be properly endorsed (or accompanied by an appropriate instrument of transfer) and otherwise in proper form for transfer, and that the person requesting such exchange shall pay to the Exchange Agent in advance any transfer or other similar Taxes required by reason of the issuance of a New Certificate representing shares of Hancock Common Stock in any name other than that of the registered holder of the Old Certificate or Old Certificates surrendered, or required for any other reason, or shall establish to the satisfaction of the Exchange Agent that such Tax has been paid or is not payable.

(d) After the Effective Time, there shall be no transfers on the stock transfer books of Trustmark of the shares of Trustmark Common Stock that were issued and outstanding immediately prior to the Effective Time. If, after the Effective Time, Old Certificates representing such shares are presented for transfer to the Exchange Agent, they shall be cancelled and exchanged for New Certificates representing shares of Hancock Common Stock, cash in lieu of fractional shares and dividends or distributions that the holder presenting such Old Certificates is entitled to, as provided in this Article II.

 

-6-


(e) Notwithstanding anything to the contrary contained herein, no New Certificates or scrip representing fractional shares of Hancock Common Stock shall be issued upon the surrender for exchange of Old Certificates or otherwise pursuant to this Agreement, no dividend or distribution with respect to Hancock Common Stock shall be payable on or with respect to any fractional share, and such fractional share interests shall not entitle the owner thereof to vote or to any other rights of a shareholder of Hancock. In lieu of the issuance of any such fractional share, Hancock shall pay to each former holder who otherwise would be entitled to receive such fractional share an amount in cash (rounded to the nearest cent) determined by multiplying (i) the average of the closing sale prices of Hancock Common Stock on The Nasdaq Global Select Stock Market (“Nasdaq”) as reported by The Wall Street Journal for the five consecutive full trading days ending on the day preceding the Closing Date (the “Hancock Share Closing Price”) by (ii) the fraction of a share (after taking into account all shares of Trustmark Common Stock held by such holder immediately prior to the Effective Time and rounded to the nearest thousandth when expressed in decimal form) of Hancock Common Stock, rounded to the nearest whole cent, which such holder would otherwise be entitled to receive pursuant to Article I. The parties acknowledge that payment of such cash consideration in lieu of issuing fractional shares is not separately bargained-for consideration, but merely represents a mechanical rounding off for purposes of avoiding the expense and inconvenience that would otherwise be caused by the issuance of fractional shares.

(f) Any portion of the Exchange Fund that remains unclaimed by the holders of Trustmark Common Stock for one year after the Effective Time shall be paid to the Surviving Corporation. Any former holders of Trustmark Common Stock who have not theretofore exchanged their Old Certificates pursuant to this Article II shall thereafter look only to the Surviving Corporation for payment of the shares of Hancock Common Stock and cash in lieu of any fractional shares and any unpaid dividends and distributions on the Hancock Common Stock deliverable in respect of each former share of Trustmark Common Stock that such holder holds as determined pursuant to this Agreement, in each case, without any interest thereon. Notwithstanding the foregoing, none of Hancock, Trustmark, the Surviving Corporation, the Exchange Agent or any other person shall be liable to any former holder of shares of Trustmark Common Stock for any amount delivered in good faith to a public official pursuant to applicable abandoned property, escheat or similar laws.

(g) Hancock shall be entitled to deduct and withhold, or cause the Exchange Agent to deduct and withhold, from any cash in lieu of fractional shares of Hancock Common Stock, cash dividends or distributions payable pursuant to this Section 2.2 or any other amounts otherwise payable pursuant to this Agreement to any holder of Trustmark Common Stock or Trustmark Equity Awards such amounts as it is required to deduct and withhold with respect to the making of such payment or vesting or settlement of such Trustmark Equity Awards under the Code or any provision of state, local or foreign Tax law, which Taxes shall be satisfied by Hancock withholding the number of shares of Hancock Common Stock necessary to satisfy applicable withholding Taxes that would otherwise be issuable to the holder of a Trustmark Equity Award in respect of such Trustmark Equity Award. To the extent that amounts or shares of Hancock Common Stock, as applicable, are so withheld by Hancock or the Exchange Agent, as the case may be, and the applicable Taxes are paid over to the appropriate governmental authority, the withheld amounts or shares of Hancock Common Stock shall be treated for all purposes of this Agreement as having been paid or delivered to the holder of Trustmark Common Stock or Trustmark Equity Awards in respect of which the deduction and withholding was made by Hancock or the Exchange Agent, as the case may be. Notwithstanding anything herein to the contrary, any amounts payable in connection with the Closing in respect of any Trustmark Equity Award pursuant to Section 1.7, with respect to employee award holders of Trustmark and its Subsidiaries may be made through the payroll system of the Surviving Corporation or one of its Subsidiaries.

 

-7-


(h) In the event any Old Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming such Old Certificate to be lost, stolen or destroyed and, if required by Hancock or the Exchange Agent, the posting by such person of a bond in such amount as Hancock or the Exchange Agent may determine is reasonably necessary as indemnity against any claim that may be made against it with respect to such Old Certificate, the Exchange Agent will issue in exchange for such lost, stolen or destroyed Old Certificate the shares of Hancock Common Stock and any cash in lieu of fractional shares deliverable in respect thereof pursuant to this Agreement.

2.3 No Appraisal or Dissenters’ Rights. In accordance with Section 13.02(b) of the MBCA, no appraisal or dissenters’ rights will be available to the holders of Trustmark Common Stock in connection with the Merger.

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF TRUSTMARK

Except (a) as disclosed in the disclosure schedule delivered by Trustmark to Hancock concurrently herewith (the “Trustmark Disclosure Schedule”); provided that (i) no such item is required to be set forth as an exception to a representation or warranty if its absence would not result in the related representation or warranty being deemed untrue or incorrect, (ii) the mere inclusion of an item in the Trustmark Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission by Trustmark that such item represents a material exception or fact, event or circumstance or that such item is reasonably likely to result in a Material Adverse Effect, and (iii) any disclosures made with respect to a section of this Article III shall be deemed to qualify (A) any other section of this Article III specifically referenced or cross-referenced and (B) other sections of this Article III to the extent it is reasonably apparent on its face (notwithstanding the absence of a specific cross-reference) from a reading of the disclosure that such disclosure applies to such other sections, or (b) as disclosed in any Trustmark Reports publicly filed prior to the date hereof (but disregarding risk factor disclosures contained under the heading “Risk Factors,” or disclosures of risks set forth in any “forward-looking statements” disclaimer or any other statements that are similarly non-specific or cautionary, predictive or forward-looking in nature), Trustmark hereby represents and warrants to Hancock as follows:

3.1 Corporate Organization.

(a) Trustmark is a corporation duly organized, validly existing and in good standing under the laws of the State of Mississippi and is a bank holding company duly registered under the Bank Holding Company Act of 1956, as amended (“BHC Act”). Trustmark has the corporate power and authority to own, lease or operate all of its properties and assets and to carry on its business as it is now being conducted in all material respects. Trustmark is duly licensed or qualified to do business and in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned,

 

-8-


leased or operated by it makes such licensing, qualification or standing necessary, except where the failure to be so licensed or qualified or to be in good standing would not, either individually or in the aggregate, reasonably be likely to have a Material Adverse Effect on Trustmark. As used in this Agreement, the term “Material Adverse Effect” means, with respect to Hancock, Trustmark or the Surviving Corporation, as the case may be, any effect, change, event, circumstance, condition, occurrence or development that, either individually or in the aggregate, has had or would reasonably be likely to have a material adverse effect on (i) the business, properties, assets, liabilities, results of operations or financial condition of such party and its Subsidiaries, taken as a whole (provided, however, that Material Adverse Effect shall not be deemed to include the impact of or effects arising from (A) changes, after the date hereof, in U.S. generally accepted accounting principles (“GAAP”) or applicable regulatory accounting requirements or interpretations thereof, (B) changes, after the date hereof, in laws, rules or regulations of general applicability to companies in the industries in which such party and its Subsidiaries operate, or interpretations thereof by courts or Governmental Entities, (C) changes, after the date hereof, in global, national or regional political conditions (including the outbreak, continuation or escalation of war or acts of terrorism or cyberattacks) or in economic or market conditions (including equity, credit and debt markets, as well as changes in interest rates) affecting the financial services industry generally and not specifically relating to such party or its Subsidiaries, (D) any international tariffs, trade policies or similar “trade” actions, (E) changes, after the date hereof, resulting from hurricanes, earthquakes, tornados, floods, wildfires or other natural disasters or from any outbreak of any disease, epidemic, pandemic or other public health event, (F) public disclosure of the execution of this Agreement, public disclosure or consummation of the transactions contemplated hereby (including any effect on a party’s relationships with its customers or employees) (it being understood that the foregoing shall not apply for purposes of the representations and warranties in Sections 3.3(b), 3.4, 4.3(b) or 4.4) or actions expressly required by this Agreement or that are taken with the prior written consent of the other party in contemplation of the transactions contemplated hereby, or (G) a decline in the trading price of a party’s common stock or the failure, in and of itself, to meet earnings projections or internal financial forecasts, but not, in either case, including any underlying causes thereof; except, with respect to subclauses (A), (B), (C), (D) or (E), to the extent that the effects of such change are disproportionately adverse to the business, properties, assets, liabilities, results of operations or financial condition of such party and its Subsidiaries, taken as a whole, as compared to other companies in the industry in which such party and its Subsidiaries operate), or (ii) the ability of such party to timely consummate the transactions contemplated hereby. As used in this Agreement, the term “Subsidiary,” when used with respect to any person, means any corporation, partnership, limited liability company, bank or other organization, whether incorporated or unincorporated, which is consolidated with such person for financial reporting purposes. True and complete copies of the Articles of Incorporation of Trustmark (the “Trustmark Articles”) and the Amended and Restated Bylaws of Trustmark (the “Trustmark Bylaws”), as in effect as of the date of this Agreement, have previously been made available by Trustmark to Hancock.

(b) Except, in the case of clauses (ii) and (iii) only, as would not reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Trustmark, each Subsidiary of Trustmark (a “Trustmark Subsidiary”) (i) is duly organized and validly existing under the laws of its jurisdiction of organization, (ii) is duly licensed or qualified to do business and, where such concept is recognized under applicable law, in good standing in all jurisdictions

 

-9-


(whether federal, state, local or foreign) where its ownership, leasing or operation of property or the conduct of its business requires it to be so licensed or qualified or in good standing, and (iii) has all requisite corporate power and authority to own, lease or operate its properties and assets and to carry on its business as now conducted. There are no restrictions on the ability of any Subsidiary of Trustmark to pay dividends or distributions, except, in the case of a Subsidiary that is a regulated entity, for restrictions on dividends or distributions generally applicable to all such regulated entities. The deposit accounts of each Subsidiary of Trustmark that is an insured depository institution are insured by the Federal Deposit Insurance Corporation (the “FDIC”) through the Deposit Insurance Fund (as defined in Section 3(y) of the Federal Deposit Insurance Act of 1950) to the fullest extent permitted by law, all premiums and assessments required to be paid in connection therewith have been paid when due, and no proceedings for the termination of such insurance are pending or, to the knowledge of Trustmark, threatened. Section 3.1(b) of the Trustmark Disclosure Schedule sets forth a true and complete list of all Subsidiaries of Trustmark as of the date hereof.

3.2 Capitalization.

(a) The authorized capital stock of Trustmark consists of 250,000,000 shares of Trustmark Common Stock, and 20,000,000 shares of preferred stock, no par value. As of October 31, 2026, no shares of capital stock or other equity or voting securities of Trustmark are issued, reserved for issuance or outstanding, other than (i) 57,735,042 shares of Trustmark Common Stock issued and outstanding, (ii) 381,344 shares of Trustmark Common Stock reserved for issuance upon the settlement of outstanding Trustmark RSU Awards, (iii) 196,245 shares of Trustmark Common Stock reserved for issuance upon the settlement of outstanding Trustmark PSU Awards assuming that performance with respect thereto is achieved at the target level, (iv) 387,734 shares of Trustmark Common Stock reserved for issuance for future grants under the Trustmark Stock Plans, and (v) zero shares of Trustmark Common Stock held in treasury. As of the date of this Agreement, except as set forth in the immediately preceding sentence and for changes since October 31, 2026 resulting from the vesting or settlement of any Trustmark Equity Awards described in the immediately preceding sentence, there are no shares of capital stock or other voting securities or equity interests of Trustmark issued, reserved for issuance or outstanding. All of the issued and outstanding shares of Trustmark Common Stock have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights, with no personal liability attaching to the ownership thereof. No bonds, debentures, notes or other indebtedness that have the right to vote on any matters on which shareholders of Trustmark may vote are issued or outstanding. Except as set forth in Section 3.2(a) of the Trustmark Disclosure Schedule, as of the date of this Agreement, no trust preferred or subordinated debt securities of Trustmark are issued or outstanding. Other than Trustmark Equity Awards issued prior to the date of this Agreement as described in this Section 3.2(a), as of the date of this Agreement, there are no outstanding subscriptions, options, warrants, puts, calls, rights, exchangeable or convertible securities, or other commitments or agreements obligating Trustmark to issue, transfer, sell, purchase, redeem or otherwise acquire any such securities.

(b) There are no voting trusts, shareholder agreements, proxies or other agreements in effect pursuant to which Trustmark or any of the Trustmark Subsidiaries has a contractual or other obligation with respect to the voting or transfer of Trustmark Common Stock or other equity interests of Trustmark. Other than the Trustmark Equity Awards, no equity-based awards (including any cash awards where the amount of payment is determined in whole or in part based on the price of any capital stock of Trustmark or any of its Subsidiaries) are outstanding.

 

-10-


(c) Trustmark owns, directly or indirectly, all of the issued and outstanding shares of capital stock or other equity ownership interests of each of the Trustmark Subsidiaries, free and clear of any liens, pledges, charges, encumbrances and security interests whatsoever (“Liens”), and all of such shares or equity ownership interests are duly authorized and validly issued and are fully paid, nonassessable (except, with respect to Trustmark Subsidiaries that are insured depository institutions, as provided under 12 U.S.C. § 55 or any comparable provision of applicable state law) and free of preemptive rights, with no personal liability attaching to the ownership thereof. No Trustmark Subsidiary has or is bound by any outstanding subscriptions, options, warrants, calls, rights, commitments or agreements of any character calling for the purchase or issuance of any shares of capital stock or any other equity security of such Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of such Subsidiary.

3.3 Authority; No Violation.

(a) Trustmark has full corporate power and authority to execute and deliver this Agreement and, subject to the shareholder and other actions described below, to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the consummation of the Merger have been duly and validly approved by the Board of Directors of Trustmark. The Board of Directors of Trustmark has determined that the Merger, on the terms and conditions set forth in this Agreement, is advisable and in the best interests of Trustmark and its shareholders, and has directed that this Agreement and the transactions contemplated hereby be submitted to Trustmark’s shareholders for approval at a duly held meeting of such shareholders and has adopted a resolution to the foregoing effect. Except for the approval of this Agreement by the affirmative vote of the holders of a majority of the votes cast by holders of outstanding Trustmark Common Stock at the Trustmark Meeting (the “Requisite Trustmark Vote”), and the adoption and approval of the Bank Merger Agreement by Trustmark as the sole shareholder of Trustmark Bank, no other corporate proceedings on the part of Trustmark or Trustmark Bank are necessary to approve this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Trustmark and (assuming due authorization, execution and delivery by Hancock) constitutes a valid and binding obligation of Trustmark, enforceable against Trustmark in accordance with its terms (except in all cases as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium, reorganization or similar laws of general applicability relating to or affecting insured depository institutions or their parent companies or the rights of creditors generally and subject to general principles of equity (the “Enforceability Exceptions”)).

 

-11-


(b) Subject to the receipt of the Requisite Trustmark Vote, neither the execution and delivery of this Agreement by Trustmark nor the consummation by Trustmark of the transactions contemplated hereby, nor compliance by Trustmark with any of the terms or provisions hereof, will (i) violate any provision of the Trustmark Articles or the Trustmark Bylaws or comparable governing documents of any Trustmark Subsidiary, or (ii) assuming that the consents, approvals and filings referred to in Section 3.4 are duly obtained and/or made, (A) violate any law, statute, code, ordinance, rule, regulation, judgment, order, writ, decree or injunction applicable to Trustmark or any of its Subsidiaries or any of their respective properties or assets, or (B) violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of the respective properties or assets of Trustmark or any of its Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which Trustmark or any of its Subsidiaries is a party, or by which they or any of their respective properties or assets may be bound, except (in the case of clause (ii) above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or creations which, either individually or in the aggregate, would not reasonably be likely to have a Material Adverse Effect on Trustmark.

3.4 Consents and Approvals. Except for (a) the filing of any required applications, filings and notices, as applicable, with Nasdaq, (b) the filing of any required applications, filings and notices, as applicable, with the Board of Governors of the Federal Reserve System (the “Federal Reserve Board”) with respect to the Merger, the FDIC in connection with the Bank Merger, the Mississippi Department of Banking and Consumer Finance (“Mississippi Department of Banking”) in connection with the Bank Merger, and approval of such applications, filings and notices and expiration of any related waiting periods, (c) the filing of any required applications, filings or notices listed on Section 3.4 of the Trustmark Disclosure Schedule or Section 4.4 of the Hancock Disclosure Schedule and approval or non-objection, as applicable, of such applications, filings and notices, (d) the filing with the Securities and Exchange Commission (the “SEC”) of a proxy statement in definitive form relating to the meetings of the shareholders of each of Trustmark and Hancock to be held in connection with this Agreement and the transactions contemplated hereby (including any amendments or supplements thereto, the “Proxy Statement”), and of the registration statement on Form S-4 in which the Proxy Statement will be included as a prospectus, to be filed with the SEC by Hancock in connection with the transactions contemplated by this Agreement (the “S-4”) and declaration of effectiveness of the S-4, (e) the filing of the Articles of Merger with the Mississippi Secretary pursuant to the MBCA and the filing of the Bank Merger Certificates with the applicable Governmental Entities as required by applicable law, and (f) such filings and approvals as are required to be made or obtained under the securities or “Blue Sky” laws of various states in connection with the issuance of the shares of Hancock Common Stock pursuant to this Agreement, no consents or approvals of or filings or registrations with any court or administrative agency or commission or other governmental authority or instrumentality or SRO (each a “Governmental Entity”) are necessary in connection with (i) the execution and delivery by Trustmark of this Agreement or (ii) the consummation by Trustmark of the Merger and the other transactions contemplated hereby (including the Bank Merger). As used in this Agreement, “SRO” means (A) any “self-regulatory organization” as defined in Section 3(a)(26) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and (B) any other United States or foreign securities exchange, futures exchange, commodities exchange or contract market. As of the date hereof, Trustmark is not aware of any reason why the necessary regulatory approvals and consents will not be received in order to permit consummation of the Merger and Bank Merger on a timely basis.

 

-12-


3.5 Reports.

(a) Trustmark and each of its Subsidiaries have timely filed (or furnished, as applicable) all reports, registrations and statements, together with any amendments required to be made with respect thereto, that they were required to file (or furnish, as applicable) since January 1, 2023 with (i) any state regulatory authority, including the Mississippi Department of Banking, (ii) the SEC, (iii) the Federal Reserve Board, (iv) the FDIC, (v) the Office of the Comptroller of the Currency (the “OCC”), (vi) any foreign regulatory authority, and (vii) any SRO ((i) – (vii), collectively, the “Regulatory Agencies”), including any report, registration or statement required to be filed (or furnished, as applicable) pursuant to the laws, rules or regulations of the United States, any state, any foreign entity, or any Regulatory Agency, and have paid all fees and assessments due and payable in connection therewith, except where the failure to file such report, registration or statement or to pay such fees and assessments, either individually or in the aggregate, would not reasonably be likely to have a Material Adverse Effect on Trustmark. Subject to Section 9.7 and except for normal examinations conducted by a Regulatory Agency in the ordinary course of business of Trustmark and its Subsidiaries, no Regulatory Agency has initiated or has pending any proceeding or, to the knowledge of Trustmark, investigation into the business or operations of Trustmark or any of its Subsidiaries since January 1, 2023, except where such proceedings or investigations would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark. Subject to Section 9.7, there (A) is no unresolved violation, criticism, or exception by any Regulatory Agency with respect to any report or statement relating to any examinations or inspections of Trustmark or any of its Subsidiaries, and (B) has been no formal or informal inquiries by, or disagreements or disputes with, any Regulatory Agency with respect to the business, operations, policies or procedures of Trustmark or any of its Subsidiaries since January 1, 2023, in each case of clauses (A) and (B), which would reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark.

(b) An accurate and complete copy of each final registration statement, prospectus, report, schedule and definitive proxy statement filed with or furnished to the SEC by Trustmark or any of its Subsidiaries pursuant to the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, as the case may be, since January 1, 2023 (the “Trustmark Reports”) is publicly available. No such Trustmark Report, at the time filed, furnished or communicated (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings, respectively), contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances in which they were made, not misleading, except that information filed or furnished as of a later date (but before the date of this Agreement) shall be deemed to modify information as of an earlier date. As of their respective dates, all Trustmark Reports filed or furnished under the Securities Act and the Exchange Act complied in all material respects with the published rules and regulations of the SEC with respect thereto. As of the date of this Agreement, no executive officer of Trustmark has failed in any respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act. As of the date of this Agreement, there are no outstanding comments from or material unresolved issues raised by the SEC with respect to any of the Trustmark Reports.

 

-13-


3.6 Financial Statements.

(a) The financial statements of Trustmark and its Subsidiaries included (or incorporated by reference) in the Trustmark Reports (including the related notes, where applicable) (i) have been prepared from, and are in accordance with, the books and records of Trustmark and its Subsidiaries in all material respects, (ii) fairly present in all material respects the consolidated results of operations, cash flows, changes in shareholders’ equity and consolidated financial position of Trustmark and its Subsidiaries for the respective fiscal periods or as of the respective dates therein set forth (subject in the case of unaudited statements to year-end audit adjustments normal in nature and amount), (iii) complied, as of their respective dates of filing with the SEC, in all material respects with applicable accounting requirements and with the published rules and regulations of the SEC with respect thereto, and (iv) have been prepared in accordance with GAAP consistently applied during the periods involved, except, in each case, as indicated in such statements or in the notes thereto. The books and records of Trustmark and its Subsidiaries have been, since January 1, 2023, and are being, maintained in all material respects in accordance with GAAP and any other applicable legal and accounting requirements. Crowe LLP has not resigned (or informed Trustmark that it intends to resign) or been dismissed as independent public accountants of Trustmark as a result of or in connection with any disagreements with Trustmark on a matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure.

(b) Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark, neither Trustmark nor any of its Subsidiaries has any liability of any nature whatsoever (whether absolute, accrued, contingent or otherwise and whether due or to become due) required by GAAP to be included on a consolidated balance sheet of Trustmark, except for those liabilities that are reflected or reserved against on the consolidated balance sheet of Trustmark included in its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026 (including any notes thereto) and for liabilities incurred in the ordinary course of business consistent with past practice since June 30, 2026, or in connection with this Agreement and the transactions contemplated hereby.

(c) The records, systems, controls, data and information of Trustmark and its Subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and direct control of Trustmark or its Subsidiaries or its accountants (including all means of access thereto and therefrom), except for any non-exclusive ownership and non-direct control that would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark. Trustmark (i) has implemented and maintains disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) to ensure that material information relating to Trustmark, including its Subsidiaries, is made known to the Chief Executive Officer and the Chief Financial Officer of Trustmark by others within those entities as appropriate to allow timely decisions regarding required disclosures and to make the certifications required by the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), and (ii) has disclosed, based on its

 

-14-


most recent evaluation prior to the date hereof, to Trustmark’s outside auditors and the Audit Committee of Trustmark’s Board of Directors (A) any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) which are reasonably likely to adversely affect Trustmark’s ability to record, process, summarize and report financial information, and (B) to the knowledge of Trustmark, any fraud, whether or not material, that involves management or other employees who have a significant role in Trustmark’s internal controls over financial reporting. These disclosures were made in writing by management to Trustmark’s auditors and Audit Committee and true, correct and complete copies of such disclosures have been made available to Hancock. To the knowledge of Trustmark, there is no reason to believe that Trustmark’s outside auditors and its Chief Executive Officer and Chief Financial Officer will not be able to give the certifications and attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act, without qualification, when next due.

(d) Since January 1, 2023, (i) neither Trustmark nor any of its Subsidiaries, nor, to the knowledge of Trustmark, any director, officer, auditor, accountant or representative of Trustmark or any of its Subsidiaries, has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or, to the knowledge of Trustmark, oral, regarding the accounting or auditing practices, procedures, methodologies or methods (including with respect to loan loss reserves, write-downs, charge-offs and accruals) of Trustmark or any of its Subsidiaries or their respective internal accounting controls, including any material complaint, allegation, assertion or written claim that Trustmark or any of its Subsidiaries has engaged in questionable accounting or auditing practices, and (ii) no employee of or attorney representing Trustmark or any of its Subsidiaries, whether or not employed or retained by Trustmark or any of its Subsidiaries, has reported evidence of a material violation of securities laws, breach of fiduciary duty or similar violation by Trustmark or any of its Subsidiaries or any of their respective officers, directors, employees or agents to the Board of Directors of Trustmark or any committee thereof or similar governing body of any Trustmark Subsidiary or any committee thereof, or, to the knowledge of Trustmark, to any director or officer of Trustmark or any Trustmark Subsidiary.

3.7 Broker’s Fees. Neither Trustmark nor any Trustmark Subsidiary nor any of their respective officers or directors has employed any broker, finder or financial advisor or incurred any liability for any broker’s fees, commissions or finder’s fees in connection with the Merger or related transactions contemplated by this Agreement other than Goldman Sachs & Co. LLC.

3.8 Absence of Certain Changes or Events.

(a) Since December 31, 2025, there has not been any effect, change, event, circumstance, condition, occurrence or development that has had or would reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark.

(b) Since December 31, 2025 through the date of this Agreement, except with respect to the transactions contemplated hereby, Trustmark and its Subsidiaries have carried on their respective businesses in all material respects in the ordinary course.

 

-15-


3.9 Legal Proceedings.

(a) Neither Trustmark nor any of its Subsidiaries is a party to any, and there are no pending or, to the knowledge of Trustmark, threatened, material legal, administrative, arbitral or other proceedings, claims, actions or governmental or regulatory investigations of any nature against Trustmark or any of its Subsidiaries or any of their current or former directors or executive officers of a material nature challenging the validity or propriety of this Agreement or the transactions contemplated hereby.

(b) There is no material injunction, order, judgment, decree, or regulatory restriction imposed upon Trustmark, any of its Subsidiaries or the assets of Trustmark or any of its Subsidiaries (or that, upon consummation of the Merger, would apply to the Surviving Corporation or any of its affiliates).

3.10 Taxes and Tax Returns.

(a) Each of Trustmark and its Subsidiaries has duly and timely filed (taking into account all applicable extensions) all material Tax Returns in all jurisdictions in which Tax Returns are required to be filed by it, and all such Tax Returns are true, correct, and complete in all material respects. Neither Trustmark nor any of its Subsidiaries is the beneficiary of any extension of time within which to file any material Tax Return. All material Taxes of Trustmark and its Subsidiaries (whether or not shown on any Tax Returns) that are due have been fully and timely paid. Each of Trustmark and its Subsidiaries has withheld and paid all material Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee, creditor, shareholder, independent contractor or other third party. Neither Trustmark nor any of its Subsidiaries has granted any extension or waiver of the limitation period applicable to any material Tax that remains in effect. The federal income Tax Returns of Trustmark and its Subsidiaries for all years up to and including the tax year ended December 31, 2020 have been examined by the Internal Revenue Service (the “IRS”) or are Tax Returns with respect to which the applicable period for assessment under applicable law, after giving effect to extensions or waivers, has expired. No deficiency with respect to a material amount of Taxes has been proposed, asserted or assessed against Trustmark or any of its Subsidiaries. There are no pending or threatened (in writing) disputes, claims, audits, examinations or other proceedings regarding any material Taxes of Trustmark and its Subsidiaries or the assets of Trustmark and its Subsidiaries. In the last six years, neither Trustmark nor any of its Subsidiaries has been informed in writing by any jurisdiction that the jurisdiction believes that Trustmark or any of its Subsidiaries was required to file any Tax Return that was not filed. Trustmark has made available to Hancock true, correct, and complete copies of any private letter ruling requests, closing agreements or gain recognition agreements with respect to Taxes requested or executed in the last six years. There are no Liens for material Taxes (except Taxes not yet due and payable) on any of the assets of Trustmark or any of its Subsidiaries. Neither Trustmark nor any of its Subsidiaries is a party to or is bound by any Tax sharing, allocation or indemnification agreement or arrangement (other than such an agreement or arrangement (i) exclusively between or among Trustmark and its Subsidiaries or (ii) contained in a commercial agreement the primary purpose of which does not relate to Taxes). Neither Trustmark nor any of its Subsidiaries (A) has been a member of an affiliated group filing a consolidated federal income Tax Return (other than a group the common parent of which was Trustmark), or (B) has any liability for the Taxes

 

-16-


of any person (other than Trustmark or any of its Subsidiaries) under Treasury Regulations Section 1.1502-6 (or any similar provision of state, local or foreign law), as a transferee or successor, by contract or otherwise. Neither Trustmark nor any of its Subsidiaries has been, within the past two years or otherwise as part of a “plan (or series of related transactions)” within the meaning of Section 355(e) of the Code of which the Merger is also a part, a “distributing corporation” or a “controlled corporation” (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of stock intended to qualify for tax-free treatment under Section 355 of the Code. Neither Trustmark nor any of its Subsidiaries has participated in a “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4(b)(2). At no time during the past five years has Trustmark been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code.

(b) As used in this Agreement, the term “Tax” or “Taxes” means all federal, state, local, and foreign income, excise, gross receipts, ad valorem, profits, gains, property, capital, sales, transfer, use, license, payroll, employment, social security, severance, unemployment, withholding, duties, excise, windfall profits, intangibles, franchise, backup withholding, value added, alternative or add-on minimum, estimated and other taxes, charges, fees, levies or like assessments together with all penalties and additions to tax and interest thereon.

(c) As used in this Agreement, the term “Tax Return” means any return, declaration, report, claim for refund, estimate, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof, supplied or required to be supplied to a Governmental Entity.

3.11 Employees and Employee Benefit Plans.

(a) Section 3.11(a) of the Trustmark Disclosure Schedule sets forth a true, and complete list of all Trustmark Benefit Plans. For purposes of this Agreement, “Trustmark Benefit Plans” means all employee benefit plans (as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”)), whether or not subject to ERISA, and all bonus, stock option, stock purchase, restricted stock, incentive, deferred compensation, retiree medical or life insurance, supplemental retirement, severance or other compensation or benefit plans, programs or arrangements, and all retention, bonus, employment, termination or severance plans, programs or arrangements or other contracts or agreements to or with respect to which Trustmark or any Subsidiary or any trade or business of Trustmark or any of its Subsidiaries, whether or not incorporated, all of which together with Trustmark would be deemed a “single employer” within the meaning of Section 4001 of ERISA (a “Trustmark ERISA Affiliate”), is a party or has any current or future obligation or that are maintained, contributed to or sponsored by Trustmark or any of its Subsidiaries or any Trustmark ERISA Affiliate, or to which Trustmark or any of its Subsidiaries is required or obligated to maintain, contribute to or sponsor, for the benefit of any current or former employee, officer, director or independent contractor of Trustmark or any of its Subsidiaries or any Trustmark ERISA Affiliate.

 

-17-


(b) Trustmark has heretofore made available to Hancock true and complete copies of (or, to the extent no such copy exists, a written description of) each of the material Trustmark Benefit Plans and the following related documents, to the extent applicable: (i) all summary plan descriptions, amendments, modifications or material supplements to any Trustmark Benefit Plan, and any related trust agreement, insurance contract or other funding vehicle documents, (ii) the annual report (Form 5500), if any, filed with the IRS for the last two plan years, (iii) the most recently received IRS determination or opinion letter, if any, relating to any such Trustmark Benefit Plan, (iv) the most recently prepared audited financial statement and actuarial report for each such Trustmark Benefit Plan (if applicable) for each of the last two years, and (v) all material non-routine filings and correspondence made with, received from or sent to any Governmental Entity in the last two years.

(c) Each Trustmark Benefit Plan and any trust related thereto has been established, operated, maintained and administered in all respects in accordance with its terms and the requirements of all applicable laws, including ERISA and the Code, except for such noncompliance as would not result in any material liability to Trustmark or its Subsidiaries.

(d) Section 3.11(d) of the Trustmark Disclosure Schedule identifies each Trustmark Benefit Plan that is intended to be qualified under Section 401(a) of the Code (the “Trustmark Qualified Plans”). The IRS has issued a favorable determination or opinion letter with respect to each Trustmark Qualified Plan and the related trust, which letter has not been revoked (nor has revocation been threatened), and, to the knowledge of Trustmark, there are no existing circumstances and no events have occurred that would have a material adverse effect on the qualified status of any Trustmark Qualified Plan or the related trust or increase the costs relating thereto.

(e) Except as set forth on Section 3.11(e) of the Trustmark Disclosure Schedule, no Trustmark Benefit Plan is subject to Title IV or Section 302 of ERISA or Section 412 or 4971 of the Code, and, none of Trustmark and its Subsidiaries nor any Trustmark ERISA Affiliate has, at any time during the last six years, maintained, sponsored, contributed to or been obligated to contribute to any plan that is subject to Title IV or Section 302 of ERISA or Section 412 or 4971 of the Code. Except as would not result in any material liability to Trustmark or its Subsidiaries, with respect to each Trustmark Benefit Plan that is subject to Title IV or Section 302 of ERISA or Section 412, 430 or 4971 of the Code: (i) no such plan is in “at-risk” status for purposes of Section 430 of the Code, (ii) no reportable event within the meaning of Section 4043(c) of ERISA for which the 30-day notice requirement has not been waived has occurred, (iii) all premiums required to be paid to the PBGC have been timely paid in full, (iv) no material liability (other than for premiums to the PBGC) under Title IV of ERISA has been or is reasonably expected to be incurred by Hancock or any of its Subsidiaries, (v) the PBGC has not instituted proceedings to terminate any such Trustmark Benefit Plan, (vi) to the knowledge of Trustmark, the most recent actuarial report for such Trustmark Benefit Plan is accurate in all material respects, and (vii) there does not exist any accumulated funding deficiency within the meaning of Section 412 of the Code or Section 302 of ERISA, whether or not waived.

(f) None of Trustmark and its Subsidiaries nor any Trustmark ERISA Affiliate maintains, sponsors or contributes to or has, at any time during the last six years, maintained, sponsored, contributed to or been obligated to contribute to any plan that is a “multiemployer plan” within the meaning of Section 4001(a)(3) of ERISA (a “Multiemployer Plan”) or a plan that has two or more contributing sponsors at least two of whom are not under

 

-18-


common control, within the meaning of Section 4063 of ERISA (a “Multiple Employer Plan”), and none of Trustmark and its Subsidiaries nor any Trustmark ERISA Affiliate has incurred any material liability to a Multiemployer Plan or Multiple Employer Plan as a result of a complete or partial withdrawal (as those terms are defined in Part I of Subtitle E of Title IV of ERISA) from a Multiemployer Plan or Multiple Employer Plan that has not been satisfied in full.

(g) Neither Trustmark nor any of its Subsidiaries sponsors, has sponsored or has any obligation with respect to any employee benefit plan that provides for any post-employment or post-retirement health or medical or life insurance benefits for retired or former employees or beneficiaries or dependents thereof, except as required by Section 4980B of the Code.

(h) All material contributions required to be made to any Trustmark Benefit Plan by applicable law or by any plan document or other contractual undertaking, and all material premiums due or payable with respect to insurance policies funding any Trustmark Benefit Plan, since January 1, 2023, have been timely made or paid in full or, to the extent not required to be made or paid on or before the date hereof, have been fully accrued in accordance with GAAP and reflected on the financial statements of Trustmark.

(i) There are no pending or, to the knowledge of Trustmark, threatened (in writing) claims (other than claims for benefits in the ordinary course), governmental investigations, audits, lawsuits or arbitrations that have been asserted or instituted, and, to the knowledge of Trustmark, no set of circumstances exists that may reasonably be likely to give rise to a material claim or lawsuit, against the Trustmark Benefit Plans, any fiduciaries thereof with respect to their duties to the Trustmark Benefit Plans or the assets of any of the trusts under any of the Trustmark Benefit Plans that could in any case reasonably be likely to result in any material liability of Trustmark or any of its Subsidiaries to the Pension Benefit Guaranty Corporation (the “PBGC”), the IRS, the Department of Labor, any defined benefit pension plan, any Multiemployer Plan, a Multiple Employer Plan, any participant in a Trustmark Benefit Plan, or any other party.

(j) None of Trustmark or its Subsidiaries nor any Trustmark ERISA Affiliate nor, to the knowledge of Trustmark, any other person, including any fiduciary, has engaged in any “prohibited transaction” (as defined in Section 4975 of the Code or Section 406 of ERISA) which could subject any of the Trustmark Benefit Plans or their related trusts, Trustmark, any of its Subsidiaries, any Trustmark ERISA Affiliate or any person that Trustmark or any of its Subsidiaries has an obligation to indemnify to any material tax or material penalty imposed under Section 4975 of the Code or Section 502 of ERISA.

(k) Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will (either alone or in conjunction with any other event) (i) entitle any employee, officer, director or independent contractor of Trustmark or any of its Subsidiaries to any payment or benefit, including severance pay, unemployment compensation, accrued pension benefit, or a change in control bonus or retention payment, (ii) result in, accelerate, cause the vesting, exercisability, funding, payment or delivery of, or increase the amount or value of, any payment, right or other benefit to any employee, officer, director or independent contractor of Trustmark or any of its Subsidiaries, (iii) accelerate

 

-19-


the timing of or trigger any funding obligation under a rabbi trust or similar funding vehicle under any Trustmark Benefit Plan, or (iv) result in any limitation on the right of Trustmark or any of its Subsidiaries or Trustmark ERISA Affiliates to amend, merge, terminate or receive a reversion of assets from any Trustmark Benefit Plan or related trust. Each asset held under each Trustmark Benefit Plan may be liquidated or terminated without the imposition of any redemption fee, surrender charge, mark-to-market adjustments or comparable liability, other than ordinary administration expenses. Without limiting the generality of the foregoing, no amount paid or payable (whether in cash, in property, or in the form of benefits) by Trustmark or any of its Subsidiaries in connection with the transactions contemplated hereby (either solely as a result thereof or as a result of such transactions in conjunction with any other event) will be an “excess parachute payment” within the meaning of Section 280G of the Code.

(l) No Trustmark Benefit Plan provides for the gross-up or reimbursement of Taxes under Section 409A or 4999 of the Code or otherwise.

(m) No Trustmark Benefit Plan is maintained outside of the United States or primarily for the benefit of individuals who perform services outside of the United States.

(n) Each Trustmark Benefit Plan that is a “nonqualified deferred compensation plan” (within the meaning of Section 409A of the Code) is in documentary compliance with, and has been operated and administered in all material respects in compliance with, Section 409A of the Code.

(o) Each Trustmark Benefit Plan that is an employee welfare benefit plan under Section 3(1) of ERISA is either (i) funded through an insurance company contract and is not a “welfare benefit fund” with the meaning of Section 419 of the Code or (ii) unfunded.

(p) There are no pending or, to the knowledge of Trustmark, threatened (in writing) material labor grievances or material unfair labor practice claims or charges against Trustmark or any of its Subsidiaries, or any strikes or other labor disputes against Trustmark or any of its Subsidiaries. Neither Trustmark nor any of its Subsidiaries are party to or bound by any collective bargaining or similar agreement with any labor union, works council or similar labor organization, or work rules or practices agreed to with any labor organization or employee association applicable to employees of Trustmark or any of its Subsidiaries, and, to the knowledge of Trustmark, there are no organizing efforts by any union or other group seeking to represent any employees of Trustmark or any of its Subsidiaries.

(q) Trustmark and its Subsidiaries are in compliance in all material respects with, and since January 1, 2023 have complied in all material respects with, all laws regarding employment and employment practices, terms and conditions of employment, wages and hours, plant closing notification, classification of employees and independent contractors, equitable pay practices, privacy right, labor disputes, employment discrimination, sexual harassment or discrimination, workers’ compensation or long-term disability policies, retaliation, immigration, family and medical leave, occupational safety and health and other laws in respect of any reduction in force (including notice, information and consultation requirements).

 

-20-


(r) (i) To the knowledge of Trustmark, no written allegations of sexual harassment, sexual misconduct or discrimination have been made in the past five years against any person who is a current or former member of the Board of Directors of Trustmark, a current or former Section 16 officer or any employee at or above job level of grade 19 (a “Senior Employee”), (ii) in the past five years neither Trustmark nor any of its Subsidiaries has entered into any settlement agreement related to allegations of sexual harassment, sexual misconduct or discrimination by any current or former member of the Board of Directors of Trustmark, any current or former Section 16 officer or any Senior Employee, and (iii) there are no proceedings currently pending or, to the knowledge of Trustmark, threatened related to any allegations of sexual harassment, sexual misconduct or discrimination by any current or former member of the Board of Directors of Trustmark, any current or former Section 16 officer or any Senior Employee.

(s) All service providers of Trustmark and its Subsidiaries perform services in the United States and neither Trustmark nor any of its Subsidiaries is subject to any non-U.S. labor or employment Laws with respect to its employees.

(t) Trustmark and its Subsidiaries have complied in all material respects with the Immigration Reform and Control Act of 1986 and all other applicable immigration laws, including with respect to the completion, retention and updating of Form I-9 (“Employment Eligibility Verification”) for each employee and, to the knowledge of Trustmark, all employees of Trustmark and its Subsidiaries are lawfully authorized to work in the United States. Trustmark and its Subsidiaries are enrolled in, and have complied in all material respects with, the U.S. Department of Homeland Security’s E-Verify program and all applicable state Laws requiring participation therein.

3.12 Compliance with Applicable Law.

(a) Trustmark and each of its Subsidiaries hold, and have at all times since January 1, 2023 held, all licenses, franchises, permits and authorizations necessary for the lawful conduct of their respective businesses and ownership of their respective properties, rights and assets under and pursuant to each (and have paid all fees and assessments due and payable in connection therewith), except where neither the cost of failure to hold nor the cost of obtaining and holding such license, franchise, permit or authorization (nor the failure to pay any fees or assessments) would, either individually or in the aggregate, reasonably be likely to have a Material Adverse Effect on Trustmark, and to the knowledge of Trustmark no suspension or cancellation of any such necessary license, franchise, permit or authorization is threatened.

(b) Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark, Trustmark and each of its Subsidiaries have complied with and are not in default or violation under any law, statute, order, rule, regulation, policy or guideline of any Governmental Entity applicable to Trustmark or any of its Subsidiaries, including (to the extent applicable to Trustmark or its Subsidiaries) all laws related to data protection or privacy (including laws relating to the privacy and security of data or information that constitutes personal data or personal information under applicable law (“Personal Data”)), the USA PATRIOT Act, the Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation B, the Fair Housing Act, the Community Reinvestment Act, the Fair Credit

 

-21-


Reporting Act and Regulation V, the Truth in Lending Act and Regulation Z, the Home Mortgage Disclosure Act and Regulation C, the Fair Debt Collection Practices Act, the Electronic Fund Transfer Act and Regulation E, the Dodd-Frank Wall Street Reform and Consumer Protection Act, any regulations promulgated by the Consumer Financial Protection Bureau, the Interagency Policy Statement on Retail Sales of Nondeposit Investment Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement Procedures Act and Regulation X, Title V of the Gramm-Leach-Bliley Act, any and all sanctions or regulations enforced by the Office of Foreign Assets Control of the United States Department of Treasury and any other law or regulation relating to bank secrecy, discriminatory lending, financing or leasing practices, money laundering prevention, Sections 23A and 23B of the Federal Reserve Act and Regulation W, the Sarbanes-Oxley Act, and all agency requirements relating to the origination, sale and servicing of mortgage and consumer loans.

(c) Trustmark Bank has a Community Reinvestment Act rating of “satisfactory” or better as of its most recently completed Community Reinvestment Act examination.

(d) Trustmark maintains a written information privacy and security program that maintains reasonable measures to protect the privacy, confidentiality and security of all Personal Data against any (i) loss or misuse of Personal Data, (ii) unauthorized or unlawful operations performed upon Personal Data, or (iii) other act or omission that compromises the security or confidentiality of Personal Data.

(e) None of Trustmark or any of its Subsidiaries, or to the knowledge of Trustmark, any director, officer, employee, agent or other person acting on behalf of Trustmark or any of its Subsidiaries has, directly or indirectly, (i) used any funds of Trustmark or any of its Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic governmental officials or employees or to foreign or domestic political parties or campaigns from funds of Trustmark or any of its Subsidiaries, (iii) violated any provision that would result in the violation of the Foreign Corrupt Practices Act of 1977, as amended, or any similar law, (iv) established or maintained any unlawful fund of monies or other assets of Trustmark or any of its Subsidiaries, (v) made any fraudulent entry on the books or records of Trustmark or any of its Subsidiaries, or (vi) made any unlawful bribe, unlawful rebate, unlawful payoff, unlawful influence payment, unlawful kickback or other unlawful payment to any person, private or public, regardless of form, whether in money, property or services, to obtain favorable treatment in securing business, to obtain special concessions for Trustmark or any of its Subsidiaries, to pay for favorable treatment for business secured or to pay for special concessions already obtained for Trustmark or any of its Subsidiaries, or is currently subject to any United States sanctions administered by the Office of Foreign Assets Control of the United States Treasury Department, except in each case as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark.

(f) As of the date hereof, Trustmark and Trustmark Bank maintain regulatory capital ratios that exceed the levels established for “well capitalized” institutions (under the relevant regulatory capital regulation of the institution’s primary bank regulator) and, as of the date hereof, neither Trustmark nor any of its Subsidiaries has received any notice from a Governmental Entity that its status as “well-capitalized” or that Trustmark Bank’s Community Reinvestment Act rating will change within one year from the date of this Agreement.

 

-22-


(g) Except as would not, either individually or in the aggregate, reasonably be likely to have a Material Adverse Effect on Trustmark, (i) Trustmark and each of its Subsidiaries have properly administered all accounts for which it acts as a fiduciary, including accounts for which it serves as a trustee, agent, custodian, personal representative, guardian, conservator or investment advisor, in accordance with the terms of the governing documents and applicable state, federal and foreign law; and (ii) none of Trustmark, any of its Subsidiaries, or any of its or its Subsidiaries’ directors, officers or employees, has committed any breach of trust or fiduciary duty with respect to any such fiduciary account, and the accountings for each such fiduciary account are true and correct and accurately reflect the assets and results of such fiduciary account.

3.13 Certain Contracts.

(a) As of the date hereof, neither Trustmark nor any of its Subsidiaries is a party to or bound by any contract, arrangement, commitment or understanding (whether written or oral, but excluding any Trustmark Benefit Plan):

(i) which is a “material contract” (as such term is defined in Item 601(b)(10) of Regulation S-K of the SEC);

(ii) which contains a provision that materially restricts the conduct of any line of business by Trustmark or any of its Subsidiaries or upon consummation of the Merger will materially restrict the ability of the Surviving Corporation or any of its Subsidiaries to (x) engage in any line of business or in any geographic region or (y) solicit any customer, client or employee of any person in any jurisdiction (other than, in the case of this clause (y), contracts with vendors or restrictions on soliciting employees arising under confidentiality or non-disclosure entered into by Trustmark or any of its Subsidiaries in the ordinary course of business);

(iii) which is a collective bargaining agreement or similar agreement with any labor organization;

(iv) (A) that is an agreement for the incurrence of indebtedness by Trustmark or any of its Subsidiaries, including any debt for borrowed money, obligations evidenced by notes, debentures or similar instruments, sale and leaseback transactions, capitalized or finance leases and other similar financing arrangements (other than deposit liabilities, trade payables, federal funds purchased, advances and loans from the Federal Home Loan Bank and securities sold under agreements to repurchase, in each case, incurred in the ordinary course of business consistent with past practice), or (B) that provides for the guarantee, support, indemnification, assumption or endorsement by Trustmark or any of its Subsidiaries of, or any similar commitment by Trustmark or any of its Subsidiaries with respect to, the obligations, liabilities or indebtedness of any other person, in the case of each of clauses (A) and (B), in an amount that can reasonably be expected to exceed $5,000,000;

 

-23-


(v) that (A) grants any right of first refusal, right of first offer or similar right with respect to any material assets, rights or properties of Trustmark or its Subsidiaries, taken as a whole, or (B) includes any exclusivity or exclusive dealing provisions;

(vi) which creates future payment obligations in excess of $1,000,000 per annum (other than any such contracts which are terminable by Trustmark or any of its Subsidiaries on 60 days or less notice without any required payment or other conditions, other than the condition of notice), other than extensions of credit, other customary banking products offered by Trustmark or its Subsidiaries, or derivatives issued or entered into in the ordinary course of business consistent with past practice;

(vii) that is a joint venture or other material partnership agreement or arrangement;

(viii) that is a settlement, consent or similar agreement and contains any material continuing obligations imposed upon Trustmark or any of its Subsidiaries;

(ix) pursuant to which (A) Trustmark or any of its Subsidiaries grant to any other person any license, covenant not to sue, release or similar right under or with respect to any Intellectual Property material to their business, taken as a whole, other than non-exclusive licenses granted in the ordinary course of business consistent with past practice to (1) service providers acting on their behalf, (2) customers or end users for their use of Trustmark’s or its Subsidiaries’ products or services, or (3) other persons where such license is incidental to a commercial agreement, the primary purpose of which is not the licensing of Intellectual Property, and which licensed rights are not material to Trustmark’s and its Subsidiaries’ business, taken as a whole, or (B) Trustmark or any of its Subsidiaries receive any license, covenant not to sue, release or similar right under or with respect to any Intellectual Property material to their business, taken as a whole, other than non-exclusive licenses for (1) commercially available, off-the-shelf software or information technology services, (2) for open source software which license is approved by the Open Source Initiative, or (3) Intellectual Property where such license is incidental to a commercial agreement, the primary purpose of which is not the licensing of Intellectual Property, and which licensed rights are not material to Trustmark’s and its Subsidiaries’ business, taken as a whole; or

(x) that relates to the acquisition or disposition of any person, business or asset and under which Trustmark or its Subsidiaries have or may have ongoing obligations or liabilities that are material to Trustmark and its Subsidiaries, taken as a whole.

Each contract, arrangement, commitment or understanding of the type described in this Section 3.13(a), whether or not set forth in the Trustmark Disclosure Schedule, is referred to herein as a “Trustmark Contract,” and neither Trustmark nor any of its Subsidiaries knows of, or has received written, or to the knowledge of Trustmark, oral notice of, any violation of any Trustmark Contract by any of the other parties thereto which would reasonably be likely to be, either individually or in the aggregate, material to Trustmark and its Subsidiaries, taken as a whole. Trustmark has made available to Hancock true, correct and complete copies of each Trustmark Contract in effect as of the date hereof.

 

-24-


(b) In each case, except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark: each Trustmark Contract is valid and binding on Trustmark or one of its Subsidiaries, as applicable, and in full force and effect, Trustmark and each of its Subsidiaries has performed all obligations required to be performed by it prior to the date hereof under each Trustmark Contract, to the knowledge of Trustmark each third-party counterparty to each Trustmark Contract has performed all obligations required to be performed by it to date under such Trustmark Contract, and no event or condition exists which constitutes or, after notice or lapse of time or both, will constitute, a default on the part of Trustmark or any of its Subsidiaries or, to the knowledge of Trustmark, any counterparty thereto, under any such Trustmark Contract.

3.14 Agreements with Regulatory Agencies. Subject to Section 9.7, neither Trustmark nor any of its Subsidiaries is subject to any cease-and-desist or other order or enforcement action issued by, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party to any commitment letter or similar undertaking to, or is subject to any order or directive by, or has been ordered to pay any civil money penalty by, or has been since January 1, 2023, a recipient of any supervisory letter from, or since January 1, 2023, has adopted any policies, procedures or board resolutions at the request of any Regulatory Agency or other Governmental Entity that currently restricts in any material respect or would reasonably be expected to restrict in any material respect the conduct of its business or that in any material manner relates to its capital adequacy, its ability to pay dividends, its credit or risk management policies, its management or its business (each, whether or not set forth in the Trustmark Disclosure Schedule, a “Trustmark Regulatory Agreement”), nor has Trustmark or any of its Subsidiaries been advised in writing or, to the knowledge of Trustmark, orally, since January 1, 2023, by any Regulatory Agency or other Governmental Entity that it is considering issuing, initiating, ordering, or requesting any such Trustmark Regulatory Agreement.

3.15 Risk Management Instruments. Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark, all interest rate swaps, caps, floors, option agreements, futures and forward contracts and other similar derivative transactions and risk management arrangements, whether entered into for the account of Trustmark or any of its Subsidiaries or for the account of a customer of Trustmark or one of its Subsidiaries, were entered into in the ordinary course of business and in accordance with applicable rules, regulations and policies of any Regulatory Agency and with counterparties reasonably believed to be financially responsible at the time and are legal, valid and binding obligations of Trustmark or one of its Subsidiaries enforceable in accordance with their terms (except as may be limited by the Enforceability Exceptions). Trustmark and each of its Subsidiaries has duly performed in all material respects all of its material obligations thereunder to the extent that such obligations to perform have accrued, and, to the knowledge of Trustmark, there are no material breaches, violations or defaults or bona fide allegations or assertions of such by any party thereunder.

 

-25-


3.16 Environmental Matters. Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark, Trustmark and its Subsidiaries are in compliance, and, since January 1, 2023 have complied, with all federal, state and local laws, regulation, orders, decrees, permits, authorizations, common laws and other legal requirements relating to: (a) the protection or restoration of the environment, health and safety as it relates to hazardous substance exposure or natural resource damages, (b) the handling, use, presence, disposal, release or threatened release of, or exposure to, any hazardous substance, or (c) noise, odor, wetlands, indoor air, pollution, environmental contamination or any injury to persons or property from exposure to any hazardous substance (collectively, “Environmental Laws”). There are no legal, administrative, arbitral or other proceedings, claims or actions, or, to the knowledge of Trustmark, any private environmental investigations or remediation activities or governmental investigations of any nature seeking to impose, or that could reasonably be likely to result in the imposition, on Trustmark or any of its Subsidiaries of any liability or obligation arising under any Environmental Law, pending or threatened against Trustmark, which liability or obligation would reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark. To the knowledge of Trustmark, there is no reasonable basis for any such proceeding, claim, action or governmental investigation that would impose any liability or obligation that would reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark. Trustmark is not subject to any agreement, order, judgment, decree, letter agreement or memorandum of agreement by or with any court, Governmental Entity, regulatory agency or third party imposing any liability or obligation with respect to any Environmental Law that would reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark.

3.17 Investment Securities.

(a) Except as would not reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Trustmark, each of Trustmark and its Subsidiaries has good title to all securities and commodities owned by it (except those sold under repurchase agreements or held in any fiduciary or agency capacity), free and clear of any Lien, except (i) as set forth in the financial statements included in the Trustmark Reports, and (ii) to the extent such securities or commodities are pledged in the ordinary course of business to secure obligations of Trustmark or its Subsidiaries. Such securities and commodities are valued on the books of Trustmark in accordance with GAAP in all material respects.

(b) Trustmark and its Subsidiaries employ, to the extent applicable, investment, securities, risk management and other policies, practices and procedures that Trustmark believes are prudent and reasonable in the context of their respective businesses, and Trustmark and its Subsidiaries have, since January 1, 2023, been in compliance with such policies, practices and procedures in all material respects.

3.18 Real Property. Except as would not reasonably be likely, either individually or in the aggregate, to have a Material Adverse Effect on Trustmark, Trustmark or a Trustmark Subsidiary has good and marketable title to all of the real property reflected in the latest audited balance sheet included in the Trustmark Reports as being owned by Trustmark or a Trustmark Subsidiary or acquired after the date thereof (except properties sold or otherwise disposed of since the date thereof in the ordinary course of business) (the “Trustmark Owned Properties”), free and clear of all material Liens, except statutory Liens securing payments not yet due, Liens for real property Taxes not yet due and payable, easements, rights of way, and other similar encumbrances that do not materially affect the value or use of the properties or assets subject thereto or affected thereby or otherwise materially impair business operations at such properties and such imperfections or irregularities of title or Liens as do not materially affect the value or use of the properties or assets subject thereto or affected thereby or otherwise materially impair business operations at

 

-26-


such properties (collectively, “Permitted Encumbrances”), and is the lessee of all leasehold estates reflected in the latest audited financial statements included in such Trustmark Reports or acquired after the date thereof (except for leases that have expired by their terms since the date thereof) (collectively with the Trustmark Owned Properties, the “Trustmark Real Property”), free and clear of all material Liens of any nature whatsoever, except for Permitted Encumbrances, and is in possession of the properties purported to be leased thereunder, and each such lease is valid without material default thereunder by the lessee or, to the knowledge of Trustmark, the lessor. There are no material pending or, to the knowledge of Trustmark, threatened condemnation proceedings against any Trustmark Real Property.

3.19 Intellectual Property.

(a) Trustmark and each of its Subsidiaries owns, or is licensed to use (in each case, free and clear of any material Liens other than any Permitted Encumbrances), all Intellectual Property necessary for the conduct of its business as currently conducted and is the exclusive owner of all Intellectual Property that it owns or purports to own that is material to the conduct of its business as currently conducted. Except as would not reasonably be likely, either individually or in the aggregate, to have a Material Adverse Effect on Trustmark, all such Intellectual Property owned or purported to be owned by Trustmark or any of its Subsidiaries is subsisting and, to the knowledge of Trustmark, valid and enforceable.

(b) Except as would not reasonably be likely, either individually or in the aggregate, to have a Material Adverse Effect on Trustmark, to the knowledge of Trustmark, (i) neither Trustmark or any of its Subsidiaries has, within the past three years, infringed, misappropriated or otherwise violated any Intellectual Property owned or licensed by any third party, (ii) the use or other exploitation by Trustmark and its Subsidiaries of Intellectual Property owned or licensed by any third party has been in accordance with the applicable licenses pursuant to which Trustmark or any Trustmark Subsidiary acquired the right to use such Intellectual Property, and (iii) since January 1, 2023, no person has asserted to Trustmark in writing that Trustmark or any of its Subsidiaries has infringed, misappropriated or otherwise violated the Intellectual Property rights of such person.

(c) To the knowledge of Trustmark, since January 1, 2023, (i) no person has asserted in writing a challenge to Trustmark’s or any of its Subsidiaries’ ownership or rights in any Intellectual Property owned or purported to be owned by them and that is material to the conduct of its business as currently conducted, or the validity or enforceability thereof, and (ii) no person has infringed, misappropriated or otherwise violated any such Intellectual Property.

(d) Trustmark and its Subsidiaries have taken commercially reasonable actions designed to protect and maintain the confidentiality and security of Personal Data and material confidential information held by or on behalf of Trustmark or any of its Subsidiaries, and to protect its information technology assets and networks against unauthorized access or control. Except as would not reasonably be likely, either individually or in the aggregate, to have a Material Adverse Effect on Trustmark, to the knowledge of Trustmark, since January 1, 2023, no third party has gained unauthorized access to (i) any information technology assets or networks controlled by Trustmark or any of its Subsidiaries or (ii) any Personal Data or other confidential information held by or on behalf of Trustmark or any of its Subsidiaries.

 

-27-


For purposes of this Agreement, “Intellectual Property” means any and all intellectual property rights and similar proprietary rights, including any trademarks, service marks, brand names, Internet domain names, logos, symbols, certification marks, trade dress and other indications of origin, the goodwill associated with the foregoing and registrations in any jurisdiction of, and applications in any jurisdiction to register, the foregoing, including any extension, modification or renewal of any such registration or application; inventions, discoveries and ideas, whether patentable or not, in any jurisdiction; patents, applications for patents (including divisions, continuations, continuations in part and renewal applications), all improvements thereto and any re-examinations, renewals, extensions or reissues thereof, in any jurisdiction; trade secrets and know-how (including processes, technologies, protocols, formulae, prototypes and confidential information and rights in any jurisdiction to limit the use or disclosure thereof by any person); writings and other works, whether copyrightable or not and whether in published or unpublished works, in any jurisdiction; and registrations or applications for registration of copyrights in any jurisdiction, and any renewals or extensions thereof.

3.20 Related Party Transactions. There are no transactions or series of related transactions, agreements, arrangements or understandings, nor are there any currently proposed transactions or series of related transactions, between Trustmark or any of its Subsidiaries, on the one hand, and any current or former director or “executive officer” (as defined in Rule 3b-7 under the Exchange Act) of Trustmark or any of its Subsidiaries or any person who beneficially owns (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) five percent (5%) or more of the outstanding Trustmark Common Stock (or any of such person’s immediate family members or affiliates) (other than Subsidiaries of Trustmark), on the other hand, of the type required to be reported in any Trustmark Report pursuant to Item 404 of Regulation S-K promulgated under the Exchange Act that have not been so reported on a timely basis.

3.21 Takeover Restrictions. The Board of Directors of Trustmark has approved this Agreement and the transactions contemplated hereby as required to render inapplicable to this Agreement and the transactions contemplated hereby any applicable provisions of the takeover laws of any state, including any “moratorium,” “control share,” “fair price,” “takeover” or “interested shareholder” law or any similar provisions of the Trustmark Articles or Trustmark Bylaws (any such laws, collectively with any similar provisions of the Trustmark Articles or Trustmark Bylaws or the Hancock Articles or Hancock Bylaws, as applicable, “Takeover Restrictions”).

3.22 Reorganization. Trustmark has not taken any action and is not aware of any fact or circumstance that could reasonably be expected to prevent the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code.

3.23 Opinion. Prior to the execution of this Agreement, the Board of Directors of Trustmark has received an opinion (which, if initially rendered orally, has been or will be confirmed by a written opinion, dated the same date) from Goldman Sachs & Co. LLC, to the effect that, as of the date thereof, and based upon and subject to the factors, assumptions and limitations set forth therein, the Exchange Ratio pursuant to this Agreement is fair, from a financial point of view, to the holders of Trustmark Common Stock. Such opinion has not been amended or rescinded as of the date of this Agreement.

 

-28-


3.24 Trustmark Information. The information relating to Trustmark and its Subsidiaries that is provided by Trustmark or its representatives specifically for inclusion in (a) the Proxy Statement, (b) the S-4, (c) the documents and financial statements of Trustmark incorporated by reference in the Proxy Statement, the S-4 or any amendment or supplement thereto, or (d) any other document filed with any other Regulatory Agency or Governmental Entity in connection herewith will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances in which they are made, not misleading. The portions of the Proxy Statement relating to Trustmark and its Subsidiaries and other portions within the reasonable control of Trustmark and its Subsidiaries will comply in all material respects with the provisions of the Exchange Act and the rules and regulations thereunder. Notwithstanding the foregoing, no representation or warranty is made by Trustmark with respect to statements made or incorporated by reference therein based on information provided or supplied by or on behalf of Hancock or its Subsidiaries for inclusion in the Proxy Statement or the S-4.

3.25 Loan Portfolio.

(a) As of the date hereof, neither Trustmark nor any of its Subsidiaries is a party to any written or oral (i) loan, loan agreement, note or borrowing arrangement (including leases, credit enhancements, commitments, guarantees and interest-bearing assets) (collectively, “Loans”) in which Trustmark or any Subsidiary of Trustmark is a creditor which as of September 30, 2026 had an outstanding balance of $5,000,000 or more, individually or when aggregated together with any other Loans in which Trustmark or any Subsidiary of Trustmark is a creditor to the same obligor (or to any other obligor that is an affiliate of, or otherwise part of the same borrower, guarantor or related borrower relationship as, such obligor) and under the terms of which the obligor (or any other obligor to which such Loans were aggregated pursuant to the foregoing) was, as of September 30, 2026, 90 days or more delinquent in payment of principal or interest, or (ii) “extensions of credit” to any “executive officer” or other “insider” of Trustmark or any of its Subsidiaries (as such terms are defined in 12 C.F.R. Part 215). Each “extension of credit” to any such “executive officer” or other “insider” of Trustmark or any of its Subsidiaries is subject to and was made and continues to be in compliance with 12 C.F.R. Part 215 in all material respects or is exempt therefrom. Except as such disclosure may be limited by any applicable law, rule or regulation, Section 3.25(a) of the Trustmark Disclosure Schedule sets forth a true, correct and complete list of all of the Loans of Trustmark and its Subsidiaries that, as of September 30, 2026, were classified by Trustmark as “Other Loans Specially Mentioned,” “Special Mention,” “Substandard,” “Doubtful,” “Loss,” “Classified,” “Criticized,” “Credit Risk Assets,” “Concerned Loans,” “Watch List,” “Nonaccrual” or words of similar import (any such Loan, a “Classified Loan”), and had an outstanding balance of $5,000,000 or more, individually or when aggregated together with any other Loans in which Trustmark or any Subsidiary of Trustmark is a creditor to the same obligor (or to any other obligor that is an affiliate of, or otherwise part of the same borrower, guarantor or related borrower relationship as, such obligor), together with the principal amount of and accrued and unpaid interest on each such Loan, and the aggregate principal amount of and accrued and unpaid interest on such Loans as of such date. As of September 30, 2026, the aggregate outstanding principal balance of (i) all Loans 90 days or more delinquent in payment of principal or interest was $40,900,000 and (ii) all Classified Loans was $242,463,000.

 

-29-


(b) Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark, each outstanding Loan of Trustmark or its Subsidiaries (i) is evidenced by notes, agreements or other evidences of indebtedness that are true, genuine and what they purport to be, (ii) to the extent carried on the books and records of Trustmark and its Subsidiaries as secured Loans, has been secured by valid Liens, which have been perfected and (iii) is the legal, valid and binding obligation of the obligor named therein, enforceable in accordance with its terms, subject to the Enforceability Exceptions.

(c) Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark, each outstanding Loan of Trustmark or its Subsidiaries (including Loans held for resale to investors) was solicited and originated, and is and has been administered and, where applicable, serviced, and the relevant Loan files are being maintained, in all material respects, in accordance with the relevant notes or other credit or security documents, the applicable written underwriting standards of Trustmark and its Subsidiaries (and, in the case of Loans held for resale to investors, the applicable underwriting standards, if any, of the applicable investors) and with all applicable federal, state and local laws, regulations and rules.

(d) None of the agreements pursuant to which Trustmark or any of its Subsidiaries has sold Loans or pools of Loans or participations in Loans or pools of Loans contains any obligation to repurchase such Loans or interests therein solely on account of a payment default (other than early payment defaults) by the obligor on any such Loan.

(e) Neither Trustmark nor any of its Subsidiaries is now, nor has it ever been since January 1, 2023, subject to any material fine, suspension, settlement or other administrative agreement or sanction by, or any reduction in any loan purchase commitment, any Governmental Entity or Regulatory Agency relating to the origination, sale or servicing of mortgage or consumer Loans.

3.26 Insurance. Except as would not reasonably be likely, either individually or in the aggregate, to have a Material Adverse Effect on Trustmark, Trustmark and its Subsidiaries are insured with reputable insurers against such risks and in such amounts as the management of Trustmark reasonably has determined to be prudent and consistent with industry practice, and neither Trustmark nor any of its Subsidiaries has received written notice to the effect that any of them are in default under any material insurance policy, each such policy is outstanding and in full force and effect and, except for policies insuring against potential liabilities of officers, directors and employees of Trustmark and its Subsidiaries, Trustmark or the relevant Subsidiary thereof is the sole beneficiary of such policies, and all premiums and other payments due under any such policy have been paid, and all claims thereunder have been filed in due and timely fashion.

 

-30-


3.27 No Investment Adviser or Broker-Dealer Subsidiary.

(a) Neither Trustmark nor any Trustmark Subsidiary serves in a capacity described in Section 9(a) or 9(b) of the Investment Company Act of 1940, as amended, nor acts as an “investment adviser” required to register as such under the Investment Advisers Act of 1940, as amended.

(b) Neither Trustmark nor any Trustmark Subsidiary is a broker-dealer required to be registered under the Exchange Act with the SEC.

3.28 No Other Representations or Warranties.

(a) Except for the representations and warranties made by Trustmark in this Article III, neither Trustmark nor any other person makes any express or implied representation or warranty with respect to Trustmark, its Subsidiaries, or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects, and Trustmark hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, neither Trustmark nor any other person makes or has made any representation or warranty to Hancock or any of its affiliates or representatives with respect to (i) any financial projection, forecast, estimate, budget or prospective information relating to Trustmark, any of its Subsidiaries or their respective businesses, or (ii) except for the representations and warranties made by Trustmark in this Article III, any oral or written information presented to Hancock or any of its affiliates or representatives in the course of their due diligence investigation of Trustmark, the negotiation of this Agreement or in the course of the transactions contemplated hereby.

(b) Trustmark acknowledges and agrees that neither Hancock nor any other person has made or is making any express or implied representation or warranty other than those contained in Article IV.

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF HANCOCK

Except (a) as disclosed in the disclosure schedule delivered by Hancock to Trustmark concurrently herewith (the “Hancock Disclosure Schedule”); provided that (i) no such item is required to be set forth as an exception to a representation or warranty if its absence would not result in the related representation or warranty being deemed untrue or incorrect, (ii) the mere inclusion of an item in the Hancock Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission by Hancock that such item represents a material exception or fact, event or circumstance or that such item is reasonably likely to result in a Material Adverse Effect, and (iii) any disclosures made with respect to a section of this Article IV shall be deemed to qualify (A) any other section of this Article IV specifically referenced or cross-referenced and (B) other sections of this Article IV to the extent it is reasonably apparent on its face (notwithstanding the absence of a specific cross-reference) from a reading of the disclosure that such disclosure applies to such other sections, or (b) as disclosed in any Hancock Reports publicly filed prior to the date hereof (but disregarding risk factor disclosures contained under the heading “Risk Factors,” or disclosures of risks set forth in any “forward-looking statements” disclaimer or any other statements that are similarly non-specific or cautionary, predictive or forward-looking in nature), Hancock hereby represents and warrants to Trustmark as follows:

 

-31-


4.1 Corporate Organization.

(a) Hancock is a corporation duly organized, validly existing and in good standing under the laws of the State of Mississippi and is a bank holding company duly registered under the BHC Act that has elected to be treated as a financial holding company under the BHC Act. Hancock has the corporate power and authority to own, lease or operate all of its properties and assets and to carry on its business as it is now being conducted in all material respects. Hancock is duly licensed or qualified to do business and in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned, leased or operated by it makes such licensing, qualification or standing necessary, except where the failure to be so licensed or qualified or to be in good standing would not, either individually or in the aggregate, reasonably be likely to have a Material Adverse Effect on Hancock. True and complete copies of the Second Amended and Restated Articles of Incorporation of Hancock (“Hancock Articles”), and Second Amended and Restated Bylaws of Hancock (“Hancock Bylaws”), as in effect as of the date of this Agreement, have previously been made available by Hancock to Trustmark.

(b) Except, in the case of clauses (ii) and (iii) only, as would not reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Hancock, each Subsidiary of Hancock (a “Hancock Subsidiary”) is duly organized and validly existing under the laws of its jurisdiction of organization, is duly licensed or qualified to do business and, where such concept is recognized under applicable law, in good standing in all jurisdictions (whether federal, state, local or foreign) where its ownership, leasing or operation of property or the conduct of its business requires it to be so licensed or qualified or in good standing and has all requisite corporate power and authority to own, lease or operate its properties and assets and to carry on its business as now conducted. There are no restrictions on the ability of any Subsidiary of Hancock to pay dividends or distributions, except, in the case of a Subsidiary that is a regulated entity, for restrictions on dividends or distributions generally applicable to all such regulated entities. The deposit accounts of each Subsidiary of Hancock that is an insured depository institution are insured by the FDIC through the Deposit Insurance Fund to the fullest extent permitted by law, all premiums and assessments required to be paid in connection therewith have been paid when due, and no proceedings for the termination of such insurance are pending or, to the knowledge of Hancock, threatened.

4.2 Capitalization.

(a) As of the date hereof, the authorized capital stock of Hancock consists of 350,000,000 shares of Hancock Common Stock, and 50,000,000 shares of preferred stock, $20.00 par value per share (“Hancock Preferred Stock”). As of October 31, 2026, no shares of capital stock or other voting securities of Hancock are issued, reserved for issuance or outstanding, other than (i) 79,504,489 shares of Hancock Common Stock issued and outstanding (including 5,225 shares of restricted Hancock Common Stock under a Hancock Stock Plan), (ii) 1,448,345 shares of Hancock Common Stock reserved for issuance upon the settlement of outstanding equity awards in respect of shares of Hancock Common Stock granted under a

 

-32-


Hancock Stock Plan or a Hancock Stock Purchase Plan (“Hancock Equity Awards”) (assuming that performance with respect to performance-vesting Hancock Equity Awards is achieved at target performance), (iii) 543,505 shares of Hancock Common Stock reserved for issuance upon the settlement of awards deferred under Hancock’s deferred compensation programs (“Hancock Deferred Stock Unit Awards”), and (iv) 1,883,561 shares of Hancock Common Stock reserved for issuance pursuant to future grants under the Hancock Stock Plans and Hancock Stock Purchase Plans. As used herein, the “Hancock Stock Plans” shall mean all employee and director equity incentive plans of Hancock in effect as of the date of this Agreement and agreements for equity awards in respect of Hancock Common Stock granted by Hancock under the inducement grant exception and “Hancock Stock Purchase Plan” shall mean any employee stock purchase or director stock purchase plan or program. As of the date of this Agreement, except as set forth in the immediately preceding sentence and for changes since October 31, 2026 resulting from the exercise, vesting, purchase or settlement of any Hancock Equity Awards described in the immediately preceding sentence, there are no shares of capital stock or other voting securities or equity interests of Hancock issued, reserved for issuance or outstanding. All of the issued and outstanding shares of Hancock Common Stock and Hancock Preferred Stock have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights, with no personal liability attaching to the ownership thereof. No bonds, debentures, notes or other indebtedness that have the right to vote on any matters on which shareholders of Hancock may vote are issued or outstanding. Other than Hancock Equity Awards and Hancock Deferred Stock Unit Awards, in each case, issued prior to the date of this Agreement as described in this Section 4.2(a), as of the date of this Agreement, there are no outstanding subscriptions, options, warrants, puts, calls, rights, exchangeable or convertible securities, or other commitments or agreements obligating Hancock to issue, transfer, sell, purchase, redeem or otherwise acquire any such securities.

(b) There are no voting trusts, shareholder agreements, proxies or other agreements in effect pursuant to which Hancock or any of its Subsidiaries has a contractual or other obligation with respect to the voting or transfer of the Hancock Common Stock or other equity interests of Hancock. Hancock has paid or made due provision for the payment of all dividends payable on the outstanding shares of Hancock Preferred Stock through the most recent scheduled dividend payment date therefor, and has complied in all material respects with terms and conditions thereof.

(c) Hancock owns, directly or indirectly, all of the issued and outstanding shares of capital stock or other equity ownership interests of each Hancock Subsidiary, free and clear of any Liens, and all of such shares or equity ownership interests are duly authorized and validly issued and are fully paid, nonassessable (except, with respect to Hancock Subsidiaries that are insured depository institutions, as provided under 12 U.S.C. § 55 or any comparable provision of applicable state law), and free of preemptive rights, with no personal liability attaching to the ownership thereof. No Hancock Subsidiary has or is bound by any outstanding subscriptions, options, warrants, calls, rights, commitments or agreements of any character calling for the purchase or issuance of any shares of capital stock or any other equity security of such Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of such Subsidiary.

 

-33-


4.3 Authority; No Violation.

(a) Hancock has full corporate power and authority to execute and deliver this Agreement and, subject to the shareholder and other actions described below, to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the consummation of the Merger have been duly and validly approved by the Board of Directors of Hancock. The Board of Directors of Hancock has determined that the Merger, on the terms and conditions set forth in this Agreement, is advisable and in the best interests of Hancock and its shareholders and has directed that this Agreement and the transactions contemplated hereby be submitted to Hancock’s shareholders for approval at a duly held meeting of such shareholders and has adopted a resolution to the foregoing effect. Except for the approval of this Agreement by the affirmative vote of the holders of a majority of the votes cast by holders of outstanding Hancock Common Stock at the Hancock Meeting (the “Requisite Hancock Vote”), and the adoption and approval of the Bank Merger Agreement by Hancock as the sole shareholder of Hancock Whitney Bank, and the adoption of resolutions to give effect to the provisions of Section 6.13, no other corporate proceedings on the part of Hancock or Hancock Whitney Bank are necessary to approve this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Hancock and (assuming due authorization, execution and delivery by Trustmark) constitutes a valid and binding obligation of Hancock, enforceable against Hancock in accordance with its terms (except in all cases as such enforceability may be limited by the Enforceability Exceptions). The shares of Hancock Common Stock to be issued in the Merger have been validly authorized and, when issued, will be validly issued, fully paid and nonassessable, and no current or past shareholder of Hancock will have any preemptive right or similar rights in respect thereof.

(b) Subject to the receipt of the Requisite Hancock Vote, neither the execution and delivery of this Agreement by Hancock, nor the consummation by Hancock of the transactions contemplated hereby, nor compliance by Hancock with any of the terms or provisions hereof, will (i) violate any provision of the Hancock Articles or the Hancock Bylaws or comparable governing documents of any Hancock Subsidiary, or (ii) assuming that the consents, approvals and filings referred to in Section 4.4 are duly obtained and/or made, (A) violate any law, statute, code, ordinance, rule, regulation, judgment, order, writ, decree or injunction applicable to Hancock, any of its Subsidiaries or any of their respective properties or assets, or (B) violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of the respective properties or assets of Hancock or any of its Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which Hancock or any of its Subsidiaries is a party, or by which they or any of their respective properties or assets may be bound, except (in the case of clause (ii) above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or creations which, either individually or in the aggregate, would not reasonably be likely to have a Material Adverse Effect on Hancock.

 

-34-


4.4 Consents and Approvals. Except for (a) the filing of any required applications, filings and notices, as applicable, with Nasdaq, (b) the filing of any required applications, filings and notices, as applicable, with the Federal Reserve Board with respect to the Merger, the FDIC in connection with the Bank Merger, the Mississippi Department of Banking in connection with the Bank Merger, Merger, and approval of such applications, filings and notices and expiration of any related waiting periods, (c) the filing of any required applications, filings or notices listed on Section 3.4 of the Trustmark Disclosure Schedule or Section 4.4 of the Hancock Disclosure Schedule and approval or non-objection, as applicable, of such applications, filings and notices, (d) the filing with the SEC of the Proxy Statement and the S-4, and declaration of effectiveness of the S-4, (e) the filing of the Articles of Merger with the Mississippi Secretary pursuant to the MBCA and the filing of the Bank Merger Certificates with the applicable Governmental Entities as required by applicable law and (f) such filings and approvals as are required to be made or obtained under the securities or “Blue Sky” laws of various states in connection with the issuance of the shares of Hancock Common Stock pursuant to this Agreement, no consents or approvals of or filings or registrations with any Governmental Entity are necessary in connection with (i) the execution and delivery by Hancock of this Agreement or (ii) the consummation by Hancock of the Merger and the other transactions contemplated hereby (including the Bank Merger). As of the date hereof, Hancock is not aware of any reason why the necessary regulatory approvals and consents will not be received in order to permit consummation of the Merger and Bank Merger on a timely basis.

4.5 Reports.

(a) Hancock and each of its Subsidiaries have timely filed or furnished, as applicable, all reports, registrations and statements, together with any amendments required to be made with respect thereto, that they were required to file (or furnish, as applicable) since January 1, 2023 with any Regulatory Agencies, including any report, registration or statement required to be filed (or furnished, as applicable) pursuant to the laws, rules or regulations of the United States, any state, any foreign entity, or any Regulatory Agency, and have paid all fees and assessments due and payable in connection therewith, except where the failure to file such report, registration or statement or to pay such fees and assessments, either individually or in the aggregate, would not reasonably be likely to have a Material Adverse Effect on Hancock. Subject to Section 9.7 and except for normal examinations conducted by a Regulatory Agency in the ordinary course of business of Hancock and its Subsidiaries, no Regulatory Agency has initiated or has pending any proceeding or, to the knowledge of Hancock, investigation into the business or operations of Hancock or any of its Subsidiaries since January 1, 2023, except where such proceedings or investigations would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock. Subject to Section 9.7, there (i) is no unresolved violation, criticism, or exception by any Regulatory Agency with respect to any report or statement relating to any examinations or inspections of Hancock or any of its Subsidiaries, and (ii) has been no formal or informal inquiries by, or disagreements or disputes with, any Regulatory Agency with respect to the business, operations, policies or procedures of Hancock or any of its Subsidiaries since January 1, 2023, in each case of clauses (i) and (ii), which would reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock.

 

-35-


(b) An accurate and complete copy of each final registration statement, prospectus, report, schedule and definitive proxy statement filed with or furnished to the SEC by Hancock or any of its Subsidiaries pursuant to the Securities Act or the Exchange Act, as the case may be, since January 1, 2023 (the “Hancock Reports”) is publicly available. No such Hancock Report, at the time filed, furnished or communicated (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings, respectively), contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances in which they were made, not misleading, except that information filed or furnished as of a later date (but before the date of this Agreement) shall be deemed to modify information as of an earlier date. As of their respective dates, all Hancock Reports filed or furnished under the Securities Act and the Exchange Act complied in all material respects with the published rules and regulations of the SEC with respect thereto. As of the date of this Agreement, no executive officer of Hancock has failed in any respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act. As of the date of this Agreement, there are no outstanding comments from or material unresolved issues raised by the SEC with respect to any of the Hancock Reports.

4.6 Financial Statements.

(a) The financial statements of Hancock and its Subsidiaries included (or incorporated by reference) in the Hancock Reports (including the related notes, where applicable) (i) have been prepared from, and are in accordance with, the books and records of Hancock and its Subsidiaries in all material respects, (ii) fairly present in all material respects the consolidated results of operations, cash flows, changes in shareholders’ equity and consolidated financial position of Hancock and its Subsidiaries for the respective fiscal periods or as of the respective dates therein set forth (subject in the case of unaudited statements to year-end audit adjustments normal in nature and amount), (iii) complied, as of their respective dates of filing with the SEC, in all material respects with applicable accounting requirements and with the published rules and regulations of the SEC with respect thereto, and (iv) have been prepared in accordance with GAAP consistently applied during the periods involved, except, in each case, as indicated in such statements or in the notes thereto. The books and records of Hancock and its Subsidiaries have been, since January 1, 2023, and are being, maintained in all material respects in accordance with GAAP and any other applicable legal and accounting requirements. PricewaterhouseCoopers LLP has not resigned (or informed Hancock that it intends to resign) or been dismissed as independent public accountants of Hancock as a result of or in connection with any disagreements with Hancock on a matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure.

(b) Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Trustmark, neither Hancock nor any of its Subsidiaries has any liability of any nature whatsoever (whether absolute, accrued, contingent or otherwise and whether due or to become due) required by GAAP to be included on a consolidated balance sheet of Hancock, except for those liabilities that are reflected or reserved against on the consolidated balance sheet of Hancock included in its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026 (including any notes thereto) and for liabilities incurred in the ordinary course of business consistent with past practice since June 30, 2026, or in connection with this Agreement and the transactions contemplated hereby.

 

-36-


(c) The records, systems, controls, data and information of Hancock and its Subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and direct control of Hancock or its Subsidiaries or accountants (including all means of access thereto and therefrom), except for any non-exclusive ownership and non-direct control that would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock. Hancock (i) has implemented and maintains disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) to ensure that material information relating to Hancock, including its Subsidiaries, is made known to the Chief Executive Officer and the Chief Financial Officer of Hancock by others within those entities as appropriate to allow timely decisions regarding required disclosures and to make the certifications required by the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act, and (ii) has disclosed, based on its most recent evaluation prior to the date hereof, to Hancock’s outside auditors and the Audit Committee of Hancock’s Board of Directors (A) any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) which are reasonably likely to adversely affect Hancock’s ability to record, process, summarize and report financial information, and (B) to the knowledge of Hancock, any fraud, whether or not material, that involves management or other employees who have a significant role in Hancock’s internal controls over financial reporting. These disclosures were made in writing by management to Hancock’s auditors and audit committee and true, correct and complete copies of such disclosures have been made available to Trustmark. To the knowledge of Hancock, there is no reason to believe that Hancock’s outside auditors and its Chief Executive Officer and Chief Financial Officer will not be able to give the certifications and attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act, without qualification, when next due.

(d) Since January 1, 2023, (i) neither Hancock nor any of its Subsidiaries, nor, to the knowledge of Hancock, any director, officer, auditor, accountant or representative of Hancock or any of its Subsidiaries, has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or, to the knowledge of Hancock, oral, regarding the accounting or auditing practices, procedures, methodologies or methods (including with respect to loan loss reserves, write-downs, charge-offs and accruals) of Hancock or any of its Subsidiaries or their respective internal accounting controls, including any material complaint, allegation, assertion or written claim that Hancock or any of its Subsidiaries has engaged in questionable accounting or auditing practices, and (ii) no employee of or attorney representing Hancock or any of its Subsidiaries, whether or not employed by Hancock or any of its Subsidiaries, has reported evidence of a material violation of securities laws, breach of fiduciary duty or similar violation by Hancock or any of its Subsidiaries or any of their respective officers, directors, employees or agents to the Board of Directors of Hancock or any committee thereof or similar governing body of any Hancock Subsidiary or any committee thereof, or, to the knowledge of Hancock, to any director or officer of Hancock or any Hancock Subsidiary.

4.7 Broker’s Fees. Neither Hancock nor any Hancock Subsidiary nor any of their respective officers or directors has employed any broker, finder or financial advisor or incurred any liability for any broker’s fees, commissions or finder’s fees in connection with the Merger or related transactions contemplated by this Agreement, other than Raymond James & Associates, Inc.

 

-37-


4.8 Absence of Certain Changes or Events.

(a) Since December 31, 2025, there has not been any effect, change, event, circumstance, condition, occurrence or development that has had or would reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock.(b) Since December 31, 2025 through the date of this Agreement, except with respect to the transactions contemplated hereby, Hancock and its Subsidiaries have carried on their respective businesses in all material respects in the ordinary course.

4.9 Legal Proceedings.

(a) Neither Hancock nor any of its Subsidiaries is a party to any, and there are no pending or, to the knowledge of Hancock, threatened, material legal, administrative, arbitral or other proceedings, claims, actions or governmental or regulatory investigations of any nature against Hancock or any of its Subsidiaries or any of their current or former directors or executive officers of a material nature challenging the validity or propriety of this Agreement or the transactions contemplated hereby.

(b) There is no material injunction, order, judgment, decree, or regulatory restriction imposed upon Hancock, any of its Subsidiaries or the assets of Hancock or any of its Subsidiaries (or that, upon consummation of the Merger, would apply to the Surviving Corporation or any of its affiliates).

4.10 Taxes and Tax Returns. Each of Hancock and its Subsidiaries has duly and timely filed (taking into account all applicable extensions) all material Tax Returns in all jurisdictions in which Tax Returns are required to be filed by it, and all such Tax Returns are true, correct, and complete in all material respects. All material Taxes of Hancock and its Subsidiaries (whether or not shown on any Tax Returns) that are due have been fully and timely paid. Each of Hancock and its Subsidiaries has withheld and paid all material Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee, creditor, shareholder, independent contractor or other third party. The federal income Tax Returns of Hancock and its Subsidiaries for all years up to and including the tax year ended December 31, 2019 have been examined by the IRS or are Tax Returns with respect to which the applicable period for assessment under applicable law, after giving effect to extensions or waivers, has expired. No deficiency with respect to a material amount of Taxes has been proposed, asserted or assessed against Hancock or any of its Subsidiaries. There are no pending or threatened (in writing) disputes, claims, audits, examinations or other proceedings regarding any material Taxes of Hancock and its Subsidiaries or the assets of Hancock and its Subsidiaries. There are no Liens for material Taxes (except Taxes not yet due and payable) on any of the assets of Hancock or any of its Subsidiaries. Neither Hancock nor any of its Subsidiaries has participated in a “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4(b)(2).

 

-38-


4.11 Compliance with Applicable Law.

(a) Hancock and each of its Subsidiaries hold, and have at all times since January 1, 2023 held, all licenses, franchises, permits and authorizations necessary for the lawful conduct of their respective businesses and ownership of their respective properties, rights and assets under and pursuant to each (and have paid all fees and assessments due and payable in connection therewith), except where neither the cost of failure to hold nor the cost of obtaining and holding such license, franchise, permit or authorization (nor the failure to pay any fees or assessments) would, either individually or in the aggregate, reasonably be likely to have a Material Adverse Effect on Hancock, and to the knowledge of Hancock, no suspension or cancellation of any such necessary license, franchise, permit or authorization is threatened.

(b) Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock, Hancock and each of its Subsidiaries have complied with and are not in default or violation under any law, statute, order, rule, regulation, policy or guideline of any Governmental Entity applicable to Hancock or any of its Subsidiaries, including (to the extent applicable to Hancock or its Subsidiaries) all laws related to data protection or privacy (including laws relating to the privacy and security of Personal Data), the USA PATRIOT Act, the Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation B, the Fair Housing Act, the Community Reinvestment Act, the Fair Credit Reporting Act and Regulation V, the Truth in Lending Act and Regulation Z, the Home Mortgage Disclosure Act and Regulation C, the Fair Debt Collection Practices Act, the Electronic Fund Transfer Act and Regulation E, the Dodd-Frank Wall Street Reform and Consumer Protection Act, any regulations promulgated by the Consumer Financial Protection Bureau, the Interagency Policy Statement on Retail Sales of Nondeposit Investment Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement Procedures Act and Regulation X, Title V of the Gramm-Leach-Bliley Act, any and all sanctions or regulations enforced by the Office of Foreign Assets Control of the United States Department of Treasury and any other law or regulation relating to bank secrecy, discriminatory lending, financing or leasing practices, money laundering prevention, Sections 23A and 23B of the Federal Reserve Act and Regulation W, the Sarbanes-Oxley Act, and all agency requirements relating to the origination, sale and servicing of mortgage and consumer loans.

(c) Hancock Whitney Bank has a Community Reinvestment Act rating of “outstanding” as of its most recently completed Community Reinvestment Act examination.

(d) Hancock maintains a written information privacy and security program that maintains reasonable measures to protect the privacy, confidentiality and security of all Personal Data against any (i) loss or misuse of Personal Data, (ii) unauthorized or unlawful operations performed upon Personal Data, or (iii) other act or omission that compromises the security or confidentiality of Personal Data.

(e) None of Hancock or any of its Subsidiaries, or to the knowledge of Hancock, any director, officer, employee, agent or other person acting on behalf of Hancock or any of its Subsidiaries has, directly or indirectly, (i) used any funds of Hancock or any of its Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic governmental officials or employees or to foreign or domestic political parties or campaigns from funds of Hancock or any of its Subsidiaries, (iii) violated any provision that would result in

 

-39-


the violation of the Foreign Corrupt Practices Act of 1977, as amended, or any similar law, (iv) established or maintained any unlawful fund of monies or other assets of Hancock or any of its Subsidiaries, (v) made any fraudulent entry on the books or records of Hancock or any of its Subsidiaries, or (vi) made any unlawful bribe, unlawful rebate, unlawful payoff, unlawful influence payment, unlawful kickback or other unlawful payment to any person, private or public, regardless of form, whether in money, property or services, to obtain favorable treatment in securing business, to obtain special concessions for Hancock or any of its Subsidiaries, to pay for favorable treatment for business secured or to pay for special concessions already obtained for Hancock or any of its Subsidiaries, or is currently subject to any United States sanctions administered by the Office of Foreign Assets Control of the United States Treasury Department, except in each case as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock.

(f) As of the date hereof, Hancock, Hancock Whitney Bank and each other insured depository institution Subsidiary of Hancock maintain regulatory capital ratios that exceed the levels established for “well capitalized” institutions (under the relevant regulatory capital regulation of the institution’s primary bank regulator) and, as of the date hereof, neither Hancock nor any of its Subsidiaries has received any notice from a Governmental Entity that its status as “well-capitalized” or that the Hancock Whitney Bank’s Community Reinvestment Act rating will change within one year from the date of this Agreement.

(g) Except as would not, either individually or in the aggregate, reasonably be likely to have a Material Adverse Effect on Hancock, (i) Hancock and each of its Subsidiaries have properly administered all accounts for which it acts as a fiduciary, including accounts for which it serves as a trustee, agent, custodian, personal representative, guardian, conservator or investment advisor, in accordance with the terms of the governing documents and applicable state, federal and foreign law; and (ii) none of Hancock, any of its Subsidiaries, or any of its or its Subsidiaries’ directors, officers or employees, has committed any breach of trust or fiduciary duty with respect to any such fiduciary account, and the accountings for each such fiduciary account are true and correct and accurately reflect the assets and results of such fiduciary account.

(h) Except as would not reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Hancock, Hancock and its Subsidiaries are in compliance, and, since January 1, 2023 have complied, with all Environmental Laws.

4.12 Certain Contracts.

(a) Each contract, arrangement, commitment or understanding (whether written or oral) which is a “material contract” (as such term is defined in Item 601(b)(10) of Regulation S-K of the SEC) to which Hancock or any of its Subsidiaries is a party or by which Hancock or any of its Subsidiaries is bound as of the date hereof has been filed as an exhibit to the most recent Annual Report on Form 10-K filed by Hancock, or a Quarterly Report on Form 10-Q or Current Report on Form 8-K subsequent thereto (each, a “Hancock Contract”), and neither Hancock nor any of its Subsidiaries knows of, or has received written, or to the knowledge of Hancock, oral notice of, any violation of any Hancock Contract by any of the other parties thereto which would reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Hancock.

 

-40-


(b) In each case, except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock, each Hancock Contract is valid and binding on Hancock or one of its Subsidiaries, as applicable, and in full force and effect, Hancock and each of its Subsidiaries have performed all obligations required to be performed by it prior to the date hereof under each Hancock Contract, to the knowledge of Hancock, each third party counterparty to each Hancock Contract has performed all obligations required to be performed by it to date under such Hancock Contract, and no event or condition exists which constitutes or, after notice or lapse of time or both, will constitute, a default on the part of Hancock or any of its Subsidiaries or, to the knowledge of Hancock, any counterparty thereto, under any such Hancock Contract.

4.13 Agreements with Regulatory Agencies. Subject to Section 9.7, neither Hancock nor any of its Subsidiaries is subject to any cease-and-desist or other order or enforcement action issued by, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party to any commitment letter or similar undertaking to, or is subject to any order or directive by, or has been ordered to pay any civil money penalty by, or has been since January 1, 2023, a recipient of any supervisory letter from, or since January 1, 2023, has adopted any policies, procedures or board resolutions at the request of any Regulatory Agency or other Governmental Entity that currently restricts in any material respect or would reasonably be expected to restrict in any material respect the conduct of its business or that in any material manner relates to its capital adequacy, its ability to pay dividends, its credit or risk management policies, its management or its business (each, whether or not set forth in the Hancock Disclosure Schedule, a “Hancock Regulatory Agreement”), nor has Hancock or any of its Subsidiaries been advised, in writing or, to the knowledge of Hancock, orally, since January 1, 2023, by any Regulatory Agency or other Governmental Entity that it is considering issuing, initiating, ordering or requesting any such Hancock Regulatory Agreement.

4.14 Information Technology. Except as would not reasonably be likely, either individually or in the aggregate, to have a Material Adverse Effect on Hancock, to the knowledge of Hancock, since January 1, 2023, no third party has gained unauthorized access to any information technology networks controlled by and material to the operation of the business of Hancock and its Subsidiaries.

4.15 Related Party Transactions. There are no transactions or series of related transactions, agreements, arrangements or understandings, nor are there any currently proposed transactions or series of related transactions, between Hancock or any of its Subsidiaries, on the one hand, and any current or former director or “executive officer” (as defined in Rule 3b-7 under the Exchange Act) of Hancock or any of its Subsidiaries or any person who beneficially owns (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) five percent (5%) or more of the outstanding Hancock Common Stock (or any of such person’s immediate family members or affiliates) (other than Subsidiaries of Hancock), on the other hand, of the type required to be reported in any Hancock Report pursuant to Item 404 of Regulation S-K promulgated under the Exchange Act that have not been so reported on a timely basis.

 

-41-


4.16 Reorganization. Hancock has not taken any action and is not aware of any fact or circumstance that could reasonably be expected to prevent the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code.

4.17 Investment Securities.

(a) Except as would not reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Hancock, each of Hancock and its Subsidiaries has good title to all securities and commodities owned by it (except those sold under repurchase agreements or held in any fiduciary or agency capacity), free and clear of any Lien, except (i) as set forth in the financial statements included in the Hancock Reports and (ii) to the extent such securities or commodities are pledged in the ordinary course of business to secure obligations of Hancock or its Subsidiaries. Such securities and commodities are valued on the books of Hancock in accordance with GAAP in all material respects.

(b) Hancock and its Subsidiaries employ, to the extent applicable, investment, securities, risk management and other policies, practices and procedures that Hancock believes are prudent and reasonable in the context of their respective businesses, and Hancock and its Subsidiaries have, since January 1, 2023, been in compliance with such policies, practices and procedures in all material respects.

4.18 Risk Management Instruments. Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock, all interest rate swaps, caps, floors, option agreements, futures and forward contracts and other similar derivative transactions and risk management arrangements, whether entered into for the account of Hancock or any of its Subsidiaries or for the account of a customer of Hancock or one of its Subsidiaries, were entered into in the ordinary course of business and in accordance with applicable rules, regulations and policies of any Regulatory Agency and with counterparties reasonably believed to be financially responsible at the time and are legal, valid and binding obligations of Hancock or one of its Subsidiaries enforceable in accordance with their terms (except as may be limited by the Enforceability Exceptions). Hancock and each of its Subsidiaries have duly performed in all material respects all of its material obligations thereunder to the extent that such obligations to perform have accrued, and, to the knowledge of Hancock, there are no material breaches, violations or defaults or bona fide allegations or assertions of such by any party thereunder.

4.19 Opinion. Prior to the execution of this Agreement, the Board of Directors of Hancock has received an opinion (which, if initially rendered orally, has been or will be confirmed by a written opinion, dated the same date) from Raymond James & Associates, Inc., to the effect that, as of the date thereof, and based upon and subject to the factors, assumptions and limitations set forth therein, the Exchange Ratio pursuant to this Agreement is fair, from a financial point of view, to Hancock. Such opinion has not been amended or rescinded as of the date of this Agreement.

 

-42-


4.20 Hancock Information. The information relating to Hancock and its Subsidiaries that is provided by Hancock or its representatives specifically for inclusion in (a) the Proxy Statement, (b) the S-4, (c) the documents and financial statements of Hancock incorporated by reference in the Proxy Statement, the S-4 or any amendment or supplement thereto, or (d) any other document filed with any other Regulatory Agency or Governmental Entity in connection herewith, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances in which they are made, not misleading. The portions of the Proxy Statement relating to Hancock and its Subsidiaries and other portions within the reasonable control of Hancock and its Subsidiaries will comply in all material respects with the provisions of the Exchange Act and the rules and regulations thereunder. Notwithstanding the foregoing, no representation or warranty is made by Hancock with respect to statements made or incorporated by reference therein based on information provided or supplied by or on behalf of Trustmark or its Subsidiaries for inclusion in the Proxy Statement or the S-4.

4.21 Loan Portfolio.

(a) Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock, each outstanding Loan of Hancock or its Subsidiaries (i) is evidenced by notes, agreements or other evidences of indebtedness that are true, genuine and what they purport to be, (ii) to the extent carried on the books and records of Hancock and its Subsidiaries as secured Loans, has been secured by valid Liens, which have been perfected, and (iii) is the legal, valid and binding obligation of the obligor named therein, and assuming due authorization, execution and delivery thereof by such obligor or obligors, enforceable in accordance with its terms, subject to the Enforceability Exceptions.

(b) Except as would not reasonably be likely to have, either individually or in the aggregate, a Material Adverse Effect on Hancock, each outstanding Loan of Hancock or its Subsidiaries (including Loans held for resale to investors) was solicited and originated, and is and has been administered and, where applicable, serviced, and the relevant Loan files are being maintained, in all material respects, in accordance with the relevant notes or other credit or security documents, the applicable written underwriting standards of Hancock and its Subsidiaries (and, in the case of Loans held for resale to investors, the applicable underwriting standards, if any, of the applicable investors) and with all applicable federal, state and local laws, regulations and rules.

(c) None of the agreements pursuant to which Hancock or any of its Subsidiaries has sold Loans or pools of Loans or participations in Loans or pools of Loans contains any obligation to repurchase such Loans or interests therein solely on account of a payment default (other than early payment defaults) by the obligor on any such Loan.

(d) There are no outstanding “extensions of credit” made by Hancock or any of its Subsidiaries to any “executive officer” or other “insider” (as each such term is defined in 12 C.F.R. Part 215) of Hancock or its Subsidiaries, other than extensions of credit that are subject to and that were made and continue to be in compliance with 12 C.F.R. Part 215 in all material respects or that are exempt therefrom.

(e) Subject to Section 9.7, neither Hancock nor any of its Subsidiaries is now, nor has it ever been since January 1, 2023, subject to any material fine, suspension, settlement or other administrative agreement or sanction by, or any reduction in any loan purchase commitment, any Governmental Entity or Regulatory Agency relating to the origination, sale or servicing of mortgage or consumer Loans.

 

-43-


4.22 Employee Benefit Plans.

(a) For purposes hereof, “Hancock Benefit Plans” means all Benefit Plans to or with respect to which Hancock or any Subsidiary or any trade or business of Hancock or any of its Subsidiaries, whether or not incorporated, all of which together with Hancock would be deemed a “single employer” within the meaning of Section 4001 of ERISA (a “Hancock ERISA Affiliate”), is a party or has any current or future obligation or that are maintained, contributed to or sponsored by Hancock or any of its Subsidiaries or any Hancock ERISA Affiliate, or to which Hancock or any of its Subsidiaries is required or obligated to maintain, contribute to or sponsor, for the benefit of any current or former employee, officer, director or independent contractor of Hancock or any of its Subsidiaries or any Hancock ERISA Affiliate.

(b) Each Hancock Benefit Plan has been established, operated, maintained and administered in all material respects in accordance with its terms and the requirements of all applicable laws, including ERISA and the Code, except for such noncompliance as would not result in any material liability to Hancock or its Subsidiaries.

(c) Except as would not result in any material liability to Hancock or its Subsidiaries, with respect to each Hancock Benefit Plan that is subject to Title IV or Section 302 of ERISA or Section 412, 430 or 4971 of the Code: (i) no such plan is in “at-risk” status for purposes of Section 430 of the Code, (ii) no reportable event within the meaning of Section 4043(c) of ERISA for which the 30 day notice requirement has not been waived has occurred, (iii) all premiums required to be paid to the PBGC have been timely paid in full, (iv) no material liability (other than for premiums to the PBGC) under Title IV of ERISA has been or is reasonably expected to be incurred by Hancock or any of its Subsidiaries, (v) the PBGC has not instituted proceedings to terminate any such Hancock Benefit Plan, (vi) to the knowledge of Hancock, the most recent actuarial report for such Hancock Benefit Plan is accurate in all material respects and (vii) there does not exist any accumulated funding deficiency within the meaning of Section 412 of the Code or Section 302 of ERISA, whether or not waived.

(d) None of Hancock and its Subsidiaries nor any Hancock ERISA Affiliate has, at any time during the last six years, contributed to or been obligated to contribute to any plan that is a Multiemployer Plan or a Multiple Employer Plan, and none of Hancock and its Subsidiaries nor any Hancock ERISA Affiliate has incurred any material liability to a Multiemployer Plan or Multiple Employer Plan as a result of a complete or partial withdrawal (as those terms are defined in Part I of Subtitle E of Title IV of ERISA) from a Multiemployer Plan or Multiple Employer Plan that has not been satisfied in full.

 

-44-


4.23 No Other Representations or Warranties.

(a) Except for the representations and warranties made by Hancock in this Article IV, neither Hancock nor any other person makes any express or implied representation or warranty with respect to Hancock, its Subsidiaries, or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects, and Hancock hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, neither Hancock nor any other person makes or has made any representation or warranty to Trustmark or any of its affiliates or representatives with respect to (i) any financial projection, forecast, estimate, budget or prospective information relating to Hancock, any of its Subsidiaries or their respective businesses, or (ii) except for the representations and warranties made by Hancock in this Article IV, any oral or written information presented to Trustmark or any of its affiliates or representatives in the course of their due diligence investigation of Hancock, the negotiation of this Agreement or in the course of the transactions contemplated hereby.

(b) Hancock acknowledges and agrees that neither Trustmark nor any other person has made or is making any express or implied representation or warranty other than those contained in Article III.

ARTICLE V

COVENANTS RELATING TO CONDUCT OF BUSINESS

5.1 Conduct of Business Prior to the Effective Time; Forbearances. During the period from the date of this Agreement to the Effective Time or earlier termination of this Agreement, except as expressly contemplated or permitted by this Agreement (including as set forth in the Trustmark Disclosure Schedule), required by law or as consented to in writing by Hancock (such consent not to be unreasonably withheld, conditioned or delayed), Trustmark shall, and shall cause its Subsidiaries to, conduct its business in the ordinary course in all material respects, and use reasonable best efforts to maintain and preserve intact its business organization and advantageous business relationships. In addition, during the period from the date of this Agreement to the Effective Time or earlier termination of this Agreement, except as set forth in the Trustmark Disclosure Schedule, as expressly contemplated or permitted by this Agreement or as required by law, Trustmark shall not, and shall not permit any of its Subsidiaries to, without the prior written consent of Hancock (such consent not to be unreasonably withheld, conditioned or delayed):

(a) other than in the ordinary course of business consistent with past practice, incur any indebtedness for borrowed money (other than indebtedness of Trustmark or any of its wholly-owned Subsidiaries to Trustmark or any of its wholly-owned Subsidiaries), or assume, guarantee, endorse or otherwise as an accommodation become responsible for the obligations of any other person (other than any wholly owned Subsidiary of Trustmark), it being understood and agreed that incurrence of indebtedness in the ordinary course of business consistent with past practice shall include federal funds borrowings and Federal Home Loan Bank borrowings, the creation of deposit liabilities, issuances of letters of credit, purchases of federal funds, sales of certificates of deposit and entry into repurchase agreements, in each case on terms and in amounts consistent with past practice;

(b) adjust, split, combine or reclassify any capital stock;

 

-45-


(c) make, declare, pay or set a record date for any dividend, or any other distribution on, or directly or indirectly redeem, purchase or otherwise acquire, any shares of its capital stock or other equity or voting securities or any securities or obligations convertible (whether currently convertible or convertible only after the passage of time or the occurrence of certain events) into or exchangeable for any shares of its capital stock or other equity or voting securities (except (i) regular quarterly cash dividends by Trustmark at a rate not in excess of $0.25 per share of Trustmark Common Stock, (ii) dividends provided for and paid on any trust preferred securities of Trustmark or its Subsidiaries, in each case in accordance with the terms thereof, (iii) dividends paid by any of the Subsidiaries of Trustmark to Trustmark or any of its wholly owned Subsidiaries, or (iv) the acceptance of shares of Trustmark Common Stock as payment for withholding taxes incurred in connection with the vesting or settlement of Trustmark Equity Awards, in each case, in accordance with past practice and the terms of the applicable award agreements);

(d) grant any stock options, stock appreciation rights, performance shares, restricted stock units, restricted shares or other equity-based awards or interests, including Trustmark Equity Awards, or grant any individual, corporation or other entity any right to acquire any shares of its capital stock or other equity or voting securities; or

(e) issue, sell or otherwise permit to become outstanding any additional shares of capital stock or other equity or voting securities or securities convertible or exchangeable into, or exercisable for or valued by reference to, any shares of its capital stock or any options, warrants, or other rights of any kind to acquire any shares of capital stock or other equity or voting securities, except for the vesting or settlement of Trustmark Equity Awards outstanding as of the date hereof or granted on or after the date hereof to the extent permitted under this Agreement;

(f) (i) sell, transfer, mortgage, encumber, license, abandon or otherwise dispose of any of its material properties or assets (including Intellectual Property), except for transfers to a wholly-owned Subsidiary, or (ii) cancel, release or assign any material indebtedness to any such person or any claims held by any person, in each case of (i) and (ii), other than in the ordinary course of business (including non-exclusive licenses of Intellectual Property granted in the ordinary course of business);

(g) except for transactions in the ordinary course of business (including by way of foreclosure or acquisitions of control in a fiduciary or similar capacity or in satisfaction of debts previously contracted in good faith), make any investment or acquisition, whether by purchase of stock or securities, contributions to capital, property transfers, merger or consolidation or formation of a joint venture or otherwise, in or of any property or assets of any other individual, corporation or other entity, in each case other than a wholly owned Subsidiary of Trustmark;

(h) in each case except for transactions in the ordinary course of business, (i) terminate, materially amend, or waive any material provision of, any Trustmark Contract, or make any material change in any instrument or agreement governing the terms of any of its securities, other than normal renewals in the ordinary course of business without material adverse changes to terms with respect to Trustmark or its Subsidiaries, or (ii) enter into any contract that would constitute a Trustmark Contract if it were in effect on the date of this Agreement (it being understood and agreed that entering into a Trustmark Contract that would be such pursuant to Sections 3.13(a)(ii), (v), (vii) or (x) is not ordinary course of business);

 

-46-


(i) except as required under applicable law or by the terms of any Trustmark Benefit Plan existing as of the date hereof, (i) enter into, adopt or terminate any Trustmark Benefit Plan (including any plans, programs, policies, agreements or arrangements that would be considered a Trustmark Benefit Plan if in effect as of the date hereof), (ii) amend (whether in writing or through the interpretation of) any Trustmark Benefit Plan (including any plans, programs, policies, agreements or arrangements adopted or entered into that would be considered a Trustmark Benefit Plan if in effect as of the date hereof), other than administrative amendments in the ordinary course of business consistent with past practice that do not increase the cost or expense of maintaining, or increase the benefits payable under, such plan, program, policy or arrangements (other than de minimis increases), (iii) increase the compensation, bonus, severance, termination pay or other benefits payable to any current, prospective or former employee, officer, director, independent contractor or consultant, (iv) pay, grant or award, or commit to pay, grant or award, any bonuses or incentive compensation, (v) accelerate the vesting of, or otherwise deviate from the terms provided in the applicable award agreement with respect to the vesting, payment, settlement or exercisability of, any Trustmark Equity Awards or other equity-based awards or other compensation, (vi) enter into any collective bargaining agreement or similar agreement or arrangement, (vii) fund or provide any funding for any rabbi trust or similar arrangement, (viii) terminate the employment or services of any Section 16 officer or any Senior Employee or any employee, independent contractor (who is a natural person) or consultant (who is a natural person) whose annual base salary or base fee is greater than $200,000, in each case other than for cause, or (ix) hire any Section 16 officer or any Senior Employee or any employee, independent contractor (who is a natural person) or consultant (who is a natural person) whose annual base salary or base fee is greater than $200,000;

(j) implement any plant closing or mass layoff as defined under the Worker Adjustment and Retraining Notification Act of 1988, as amended, or any similar U.S. state or local law;

(k) except for debt workouts in the ordinary course of business, settle any claim, suit, action or proceeding (i) in an amount and for consideration in excess of $150,000 individually or $300,000 in the aggregate (net of any insurance proceeds or indemnity, contribution or similar payments received by Trustmark or any of its Subsidiaries in respect thereof), or (ii) that would impose any material restriction on the business of Trustmark or its Subsidiaries or the Surviving Corporation or its Subsidiaries;

(l) take any action or knowingly fail to take any action where such action or failure to act could reasonably be expected to prevent the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code;

(m) amend the Trustmark Articles, the Trustmark Bylaws, or comparable governing documents of its “Significant Subsidiaries” (as such term is defined in Rule 1-02 of Regulation S-X promulgated under the Exchange Act);

 

-47-


(n) merge or consolidate itself or any of its Significant Subsidiaries with any other person, or restructure, reorganize or completely or partially liquidate or dissolve it or any of its Significant Subsidiaries;

(o) materially restructure or materially change its investment securities or derivatives portfolio or its interest rate exposure, through purchases, sales or otherwise, or the manner in which the portfolio is classified or reported, except as may be required by GAAP or by applicable laws, regulations, guidelines or policies imposed by any Governmental Entity or requested by a Governmental Entity;

(p) implement or adopt any change in its accounting principles, practices or methods, other than as may be required by GAAP or by applicable laws, regulations, guidelines or policies imposed by any Governmental Entity;

(q) (i) enter into any material new line of business or change in any material respect its lending, investment, underwriting, risk and asset liability management and other banking and operating, hedging policies, securitization and servicing policies (including any change in the maximum ratio or similar limits as a percentage of its capital exposure applicable with respect to its loan portfolio or any segment thereof), except as required by such policies or applicable law, regulation or policies imposed by any Governmental Entity, or (ii) make any loans or extensions of credit or renewals thereof, except in the ordinary course of business consistent with past practice and (A) in the case of any loan or extension of credit or renewal thereof with a risk rating of 5 or lower/better (as determined in the ordinary course of business consistent with past practice under Trustmark’s and its Subsidiaries’ lending policies in effect as of the date hereof), not in excess of $20,000,000, and (B) in the case of any loan or extension of credit or renewal thereof with a risk rating of 6 or higher/worse (as determined in the ordinary course of business consistent with past practice under Trustmark’s and its Subsidiaries’ lending policies in effect as of the date hereof), not in excess of $10,000,000; provided that any consent from Hancock sought pursuant to this clause (ii) shall not be unreasonably withheld; provided, further, that, if Hancock does not respond to any such request for consent within two business days after the relevant loan package is provided to Hancock, such non-response shall be deemed to constitute consent pursuant to this clause (ii);

(r) make, or commit to make, any capital expenditures that exceed Trustmark’s capital expenditure budget set forth in Section 5.1(r) of the Trustmark Disclosure Schedule by more than five percent (5%);

(s) make, change or revoke any material Tax election, change an annual Tax accounting period, adopt or change any material Tax accounting method, file any amended material Tax Return, enter into any closing agreement with respect to Taxes, or settle any material Tax claim, audit, assessment or dispute or surrender any right to claim a refund of a material amount of Taxes;

(t) (i) make any application for the opening or relocation of, or open or relocate, any branch office, loan production office or other significant office or operations facility of Trustmark or its Subsidiaries, (ii) other than in consultation with Hancock, make any application for the closing of or close any branch, or (iii) other than in consultation with Hancock, purchase any new real property (other than other real estate owned (OREO) properties in the ordinary course) in an amount in excess of $250,000 for any individual property or enter into, amend or renew any material lease with respect to real property requiring aggregate payments under any individual lease in excess of $100,000;

 

-48-


(u) knowingly take any action that is intended to or would reasonably be likely to adversely affect or materially delay the ability of Trustmark or its Subsidiaries to obtain any necessary approvals of any Governmental Entity required for the transactions contemplated hereby or by the Bank Merger Agreement or the Requisite Trustmark Vote or to perform its covenants and agreements under this Agreement or the Bank Merger Agreement or to consummate the transactions contemplated hereby or thereby; or

(v) agree to take, make any commitment to take, or adopt any resolutions of its Board of Directors or similar governing body in support of, any of the actions prohibited by this Section 5.1.

5.2 Hancock Forbearances. During the period from the date of this Agreement to the Effective Time or earlier termination of this Agreement, Hancock shall, and shall cause its Subsidiaries to, use reasonable best efforts to maintain and preserve intact its business organization and advantageous business relationships. In addition, during the period from the date of this Agreement to the Effective Time or earlier termination of this Agreement, except as set forth in the Hancock Disclosure Schedule, as expressly contemplated or permitted by this Agreement or as required by law, Hancock shall not, and shall not permit any of its Subsidiaries to, without the prior written consent of Trustmark (such consent not to be unreasonably withheld, conditioned or delayed):

(a) amend the Hancock Articles or the Hancock Bylaws in a manner that would materially and adversely affect the holders of Trustmark Common Stock relative to other holders of Hancock Common Stock;

(b) adjust, split, combine or reclassify any capital stock of Hancock or make, declare or pay any extraordinary dividend on any capital stock of Hancock;

(c) make any material investment whether by purchase of stock or securities, contributions to capital, property transfers, merger or consolidation or formation of a joint venture or otherwise, in or of any property or assets of any other individual, corporation or other entity, other than a wholly owned Subsidiary of Hancock, except for transactions in the ordinary course of business or in a transaction that, together with such other transactions, is not reasonably likely to prevent or materially delay the receipt of the Requisite Regulatory Approvals or the Closing;

(d) merge or consolidate itself or Hancock Whitney Bank with any other person (i) where it or Hancock Whitney Bank is not the surviving person or (ii) if the merger or consolidation is reasonably likely to prevent, materially delay or materially impair the receipt of the Requisite Regulatory Approvals or the Closing;

 

-49-


(e) take any action or knowingly fail to take any action where such action or failure to act could reasonably be expected to prevent the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code;

(f) knowingly take any action that is intended to or would reasonably be likely to adversely affect or materially delay the ability of Hancock or its Subsidiaries to obtain any necessary approvals of any Governmental Entity required for the transactions contemplated hereby or by the Bank Merger Agreement or the Requisite Hancock Vote or to perform its covenants and agreements under this Agreement or the Bank Merger Agreement or to consummate the transactions contemplated hereby or thereby; or

(g) agree to take, make any commitment to take, or adopt any resolutions of its Board of Directors or similar governing body in support of, any of the actions prohibited by this Section 5.2.

ARTICLE VI

ADDITIONAL AGREEMENTS

6.1 Regulatory Matters.

(a) Hancock and Trustmark shall promptly prepare and file with the SEC the Proxy Statement and Hancock shall promptly prepare and file with the SEC the S-4, in which the Proxy Statement will be included as a prospectus. Hancock and Trustmark, as applicable, shall use reasonable best efforts to make such filings within 30 days of the date of this Agreement. Each of Hancock and Trustmark shall use their reasonable best efforts to have the S-4 declared effective under the Securities Act as promptly as practicable after such filing and to keep the S-4 effective for so long as necessary to consummate the transactions contemplated by this Agreement, and Trustmark shall thereafter mail or deliver the Proxy Statement to its shareholders. Hancock shall also use its reasonable best efforts to obtain all necessary state securities law or “Blue Sky” permits and approvals required to carry out the transactions contemplated by this Agreement as promptly as practicable, and Trustmark shall furnish all information concerning Trustmark and the holders of Trustmark Common Stock as may be reasonably requested in connection with any such action.

(b) The parties hereto shall cooperate with each other and use their reasonable best efforts to promptly prepare and file all necessary documentation, to effect all applications, notices, petitions and filings (and in the case of the applications, notices, petitions and filings required to obtain the Requisite Regulatory Approvals, use their reasonable best efforts to make such filings within 30 days of the date of this Agreement), to obtain as promptly as practicable all permits, consents, approvals and authorizations of all third parties and Governmental Entities which are necessary or advisable to consummate the transactions contemplated by this Agreement (including the Merger and the Bank Merger), and to comply with the terms and conditions of all such permits, consents, approvals and authorizations of all such third parties and Governmental Entities. Hancock and Trustmark shall each use, and shall each cause their applicable Subsidiaries to use, reasonable best efforts to obtain each such Requisite Regulatory Approval and any approvals required for the Bank Merger as promptly as reasonably practicable.

 

-50-


The parties shall cooperate with each other in connection therewith (including the furnishing of any information and any reasonable undertaking or commitments that may be required to obtain the Requisite Regulatory Approvals) and shall respond as promptly as practicable to the requests of Governmental Entities for documents and information. Hancock and Trustmark shall have the right to review in advance, and, to the extent practicable, each will consult the other on, in each case subject to applicable law, all the information relating to Trustmark or Hancock, as the case may be, and any of their respective Subsidiaries, which appears in any filing made with, or written materials submitted to, any third party or any Governmental Entity in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each of the parties hereto shall act reasonably and as promptly as practicable. Each party will provide the other with copies of any applications and all correspondence relating thereto prior to filing and with sufficient opportunity to comment, other than any portions of material filed in connection therewith that contain competitively sensitive business or other proprietary information or confidential supervisory information filed under a claim of confidentiality. The parties hereto agree that they will consult with each other with respect to the obtaining of all permits, consents, approvals and authorizations of all third parties and Governmental Entities necessary or advisable to consummate the transactions contemplated by this Agreement and each party will keep the other apprised of the status of matters relating to completion of the transactions contemplated herein. Each party shall consult with the other in advance of any meeting or conference with any Governmental Entity in connection with the transactions contemplated by this Agreement and, to the extent permitted by such Governmental Entity, give the other party and/or its counsel the opportunity to attend and participate in such meetings and conferences; provided that the foregoing shall not apply to routine communications with a Governmental Entity solely regarding the status or timing of the regulatory approval process; and provided further, that each party shall promptly advise the other party with respect to substantive matters that are addressed in any meeting or conference with any Governmental Entity which the other party does not attend or participate in, to the extent permitted by such Governmental Entity and applicable law.

(c) In furtherance and not in limitation of the foregoing, each of Hancock and Trustmark shall use its reasonable best efforts to (i) avoid the entry of, or to have vacated, lifted, reversed or overturned any decree, judgment, injunction or other order, whether temporary, preliminary or permanent, that would restrain, prevent or delay the Closing, and (ii) avoid or eliminate each and every impediment so as to enable the Closing to occur as soon as possible, including proposing, negotiating, committing to and effecting, by consent decree, hold separate order, or otherwise, the sale, divestiture or disposition of businesses or assets of Hancock, Trustmark and their respective Subsidiaries. Notwithstanding the foregoing, nothing contained herein shall be deemed to require Hancock or Trustmark or any of their respective Subsidiaries, and neither Hancock nor Trustmark nor any of their respective Subsidiaries shall be permitted (without the written consent of the other party), to take any action, or commit to take any action, or agree to any condition, divestiture or restriction, in connection with the foregoing or the obtaining of any permits, consents, approvals and authorizations of Governmental Entities that would reasonably be likely to have a material adverse effect on the Surviving Corporation and its Subsidiaries, taken as a whole, after giving effect to the Merger (a “Materially Burdensome Regulatory Condition”).

 

-51-


(d) Hancock and Trustmark shall, upon request, furnish each other with all information concerning themselves, their Subsidiaries, directors, officers and shareholders and such other matters as may be reasonably necessary or advisable in connection with the Proxy Statement, the S-4 or any other statement, filing, notice or application made by or on behalf of Hancock, Trustmark or any of their respective Subsidiaries to any Governmental Entity in connection with the Merger, the Bank Merger and the other transactions contemplated by this Agreement. Each of Hancock and Trustmark agrees, as to itself and its Subsidiaries, that none of the information supplied or to be supplied by it specifically for inclusion or incorporation by reference in (i) the S-4 will, at the time the S-4 and each amendment or supplement thereto, if any, is filed and becomes effective under the Securities Act, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) the Proxy Statement and any amendment or supplement thereto will, at the time of filing and the date of mailing to the shareholders of Trustmark and at the time of the Trustmark Meeting and the Hancock Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which such statement was made, not misleading, and (iii) any applications, notices and filings required in order to obtain the Requisite Regulatory Approvals will, at the time each is filed, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading. Each of Hancock and Trustmark further agrees that if it becomes aware that any information furnished by it would cause any of the statements in the S-4 or the Proxy Statement to be false or misleading with respect to any material fact, or to omit to state any material fact necessary to make the statements therein not false or misleading, to promptly inform the other party thereof and to take appropriate steps to correct the S-4 or the Proxy Statement.

(e) Hancock and Trustmark shall promptly advise each other upon receiving any communication from any Governmental Entity whose consent or approval is required for consummation of the transactions contemplated by this Agreement that causes such party to believe that there is a reasonable likelihood that any Requisite Regulatory Approval will not be obtained or that the receipt of any such approval could be materially delayed.

6.2 Access to Information.

(a) Subject to Section 9.7, upon reasonable notice and subject to applicable laws, each of Hancock and Trustmark, for the purposes of verifying the representations and warranties of the other and preparing for the Merger and the other matters contemplated by this Agreement, shall, and shall cause each of their respective Subsidiaries to, afford to the officers, employees, accountants, counsel, advisors and other representatives of the other party, access, during normal business hours during the period prior to the Effective Time, to all its properties, books, contracts, personnel, information technology systems, and records, and each shall reasonably cooperate with the other party in preparing to execute after the Effective Time the conversion or consolidation of systems and business operations generally (including by entering into customary confidentiality, non-disclosure and similar agreements with such service providers), and, during such period, during normal business hours and in a manner so as not to interfere with normal business operations, each of Hancock and Trustmark shall, and shall cause its respective Subsidiaries to, make available to the other party such information concerning its

 

-52-


business, properties and personnel as such party may reasonably request. Each party shall use commercially reasonable efforts to minimize any interference with the other party’s regular business operations during any such access. Neither Hancock nor Trustmark nor any of their respective Subsidiaries shall be required to provide access to or to disclose information where such access or disclosure would violate or prejudice the rights of Hancock’s or Trustmark’s, as the case may be, customers, jeopardize the attorney-client privilege of the institution in possession or control of such information (after giving due consideration to the existence of any common interest, joint defense or similar agreement between the parties) or contravene any law, rule, regulation, order, judgment, decree, fiduciary duty or binding agreement entered into prior to the date of this Agreement. The parties hereto will make appropriate substitute disclosure arrangements under circumstances in which the restrictions of the preceding sentence apply.

(b) Each of Hancock and Trustmark shall hold all information furnished by or on behalf of the other party or any of such party’s Subsidiaries or representatives pursuant to Section 6.2(a) in confidence to the extent required by, and in accordance with, the provisions of the confidentiality agreement, dated October 1, 2026, between Hancock and Trustmark (the “Confidentiality Agreement”).

(c) No investigation by either of the parties or their respective representatives shall affect or be deemed to modify or waive the representations and warranties of the other set forth herein. Nothing contained in this Agreement shall give either party, directly or indirectly, the right to control or direct the operations of the other party prior to the Effective Time. Prior to the Effective Time, each party shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries’ respective operations.

6.3 Trustmark Shareholder Approval.

(a) Trustmark shall take, in accordance with applicable law and the Trustmark Articles and Trustmark Bylaws, all actions necessary to convene a meeting of its shareholders (the “Trustmark Meeting”) to be held as soon as reasonably practicable after the S-4 is declared effective for the purpose of obtaining the Requisite Trustmark Vote required in connection with this Agreement and the Merger. Trustmark shall engage a proxy solicitor reasonably acceptable to Hancock to assist in the solicitation of proxies from shareholders relating to the Requisite Trustmark Vote. The Board of Directors of Trustmark shall use its reasonable best efforts to obtain from the shareholders of Trustmark the Requisite Trustmark Vote, including by communicating to its shareholders its recommendation (and including such recommendation in the Proxy Statement) that they approve this Agreement and the transactions contemplated hereby (the “Trustmark Board Recommendation”). Trustmark and the Trustmark Board of Directors shall not (i) withhold, withdraw, modify or qualify in a manner adverse to Hancock the Trustmark Board Recommendation, (ii) fail to make the Trustmark Board Recommendation in the Proxy Statement, (iii) adopt, approve, recommend or endorse a Trustmark Acquisition Proposal or publicly announce an intention to adopt, approve, recommend or endorse a Trustmark Acquisition Proposal, (iv) fail to publicly and without qualification (A) recommend against any Trustmark Acquisition Proposal or (B) reaffirm the Trustmark Board Recommendation within ten business days (or such fewer number of days as remains prior to the Trustmark Meeting) after a Trustmark Acquisition Proposal is made public or any request by the other party to do so, or (v) publicly propose to do any of the foregoing (any of the foregoing a

 

-53-


“Trustmark Adverse Recommendation Change”). However, subject to Section 8.1 and Section 8.2, if the Board of Directors of Trustmark, after receiving the advice of its outside counsel and, with respect to financial matters, its financial advisors, determines in good faith that it would more likely than not result in a violation of its fiduciary duties under applicable law to continue to recommend this Agreement and the Merger, then, prior to the receipt of the Requisite Trustmark Vote, in submitting this Agreement and the Merger to its shareholders, the Board of Directors of Trustmark may withhold or withdraw or modify or qualify in a manner adverse to Hancock the Trustmark Board Recommendation or may submit this Agreement and the Merger to its shareholders without recommendation (although the resolutions approving this Agreement as of the date hereof may not be rescinded or amended), in which event the Board of Directors of Trustmark may communicate the basis for its lack of recommendation to its shareholders in the Proxy Statement or an appropriate amendment or supplement thereto; provided that the Board of Directors of Trustmark may not take any actions under this sentence unless (1) it gives Hancock at least three business days’ prior written notice of its intention to take such action and a reasonable description of the event or circumstances giving rise to its determination to take such action (including, in the event such action is taken by the Board of Directors of Trustmark in response to a Trustmark Acquisition Proposal, the latest material terms and conditions and the identity of the third party in any such Trustmark Acquisition Proposal, or any amendment or modification thereof, or describe in reasonable detail such other event or circumstances), and (2) at the end of such notice period, the Board of Directors of Trustmark takes into account any amendment or modification to this Agreement proposed by Hancock and after receiving the advice of its outside counsel and, with respect to financial matters, its financial advisors, determines in good faith that it would nevertheless more likely than not result in a violation of its fiduciary duties under applicable law to continue to recommend this Agreement and the Merger. Any material amendment to any Trustmark Acquisition Proposal will be deemed to be a new Trustmark Acquisition Proposal for purposes of this Section 6.3 and will require a new notice period as referred to in this Section 6.3.

(b) Trustmark shall adjourn or postpone the Trustmark Meeting, if, as of the time for which such meeting is originally scheduled, there are insufficient shares of Trustmark Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of such meeting, or if on the date of such meeting, Trustmark has not received proxies representing a sufficient number of shares necessary to obtain the Requisite Trustmark Vote. Notwithstanding anything to the contrary herein, unless this Agreement has been terminated in accordance with its terms, the Trustmark Meeting shall be convened and this Agreement and the Merger shall be submitted to the shareholders of Trustmark at the Trustmark Meeting, for the purpose of voting on the approval of this Agreement and the Merger and the other matters contemplated hereby, and nothing contained herein shall be deemed to relieve Trustmark of such obligation. Trustmark shall only be required to adjourn or postpone the Trustmark Meeting two (2) times pursuant to the first sentence of this Section 6.3(b).

 

-54-


6.4 Hancock Shareholder Approval.

(a) Hancock shall take, in accordance with applicable law and the Hancock Articles and Hancock Bylaws, all actions necessary to convene a meeting of its shareholders (the “Hancock Meeting”) to be held as soon as reasonably practicable after the S-4 is declared effective for the purpose of obtaining the Requisite Hancock Vote required in connection with this Agreement and the Merger. Hancock shall engage a proxy solicitor reasonably acceptable to Trustmark to assist in the solicitation of proxies from shareholders relating to the Requisite Hancock Vote. The Board of Directors of Hancock shall use its reasonable best efforts to obtain from the shareholders of Hancock the Requisite Hancock Vote, including by communicating to its shareholders its recommendation (and including such recommendation in the Proxy Statement) that they approve this Agreement and the transactions contemplated hereby (the “Hancock Board Recommendation”). Hancock and the Hancock Board of Directors shall not (i) withhold, withdraw, modify or qualify in a manner adverse to Trustmark the Hancock Board Recommendation, (ii) fail to make the Hancock Board Recommendation in the Proxy Statement, (iii) adopt, approve, recommend or endorse a Hancock Acquisition Proposal or publicly announce an intention to adopt, approve, recommend or endorse a Hancock Acquisition Proposal, (iv) fail to publicly and without qualification (A) recommend against any Hancock Acquisition Proposal or (B) reaffirm the Hancock Board Recommendation within ten business days (or such fewer number of days as remains prior to the Hancock Meeting) after a Hancock Acquisition Proposal is made public or any request by the other party to do so, or (v) publicly propose to do any of the foregoing (any of the foregoing a “Hancock Adverse Recommendation Change”). However, subject to Section 8.1 and Section 8.2, if the Board of Directors of Hancock, after receiving the advice of its outside counsel and, with respect to financial matters, its financial advisors, determines in good faith that it would more likely than not result in a violation of its fiduciary duties under applicable law to continue to recommend this Agreement and the Merger, then, prior to the receipt of the Requisite Hancock Vote, in submitting this Agreement and the Merger to its shareholders, the Board of Directors of Hancock may withhold or withdraw or modify or qualify in a manner adverse to Trustmark the Hancock Board Recommendation or may submit this Agreement and the Merger to its shareholders without recommendation (although the resolutions approving this Agreement as of the date hereof may not be rescinded or amended), in which event the Board of Directors of Hancock may communicate the basis for its lack of recommendation to its shareholders in the Proxy Statement or an appropriate amendment or supplement thereto; provided that the Board of Directors of Hancock may not take any actions under this sentence unless (1) it gives Trustmark at least three business days’ prior written notice of its intention to take such action and a reasonable description of the event or circumstances giving rise to its determination to take such action (including, in the event such action is taken by the Board of Directors of Hancock in response to a Hancock Acquisition Proposal, the latest material terms and conditions and the identity of the third party in any such Hancock Acquisition Proposal, or any amendment or modification thereof, or describe in reasonable detail such other event or circumstances), and (2) at the end of such notice period, the Board of Directors of Hancock takes into account any amendment or modification to this Agreement proposed by Trustmark and after receiving the advice of its outside counsel and, with respect to financial matters, its financial advisors, determines in good faith that it would nevertheless more likely than not result in a violation of its fiduciary duties under applicable law to continue to recommend this Agreement and the Merger. Any material amendment to any Hancock Acquisition Proposal will be deemed to be a new Hancock Acquisition Proposal for purposes of this Section 6.4 and will require a new notice period as referred to in this Section 6.4.

 

-55-


(b) Hancock shall adjourn or postpone the Hancock Meeting, if, as of the time for which such meeting is originally scheduled, there are insufficient shares of Hancock Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of such meeting, or if on the date of such meeting, Hancock has not received proxies representing a sufficient number of shares necessary to obtain the Requisite Hancock Vote. Notwithstanding anything to the contrary herein, unless this Agreement has been terminated in accordance with its terms, the Hancock Meeting shall be convened and this Agreement and the Merger shall be submitted to the shareholders of Hancock at the Hancock Meeting, for the purpose of voting on the approval of this Agreement and the Merger and the other matters contemplated hereby, and nothing contained herein shall be deemed to relieve Hancock of such obligation. Hancock shall only be required to adjourn or postpone the Hancock Meeting two (2) times pursuant to the first sentence of this Section 6.4(b).

6.5 Legal Conditions to Merger. Subject in all respects to Section 6.1 of this Agreement, each of Hancock and Trustmark shall, and shall cause its Subsidiaries to, use their reasonable best efforts, in each case as promptly as practicable, (a) to take, or cause to be taken, all actions necessary, proper or advisable to comply promptly with all legal and regulatory requirements that may be imposed on such party or its Subsidiaries with respect to the Merger and the Bank Merger and, subject to the conditions set forth in Article VII hereof, to consummate the transactions contemplated by this Agreement, and (b) to obtain (and to cooperate with the other party to obtain) any material consent, authorization, order or approval of, or any exemption by, any Governmental Entity and any other third party that is required to be obtained by Trustmark or Hancock or any of their respective Subsidiaries in connection with the Merger, the Bank Merger and the other transactions contemplated by this Agreement.

6.6 Stock Exchange Listing. Hancock shall cause the shares of Hancock Common Stock to be issued in the Merger to be approved for listing on the Nasdaq, subject to official notice of issuance, prior to the Effective Time.

6.7 Tax Treatment.

(a) Hancock shall use its reasonable best efforts to, and cause each of its Subsidiaries to, (i) cause the Merger to qualify as a “reorganization” within the meaning of Section 368(a) of the Code, and (ii) obtain the opinion of counsel referred to in Section 7.2(c). Hancock shall not take any action (or fail to take any action, including failing to use its reasonable best efforts to proscribe any of its respective Subsidiaries from taking any action) that could reasonably be expected to prevent or impede such qualification.

(b) Trustmark shall use its reasonable best efforts to, and cause each of its Subsidiaries to, (i) cause the Merger to qualify as a “reorganization” within the meaning of Section 368(a) of the Code, and (ii) obtain the opinion of counsel referred to in Section 7.3(c). Trustmark shall not take any action (or fail to take any action, including failing to use its reasonable best efforts to proscribe any of its Subsidiaries from taking any action) that could reasonably be expected to prevent or impede such qualification.

(c) Unless otherwise required pursuant to a “determination” within the meaning of Section 1313(a) of the Code, (i) each of the parties hereto shall report the Merger for U.S. federal income Tax purposes as a “reorganization” within the meaning of Section 368(a) of the Code in all Tax Returns, and (ii) none of the parties hereto shall take any Tax reporting position inconsistent with the characterization of the transactions contemplated by this Agreement as a “reorganization” under Section 368(a) of the Code. The parties hereto adopt this Agreement as a plan of reorganization for purposes of Sections 354 and 361 of the Code and Treasury Regulations Section 1.368-2(g).

 

-56-


(d) Each of Trustmark and Hancock shall deliver to Trustmark’s counsel and Hancock’s counsel at such time or times as reasonably requested by Trustmark’s counsel or Hancock’s counsel letters signed by an officer thereof for the purposes of obtaining the (i) Tax opinion from Hancock’s counsel described in Section 7.2(c) and (ii) the Tax opinion from Trustmark’s counsel described in Section 7.3(c).

6.8 Employee Matters.

(a) Hancock shall provide the employees of Trustmark and its Subsidiaries as of the Effective Time (the “Continuing Employees”), for so long as they are employed for the period beginning at the Effective Time and continuing through the first anniversary thereof (or such shorter period as specified in clause (ii)), with the following: (i) annual base salary or wages, as applicable, that are no less than the annual base salary or wages in effect for each such employee immediately prior to the Effective Time, (ii) from the Effective Time through the end of the quarter in which the bank systems conversion occurs (or such other time as is in the best interests of the employees of the Surviving Corporation), target annual bonus, commission and other short-term cash incentive compensation opportunities, as applicable, that are no less than the target annual bonus, commission and other short-term cash incentive compensation opportunities in effect for such employee immediately prior to the Effective Time, and (iii) employee benefits (excluding change in control or retention arrangements, any frozen benefit plans of Hancock and its Subsidiaries or benefit plans that exclusively provide benefits to grandfathered employees of Hancock and its Subsidiaries) that are substantially comparable in the aggregate to those provided to similarly situated employees of Hancock or its Subsidiaries; provided that, until such time as Hancock fully integrates the Continuing Employees into its plans, participation in the Trustmark Benefit Plans shall be deemed to satisfy the foregoing standard, it being understood that the Continuing Employees may commence participating in the plans of Hancock and its Subsidiaries on different dates following the Effective Time with respect to different benefit plans. For a period beginning at the Effective Time and continuing through the first anniversary thereof, each Continuing Employee who is not party to an individual agreement providing for severance or termination benefits and is terminated by Hancock in a qualifying termination under the Hancock Severance Pay Plan, as amended prior to Closing as set forth in Section 6.8(a) of the Trustmark Disclosure Schedule, shall be eligible to receive the severance benefits thereunder, subject to the terms and conditions of such plan and such employee’s execution (and non-revocation) of a release of claims.

(b) With respect to any employee benefit plans of Hancock or its Subsidiaries in which any Continuing Employees become eligible to participate on or after the Effective Time (the “New Plans”), Hancock and its Subsidiaries shall: (i) waive all pre-existing conditions, exclusions and waiting periods with respect to participation and coverage requirements applicable to such employees and their eligible dependents under any New Plans, except to the extent such pre-existing conditions, exclusions or waiting periods would apply under the analogous Trustmark Benefit Plan; (ii) use commercially reasonable efforts to provide each such employee and their eligible dependents with credit for any co-payments or coinsurance and

 

-57-


deductibles paid prior to the Effective Time under a Trustmark Benefit Plan that provides health care benefits (including medical, dental and vision), to the same extent that such credit was given under the analogous Trustmark Benefit Plan prior to the Effective Time, in satisfying any applicable deductible, co-payment, coinsurance or maximum out-of-pocket requirements under any New Plans; and (iii) recognize all service of such employees with Trustmark and its Subsidiaries for all purposes in any New Plan to the same extent that such service was taken into account under the analogous Trustmark Benefit Plan prior to the Effective Time; provided that the foregoing service recognition shall not apply (A) to the extent it would result in duplication of benefits for the same period of service, (B) for purposes of any retiree medical plan or defined benefit pension plan, (C) for purposes of any benefit plan that is a frozen plan or provides grandfathered benefits, or (D) for purposes of any equity incentive awards granted by Hancock.

(c) Effective as of the Effective Time, Hancock agrees to assume and honor all Trustmark Benefit Plans in accordance with their terms as of the date hereof, it being understood that this sentence shall not be construed to limit the ability of Hancock or any of its Subsidiaries or affiliates to amend or terminate any Trustmark Benefit Plan to the extent that such amendment or termination is permitted by the terms of the applicable plan.

(d) Unless otherwise requested by Hancock in writing at least five business days prior to the Effective Time, Trustmark shall cause any 401(k) plan sponsored or maintained by Trustmark (the “Trustmark 401(k) Plan”) to be terminated effective as of the day immediately prior to the Effective Time and contingent upon the occurrence of the Closing. In the event that the Trustmark 401(k) Plan is terminated, the Continuing Employees shall be eligible to participate, effective as soon as reasonably practicable (and not more than 30 days) after the Effective Time, in a 401(k) plan sponsored or maintained by Hancock or one of its Subsidiaries (a “Hancock 401(k) Plan”). Trustmark and Hancock shall take any and all actions as may be required, including amendments to the Trustmark 401(k) Plan and/or Hancock 401(k) Plan to permit the Continuing Employees who are then actively employed to make rollover contributions to the Hancock 401(k) Plan of “eligible rollover distributions” (with the meaning of Section 401(a)(31) of the Code) in the form of cash, notes (in the case of loans) or a combination thereof. Trustmark shall provide Hancock with evidence that the Trustmark 401(k) Plan has been terminated or amended, as applicable, in accordance with this Section 6.8(d); provided that prior to amending or terminating the Trustmark 401(k) Plan, Trustmark shall provide the form and substance of any applicable resolutions or amendments to Hancock for review and approval (which approval shall not be unreasonably withheld, conditioned or delayed).

(e) On and after the date hereof, any broad-based employee notices or communication materials (including any website posting) to be provided or communicated by Trustmark with respect to employment, compensation or benefits matters addressed in this Agreement or related, directly or indirectly, to the transactions contemplated by this Agreement shall be subject to the prior prompt review and comment of Hancock, and Trustmark shall consider in good faith revising such notice or communication to reflect any comments or advice that Hancock timely provides.

 

-58-


(f) Nothing in this Agreement shall confer upon any employee, officer, director or consultant of Trustmark or any of its Subsidiaries or affiliates any right to continue in the employ or service of the Surviving Corporation, Trustmark, Hancock, or any Subsidiary or affiliate thereof, or shall interfere with or restrict in any way the rights of the Surviving Corporation, Trustmark, Hancock or any Subsidiary or affiliate thereof to discharge or terminate the services of any employee, officer, director or consultant of Trustmark or any of its Subsidiaries or affiliates at any time for any reason whatsoever, with or without cause. Nothing in this Agreement shall be deemed to (i) establish, amend, or modify any Trustmark Benefit Plan, New Plan or any other benefit or employment plan, program, agreement or arrangement, or (ii) alter or limit the ability of the Hancock or any of its Subsidiaries or affiliates to amend, modify or terminate any particular Trustmark Benefit Plan, New Plan or any other benefit or employment plan, program, agreement or arrangement after the Effective Time to the extent that such amendment, modification or termination is permitted by the terms of the applicable plan, program, agreement or arrangement. Without limiting the generality of Section 9.12, nothing in this Agreement, express or implied, is intended to or shall confer upon any person, including any current or former employee, officer, director or consultant of Trustmark or any of its Subsidiaries or affiliates, any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

6.9 Indemnification; Directors’ and Officers’ Insurance.

(a) From and after the Effective Time, the Surviving Corporation shall indemnify and hold harmless, to the fullest extent permitted by applicable law, each present and former director, officer or employee of Trustmark and its Subsidiaries (in each case, when acting in such capacity) (collectively, the “Trustmark Indemnified Parties”) against any costs or expenses (including reasonable attorneys’ fees), judgments, fines, losses, damages or liabilities incurred in connection with any threatened or actual claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, whether arising before or after the Effective Time, arising in whole or in part out of, or pertaining to, the fact that such person is or was a director, officer or employee of Trustmark or any of its Subsidiaries or is or was serving at the request of Trustmark or any of its Subsidiaries as a director or officer of another person and pertaining to matters, acts or omissions existing or occurring at or prior to the Effective Time, including matters, acts or omissions occurring in connection with the approval of this Agreement and the transactions contemplated by this Agreement, and the Surviving Corporation shall also advance expenses as incurred by the Trustmark Indemnified Party to the fullest extent permitted by applicable law; provided that in the case of advancement of expenses the Trustmark Indemnified Party to whom expenses are advanced provides an undertaking (in a reasonable and customary form) to repay such advances if it is ultimately determined that such Trustmark Indemnified Party is not entitled to indemnification.

(b) For a period of six years after the Effective Time, the Surviving Corporation shall maintain in effect the current policies of directors’ and officers’ liability insurance maintained by Trustmark (provided that the Surviving Corporation may substitute therefor policies with a substantially comparable insurer of at least the same coverage and amounts containing terms and conditions which are no less advantageous to the insured) with respect to claims against the present and former officers and directors of Trustmark or any of its Subsidiaries arising from facts or events which occurred at or before the Effective Time (including the transactions contemplated by this Agreement); provided, however, that the Surviving Corporation shall not be obligated to expend, on an annual basis, an amount in excess of three hundred percent (300%) of the current annual premium paid as of the date hereof by

 

-59-


Trustmark for such insurance (the “Premium Cap”), and if such premiums for such insurance would at any time exceed the Premium Cap, then the Surviving Corporation shall cause to be maintained policies of insurance that, in its good-faith determination, provide the maximum coverage available at an annual premium equal to the Premium Cap. In lieu of the foregoing, Trustmark, in consultation with, but only upon the consent of Hancock, may (and at the request of Hancock, Trustmark shall use its reasonable best efforts to) obtain at or prior to the Effective Time a six year “tail” policy under Trustmark’s existing directors’ and officers’ insurance policy providing equivalent coverage to that described in the preceding sentence if and to the extent that the same may be obtained for an amount that, in the aggregate, does not exceed the Premium Cap. If Trustmark purchases such a tail policy, the Surviving Corporation shall maintain such tail policy in full force and effect and continue to honor its obligations thereunder.

(c) The provisions of this Section 6.9 shall survive the Effective Time and are intended to be for the benefit of, and shall be enforceable by, each Trustmark Indemnified Party and his or her heirs and representatives. If the Surviving Corporation or any of its successors or assigns consolidates with or merges into any other entity and is not the continuing or surviving entity of such consolidation or merger, transfers all or substantially all of its assets or deposits to any other entity or engages in any similar transaction, then in each case, the Surviving Corporation will cause proper provision to be made so that the successors and assigns of the Surviving Corporation will expressly assume the obligations set forth in this Section 6.9.

(d) The obligations of the Surviving Corporation, Hancock and Trustmark under this Section 6.9 shall not be terminated or modified in a manner so as to adversely affect any Trustmark Indemnified Party or any other person entitled to the benefit of this Section 6.9 without the prior written consent of the affected person.

6.10 Additional Agreements. In case at any time after the Effective Time any further action is necessary or desirable to carry out the purposes of this Agreement or to vest Hancock or the Surviving Corporation with full title to all properties, assets, rights, approvals, immunities and franchises of any of the parties to the Merger, the then current officers and directors of each party to this Agreement and their respective Subsidiaries shall take, or cause to be taken, all such necessary action as may be reasonably requested by the other party, at the expense of the party who makes any such request.

6.11 Advice of Changes. Hancock and Trustmark shall each promptly advise the other party of any effect, change, event, circumstance, condition, occurrence or development known to it (a) that has had or is reasonably likely to have a Material Adverse Effect on it, or (b) which it believes would or would be reasonably likely to cause or constitute a material breach of any of its representations, warranties or covenants contained herein or that reasonably could be expected to give rise, individually or in the aggregate, to the failure of a condition in Article VII; provided that any failure to give notice in accordance with the foregoing with respect to any breach shall not be deemed to constitute a violation of this Section 6.11 or the failure of any condition set forth in Sections 7.2 or 7.3 to be satisfied, or otherwise constitute a breach of this Agreement by the party failing to give such notice, in each case unless the underlying breach would independently result in a failure of the conditions set forth in Sections 7.2 or 7.3 to be satisfied; and provided, further, that the delivery of any notice pursuant to this Section 6.11 shall not cure any breach of, or noncompliance with, any other provision of this Agreement or limit the remedies available to the party receiving such notice.

 

-60-


6.12 Dividends. After the date of this Agreement, each of Hancock and Trustmark shall coordinate with the other the declaration of any dividends in respect of Hancock Common Stock and Trustmark Common Stock and the record dates and payment dates relating thereto, it being the intention of the parties hereto that holders of Trustmark Common Stock shall not receive two (2) dividends, or fail to receive one (1) dividend, in any quarter with respect to their shares of Trustmark Common Stock and any shares of Hancock Common Stock any such holder receives in exchange therefor in the Merger.

6.13 Trustmark Director Appointments; Central Mississippi Advisory Board

(a) Hancock shall take all requisite action so that, effective as of the Effective Time, five (5) individuals currently serving as directors of Trustmark are appointed to the Board of Directors of Hancock. The five (5) individuals shall be identified and selected by the Nominating and Corporate Governance Committee of the Board of Directors of Hancock, in accordance with Hancock’s standard director nomination, vetting and governance process (including satisfaction of applicable director independence, qualification and committee eligibility criteria), after considering the recommendations of the Chair of the Board of Directors of Trustmark and the Chief Executive Officer of Trustmark; provided that one (1) of the five (5) seats shall be allocated to the current Chief Executive Officer of Trustmark. Hancock shall take all actions necessary and appropriate (including increasing the size of its Board of Directors) to effectuate the foregoing appointments as of the Effective Time.

(b) Effective as of the Effective Time, Hancock shall establish an advisory board for the Jackson, Mississippi metropolitan area (the “Central Mississippi Advisory Board”). The members of the Central Mississippi Advisory Board shall be appointed by Hancock after considering the recommendations of the Chair of the Board of Directors of Trustmark and the Chief Executive Officer of Trustmark. The Central Mississippi Advisory Board shall have an advisory role and shall operate pursuant to a charter adopted by Hancock, which charter shall set forth the composition, term, meeting frequency and compensation of the members.

6.14 Acquisition Proposals.

(a) Trustmark shall not, and shall cause its Subsidiaries and use its reasonable best efforts to cause its and their officers, directors, agents, advisors and representatives (collectively, “Trustmark Representatives”) not to, directly or indirectly, (i) initiate, solicit, knowingly encourage or knowingly facilitate any inquiries or proposals with respect to, (ii) engage or participate in any negotiations with any person concerning or (iii) provide any confidential or nonpublic information or data to, or have or participate in any discussions with, any person relating to, any Trustmark Acquisition Proposal, except to notify a person that has made or, to the knowledge of Trustmark, is making any inquiries with respect to, or is considering making, a Trustmark Acquisition Proposal of the existence of the provisions of this Section 6.14(a); provided that, prior to the receipt of the Requisite Trustmark Vote, in the event Trustmark receives an unsolicited bona fide written Trustmark Acquisition Proposal, it may, and may permit its Subsidiaries and its and its Subsidiaries’ Trustmark Representatives to, furnish or

 

-61-


cause to be furnished nonpublic information or data and participate in such negotiations or discussions to the extent that its Board of Directors concludes in good faith (after receiving the advice of its outside counsel, and with respect to financial matters, its financial advisors) that failure to take such actions would be more likely than not to result in a violation of its fiduciary duties under applicable law; provided, further, that, prior to or concurrently with providing any nonpublic information permitted to be provided pursuant to the foregoing proviso, Trustmark shall have provided such information to Hancock, and shall have entered into a confidentiality agreement with such third party on terms no less favorable to it than the Confidentiality Agreement, which confidentiality agreement shall not provide such person with any exclusive right to negotiate with Trustmark. Trustmark will, and will use its reasonable best efforts to cause its Trustmark Representatives to, immediately cease and cause to be terminated any activities, discussions or negotiations conducted before the date of this Agreement with any person other than Hancock with respect to any Trustmark Acquisition Proposal. Trustmark will promptly (and in any event within one business day) advise Hancock following receipt of any Trustmark Acquisition Proposal or any inquiry which could reasonably be expected to lead to a Trustmark Acquisition Proposal, and the substance thereof (including the material terms and conditions of and the identity of the person making such inquiry or Trustmark Acquisition Proposal) and will keep Hancock reasonably apprised of any related developments, discussions and negotiations on a current basis, including any amendments to or revisions of the material terms of such inquiry or Trustmark Acquisition Proposal. Trustmark shall use its reasonable best efforts, subject to applicable law and the fiduciary duties of the Board of Directors of Trustmark, to enforce any existing confidentiality or standstill agreements to which it or any of its Subsidiaries is a party in accordance with the terms thereof. During the term of this Agreement, Trustmark shall not, and shall cause its Subsidiaries and its and their Trustmark Representatives not to, on its behalf, enter into any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or other similar agreement (other than a confidentiality agreement referred to and entered into in accordance with this Section 6.14(a)) relating to any Trustmark Acquisition Proposal. As used in this Agreement, “Trustmark Acquisition Proposal” shall mean, other than the transactions contemplated by this Agreement, any offer, inquiry or proposal relating to, or any third party indication of interest in, (A) any acquisition or purchase, direct or indirect, of twenty-five percent (25%) or more of the consolidated assets of Trustmark and its Subsidiaries or twenty-five percent (25%) or more of any class of equity or voting securities of Trustmark or its Subsidiaries whose assets, individually or in the aggregate, constitute twenty-five percent (25%) or more of the consolidated assets of Trustmark, (B) any tender offer or exchange offer that, if consummated, would result in such third party beneficially owning twenty-five percent (25%) or more of any class of equity or voting securities of Trustmark or its Subsidiaries whose assets, individually or in the aggregate, constitute twenty-five percent (25%) or more of the consolidated assets of Trustmark, or (C) a merger, consolidation, share exchange or other business combination, reorganization or similar transaction involving Trustmark or its Subsidiaries whose assets, individually or in the aggregate, constitute twenty-five percent (25%) or more of the consolidated assets of Trustmark.

(b) Hancock shall not, and shall cause its Subsidiaries and use its reasonable best efforts to cause its and their officers, directors, agents, advisors and representatives (collectively, “Hancock Representatives”) not to, directly or indirectly, (i) initiate, solicit, knowingly encourage or knowingly facilitate any inquiries or proposals with respect to, (ii) engage or participate in any negotiations with any person concerning or (iii) provide any

 

-62-


confidential or nonpublic information or data to, or have or participate in any discussions with, any person relating to, any Hancock Acquisition Proposal, except to notify a person that has made or, to the knowledge of Hancock, is making any inquiries with respect to, or is considering making, a Hancock Acquisition Proposal of the existence of the provisions of this Section 6.14(b); provided that, prior to the receipt of the Requisite Hancock Vote, in the event Hancock receives an unsolicited bona fide written Hancock Acquisition Proposal, it may, and may permit its Subsidiaries and its and its Subsidiaries’ Hancock Representatives to, furnish or cause to be furnished nonpublic information or data and participate in such negotiations or discussions to the extent that its Board of Directors concludes in good faith (after receiving the advice of its outside counsel, and with respect to financial matters, its financial advisors) that failure to take such actions would be more likely than not to result in a violation of its fiduciary duties under applicable law; provided, further, that, prior to or concurrently with providing any nonpublic information permitted to be provided pursuant to the foregoing proviso, Hancock shall have provided such information to Trustmark, and shall have entered into a confidentiality agreement with such third party on terms no less favorable to it than the Confidentiality Agreement, which confidentiality agreement shall not provide such person with any exclusive right to negotiate with Hancock. Hancock will, and will use its reasonable best efforts to cause its Hancock Representatives to, immediately cease and cause to be terminated any activities, discussions or negotiations conducted before the date of this Agreement with any person other than Trustmark with respect to any Hancock Acquisition Proposal. Hancock will promptly (and in any event within one business day) advise Trustmark following receipt of any Hancock Acquisition Proposal or any inquiry which could reasonably be expected to lead to a Hancock Acquisition Proposal, and the substance thereof (including the material terms and conditions of and the identity of the person making such inquiry or Hancock Acquisition Proposal) and will keep Trustmark reasonably apprised of any related developments, discussions and negotiations on a current basis, including any amendments to or revisions of the material terms of such inquiry or Hancock Acquisition Proposal. Hancock shall use its reasonable best efforts, subject to applicable law and the fiduciary duties of the Board of Directors of Hancock, to enforce any existing confidentiality or standstill agreements to which it or any of its Subsidiaries is a party in accordance with the terms thereof. During the term of this Agreement, Hancock shall not, and shall cause its Subsidiaries and its and their Hancock Representatives not to on its behalf, enter into any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or other similar agreement (other than a confidentiality agreement referred to and entered into in accordance with this Section 6.14(b)) relating to any Hancock Acquisition Proposal. As used in this Agreement, “Hancock Acquisition Proposal” shall mean, other than the transactions contemplated by this Agreement, any offer, inquiry or proposal relating to, or any third party indication of interest in, (A) any acquisition or purchase, direct or indirect, of twenty-five percent (25%) or more of the consolidated assets of Hancock and its Subsidiaries or twenty-five percent (25%) or more of any class of equity or voting securities of Hancock or its Subsidiaries whose assets, individually or in the aggregate, constitute twenty-five percent (25%) or more of the consolidated assets of Hancock, (B) any tender offer or exchange offer that, if consummated, would result in such third party beneficially owning twenty-five percent (25%) or more of any class of equity or voting securities of Hancock or its Subsidiaries whose assets, individually or in the aggregate, constitute twenty-five percent (25%) or more of the consolidated assets of Hancock, or (C) a merger, consolidation, share exchange or other business combination, reorganization or similar transaction involving Hancock or its Subsidiaries whose assets, individually or in the aggregate, constitute twenty-five percent (25%) or more of the consolidated assets of Hancock.

 

-63-


(c) Nothing contained in this Agreement shall prevent either party or its Board of Directors from complying with Rule 14d-9 and Rule 14e-2 under the Exchange Act with respect to a Trustmark Acquisition Proposal or a Hancock Acquisition Proposal or from making any legally required disclosure to such party’s shareholders; provided that such Rules and disclosures will in no way eliminate or modify the effect that any action pursuant to such Rules or any such disclosures would otherwise have under this Agreement.

6.15 Public Announcements. Trustmark and Hancock shall each use their reasonable best efforts to develop a joint communications plan, to ensure that all press releases and other public statements with respect to the transactions contemplated hereby shall be consistent with such joint communications plan, and except in respect of (a) any announcement required by applicable law or regulation, or a request by a Governmental Entity, (b) communications that are substantially similar to communications previously approved pursuant to this Section 6.15, (c) communications permitted by Sections 6.3 or 6.4, or (d) an obligation pursuant to any listing agreement with or rules of any securities exchange, Trustmark and Hancock agree to consult with each other and to obtain the advance approval of the other party (which approval shall not be unreasonably withheld, conditioned or delayed) before issuing any press release or, to the extent practical, otherwise making any public statement with respect to this Agreement or the transactions contemplated hereby.

6.16 Change of Method. Hancock may at any time change the method of effecting the Merger if and to the extent requested by Hancock, and Trustmark agrees to enter into such amendments to this Agreement as Hancock may reasonably request in order to give effect to such restructuring; provided, however, that no such change or amendment shall (a) alter or change the amount or kind of the Merger Consideration provided for in this Agreement, (b) adversely affect the Tax treatment of the Merger with respect to Trustmark’s shareholders, or (c) be reasonably likely to cause the Closing to be materially delayed or the receipt of the Requisite Regulatory Approvals to be prevented or materially delayed.

6.17 Restructuring Efforts. If Trustmark shall have failed to obtain the Requisite Trustmark Vote at the duly convened Trustmark Meeting or any adjustment or postponement thereof, if Hancock shall have failed to obtain the Requisite Hancock Vote at the duly convened Hancock Meeting or any adjournment or postponement thereof, the parties shall in good faith use their reasonable best efforts to negotiate a restructuring of the transactions contemplated by this Agreement (provided, however, that no party shall have any obligation to agree to (a) alter or change any material term of this Agreement, including the amount or kind of the Merger Consideration, in a manner adverse to such party or its shareholders, or (b) adversely affect the Tax treatment of the Merger with respect to such party or its shareholders) and/or resubmit this Agreement and the transactions contemplated hereby (or as restructured pursuant to this Section 6.17) to its shareholders for approval.

 

-64-


6.18 Takeover Restrictions. Trustmark shall not take any action that would cause any Takeover Restriction to become applicable to this Agreement, the Merger, or any of the other transactions contemplated hereby, and Trustmark shall take all necessary steps to exempt (or ensure the continued exemption of) the Merger and the other transactions contemplated hereby from any applicable Takeover Restriction now or hereafter in effect. If any Takeover Restriction may become, or may purport to be, applicable to the transactions contemplated hereby, Trustmark will grant such approvals and take such actions as are necessary so that the transactions contemplated by this Agreement may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to eliminate or minimize the effects of any Takeover Restriction on any of the transactions contemplated by this Agreement, including, if necessary, challenging the validity or applicability of any such Takeover Restriction.

6.19 Exemption from Liability Under Section 16(b). Trustmark and Hancock agree that, in order to most effectively compensate and retain those officers and directors of Trustmark subject to the reporting requirements of Section 16(a) of the Exchange Act (the “Trustmark Insiders”), both prior to and after the Effective Time, it is desirable that Trustmark Insiders not be subject to a risk of liability under Section 16(b) of the Exchange Act to the fullest extent permitted by applicable law in connection with the conversion of shares of Trustmark Common Stock and Trustmark Restricted Stock Unit Awards in the Merger, and for that compensatory and retentive purpose agree to the provisions of this Section 6.19. The Boards of Directors of Hancock and of Trustmark, or a committee of non-employee directors thereof (as such term is defined for purposes of Rule 16b-3(d) under the Exchange Act), shall prior to the Effective Time, take all such steps as may be necessary or appropriate to cause (a) in the case of Trustmark, any dispositions of Trustmark Common Stock or Trustmark Restricted Stock Unit Awards by Trustmark Insiders and (b) in the case of Hancock, any acquisitions of Hancock Common Stock or equity awards of Hancock into which the Trustmark Equity awards are converted by any Trustmark Insiders who, immediately following the Merger, will be officers or directors of Hancock subject to the reporting requirements of Section 16(a) of the Exchange Act, in each case pursuant to the transactions contemplated by this Agreement, to be exempt from liability pursuant to Rule 16b-3 under the Exchange Act to the fullest extent permitted by applicable law.

6.20 Litigation and Claims. Each of Hancock and Trustmark shall, to the extent permitted under applicable law and regulation, promptly notify the other party in writing of any action, arbitration, audit, hearing, investigation, litigation, suit, subpoena or summons issued, commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Entity or arbitrator pending or, to the knowledge of Hancock or Trustmark, as applicable, threatened against Hancock, Trustmark or any of their respective Subsidiaries that (a) questions or would reasonably be expected to question the validity of this Agreement, the Bank Merger Agreement or the other agreements contemplated hereby or thereby or any actions taken or to be taken by Hancock, Trustmark, or their respective Subsidiaries with respect hereto or thereto, or (b) seeks to enjoin or otherwise restrain the transactions contemplated hereby or thereby. Trustmark shall give Hancock the opportunity to participate at its own expense in the defense or settlement of any shareholder litigation against Trustmark and/or its directors or affiliates relating to the transactions contemplated by this Agreement, and no such settlement shall be agreed without Hancock’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed).

 

-65-


6.21 Assumption of Trustmark Debt. Effective at the Effective Time (or at the effective time of the Bank Merger for any debt of Trustmark Bank), Hancock or Hancock Whitney Bank, as applicable, shall, to the extent permitted thereunder and required thereby, assume the due and punctual performance and observance of the covenants to be performed by Trustmark or Trustmark Bank pursuant to the definitive documents governing the short-term and long-term borrowings set forth on Section 6.21 of the Trustmark Disclosure Schedule, and the due and punctual payment of the principal of such borrowings (and premium, if any) and interest thereon. In connection therewith, (a) Hancock and Trustmark shall, and shall cause Hancock Whitney Bank and Trustmark Bank respectively to, cooperate and use reasonable best efforts to execute and deliver any supplemental indentures, if applicable, and (b) Hancock and Trustmark shall, and shall cause Hancock Whitney Bank and Trustmark Bank respectively to, use reasonable best efforts to execute and deliver any officer’s certificates or other documents, and to provide any opinions of counsel to the trustee thereof, in each case, required to make such assumption effective as of the Effective Time or the effective time of the Bank Merger, as applicable.

ARTICLE VII

CONDITIONS PRECEDENT

7.1 Conditions to Each Party’s Obligation to Effect the Merger. The respective obligations of the parties to effect the Merger shall be subject to the satisfaction at or prior to the Effective Time of the following conditions:

(a) Shareholder Approval. This Agreement shall have been approved by the shareholders of Trustmark by the Requisite Trustmark Vote and by the shareholders of Hancock by the Requisite Hancock Vote.

(b) Stock Exchange Listing. The shares of Hancock Common Stock that shall be issuable pursuant to this Agreement shall have been authorized for listing on Nasdaq, subject to official notice of issuance.

(c) S-4. The S-4 shall have become effective under the Securities Act and no stop order suspending the effectiveness of the S-4 shall have been issued and no proceedings for that purpose shall have been initiated or threatened by the SEC and not withdrawn.

(d) No Injunctions or Restraints; Illegality. No order, injunction or decree issued by any court or Governmental Entity of competent jurisdiction or other legal restraint or prohibition preventing the consummation of the Merger, the Bank Merger or any of the other transactions contemplated by this Agreement shall be in effect. No law, statute, rule, regulation, order, injunction or decree shall have been enacted, entered, promulgated or enforced by any Governmental Entity which prohibits or makes illegal consummation of the Merger, the Bank Merger or any of the other transactions contemplated by this Agreement.

 

-66-


(e) Regulatory Approvals. All regulatory authorizations, consents, orders or approvals (i) from the Federal Reserve Board, the FDIC and the Mississippi Department of Banking, and (ii) set forth in Sections 3.4 and 4.4 which are necessary to consummate the transactions contemplated by this Agreement, including the Merger and the Bank Merger, or those the failure of which to be obtained would reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Hancock or the Surviving Corporation, shall have been obtained and shall remain in full force and effect and all statutory waiting periods in respect thereof shall have expired (such approvals and the expiration of such waiting periods being referred to herein as the “Requisite Regulatory Approvals”), and no Requisite Regulatory Approval shall have resulted in the imposition of any Materially Burdensome Regulatory Condition.

7.2 Conditions to Obligations of Hancock. The obligation of Hancock to effect the Merger is also subject to the satisfaction, or waiver by Hancock, at or prior to the Effective Time, of the following conditions:

(a) Representations and Warranties. The representations and warranties of Trustmark set forth in (i) Sections 3.2(a) and 3.8(a) (in each case after giving effect to the lead in to Article III) shall be true and correct (other than, in the case of 3.2(a), such failures to be true and correct as are de minimis), in each case as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case as of such earlier date), and (ii) Sections 3.1(a), 3.1(b) (with respect to Trustmark Bank only), 3.2(c) (with respect to Trustmark Bank only) and 3.3(a) (in each case after giving effect to the lead in to Article III) shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case as of such earlier date). All other representations and warranties of Trustmark set forth in this Agreement (read without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties but, in each case, after giving effect to the lead-in to Article III) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case as of such earlier date); provided, however, that for purposes of this sentence, such representations and warranties shall be deemed to be true and correct unless the failure or failures of such representations and warranties to be so true and correct, either individually or in the aggregate, and without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties, has had or would reasonably be likely to have a Material Adverse Effect on Trustmark or the Surviving Corporation. Hancock shall have received a certificate signed on behalf of Trustmark by the Chief Executive Officer or the Chief Financial Officer of Trustmark to the foregoing effect.

(b) Performance of Obligations of Trustmark. Trustmark shall have performed in all material respects the obligations, covenants and agreements required to be performed by it under this Agreement at or prior to the Closing Date, and Hancock shall have received a certificate signed on behalf of Trustmark by the Chief Executive Officer or the Chief Financial Officer of Trustmark to such effect.

 

-67-


(c) Federal Tax Opinion. Hancock shall have received the opinion of Wachtell, Lipton, Rosen & Katz (or other nationally recognized tax counsel), in form and substance reasonably satisfactory to Hancock, dated as of the Closing Date, to the effect that, on the basis of facts, representations and assumptions set forth or referred to in such opinion, the Merger will qualify as a “reorganization” within the meaning of Section 368(a) of the Code. In rendering such opinion, counsel may require and rely upon representations contained in certificates of officers of Hancock and Trustmark reasonably satisfactory in form and substance to such counsel.

7.3 Conditions to Obligations of Trustmark. The obligation of Trustmark to effect the Merger is also subject to the satisfaction or waiver by Trustmark at or prior to the Effective Time of the following conditions:

(a) Representations and Warranties. The representations and warranties of Hancock set forth in (i) Sections 4.2(a) and 4.8(a) (in each case after giving effect to the lead in to Article IV) shall be true and correct (other than, in the case of Section 4.2(a), such failures to be true and correct as are de minimis) in each case as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case as of such earlier date), and (ii) Sections 4.1(a), 4.1(b) (with respect to Hancock Whitney Bank only), 4.2(c) (with respect to Hancock Whitney Bank only) and 4.3(a) (in each case after giving effect to the lead in to Article IV) shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case as of such earlier date). All other representations and warranties of Hancock set forth in this Agreement (read without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties but, in each case, after giving effect to the lead-in to Article IV) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case as of such earlier date); provided, however, that for purposes of this sentence, such representations and warranties shall be deemed to be true and correct unless the failure or failures of such representations and warranties to be so true and correct, either individually or in the aggregate, and without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties, has had or would reasonably be likely to have a Material Adverse Effect on Hancock. Trustmark shall have received a certificate signed on behalf of Hancock by the Chief Executive Officer or the Chief Financial Officer of Hancock to the foregoing effect.

(b) Performance of Obligations of Hancock. Hancock shall have performed in all material respects the obligations, covenants and agreements required to be performed by it under this Agreement at or prior to the Closing Date, and Trustmark shall have received a certificate signed on behalf of Hancock by the Chief Executive Officer or the Chief Financial Officer of Hancock to such effect.

(c) Federal Tax Opinion. Trustmark shall have received the opinion of Covington & Burling LLP (or other nationally recognized tax counsel), in form and substance reasonably satisfactory to Trustmark, dated as of the Closing Date, to the effect that, on the basis of facts, representations and assumptions set forth or referred to in such opinion, the Merger will qualify as a “reorganization” within the meaning of Section 368(a) of the Code. In rendering such opinion, counsel may require and rely upon representations contained in certificates of officers of Hancock and Trustmark reasonably satisfactory in form and substance to such counsel.

 

-68-


ARTICLE VIII

TERMINATION AND AMENDMENT

8.1 Termination. This Agreement may be terminated at any time prior to the Effective Time, whether before or after receipt of the Requisite Trustmark Vote or the Requisite Hancock Vote:

(a) by mutual consent of Hancock and Trustmark in a written instrument;

(b) by either Hancock or Trustmark if any Governmental Entity that must grant a Requisite Regulatory Approval has denied approval of the Merger or the Bank Merger and such denial has become final and nonappealable, or any Governmental Entity of competent jurisdiction shall have issued a final nonappealable order, injunction or decree permanently enjoining or otherwise prohibiting or making illegal the consummation of the Merger or the Bank Merger, provided, however, that the right to terminate this Agreement pursuant to this Section 8.1(b) shall not be available to any party whose failure to perform or observe the obligations, covenants and agreements of such party set forth herein shall have been the primary cause of such denial or order;

(c) by either Hancock or Trustmark if the Merger shall not have been consummated on or before the first anniversary of the date of this Agreement (the “Termination Date”), provided, however, that the right to terminate this Agreement pursuant to this Section 8.1(c) shall not be available to any party whose failure to perform or observe the obligations, covenants and agreements of such party set forth herein shall have been the primary cause the transaction has not been consummated by such time;

(d) by either Hancock or Trustmark (provided that the terminating party is not then in material breach of any representation, warranty, obligation, covenant or other agreement contained herein) if there shall have been a breach of any of the obligations, covenants or agreements or any of the representations or warranties (or any such representation or warranty shall cease to be true) set forth in this Agreement on the part of Trustmark, in the case of a termination by Hancock, or Hancock, in the case of a termination by Trustmark, which breach or failure to be true, either individually or in the aggregate with all other breaches by such party (or failures of such representations or warranties to be true), would constitute, if occurring or continuing on the Closing Date, the failure of a condition set forth in Section 7.2, in the case of a termination by Hancock, or Section 7.3, in the case of a termination by Trustmark, and which is not cured by the earlier of the Termination Date and 45 days following written notice to Trustmark, in the case of a termination by Hancock, or Hancock, in the case of a termination by Trustmark, or by its nature or timing cannot be cured during such period;

(e) by Trustmark, if Hancock or the Board of Directors of Hancock shall have (i) made a Hancock Adverse Recommendation Change or (ii) breached its obligations under Section 6.4 or Section 6.14 in any material respect; or

 

-69-


(f) by Hancock, if Trustmark or the Board of Directors of Trustmark shall have (i) made a Trustmark Adverse Recommendation Change or (ii) breached its obligations under Section 6.3 or Section 6.14 in any material respect.

The party desiring to terminate this Agreement pursuant to clauses (b), (c), (d), (e) or (f) of this Section 8.1 shall give written notice of such termination to the other party in accordance with Section 9.5, specifying the provision or provisions hereof pursuant to which such termination is effected.

8.2 Effect of Termination.

(a) In the event of termination of this Agreement by either Hancock or Trustmark as provided in Section 8.1, this Agreement shall forthwith become void and have no effect, and none of Hancock, Trustmark, any of their respective Subsidiaries or any of the officers or directors of any of them shall have any liability of any nature whatsoever hereunder, or in connection with the transactions contemplated hereby, except that (i) Section 6.2(b) and this Section 8.2 and Article IX (other than Section 9.13) shall survive any termination of this Agreement, and (ii) notwithstanding anything to the contrary contained in this Agreement, neither Hancock nor Trustmark shall be relieved or released from any liabilities or damages arising out of its Willful Breach of any provision of this Agreement occurring prior to termination (which, in the case of Trustmark, shall include the loss to the holders of its capital stock and of Trustmark Equity Awards of the economic benefits of the Merger (including the loss of premium offered to the shareholders of Trustmark), it being understood that Trustmark shall be entitled to pursue damages for such losses and to enforce the right to recover such losses on behalf of its shareholders and the holders of Trustmark Equity Awards in its sole and absolute discretion, and any amounts received by Trustmark in connection therewith may be retained by Trustmark). “Willful Breach” shall mean a material breach of, or material failure to perform any of the covenants or other agreements contained in this Agreement, that is a consequence of an act or willful failure to act by the breaching or non-performing party with actual knowledge that such party’s act or failure to act would, or would reasonably be expected to, result in or constitute such breach of or such failure of performance under this Agreement.

(b) (i) In the event that after the date of this Agreement and prior to the termination of this Agreement, a bona fide Trustmark Acquisition Proposal shall have been communicated to or otherwise made known to the Board of Directors or senior management of Trustmark or shall have been made directly to its shareholders generally or any person shall have publicly announced (and not withdrawn at least two business days prior to the Trustmark Meeting) a Trustmark Acquisition Proposal with respect to Trustmark and (A) thereafter this Agreement is terminated by either Hancock or Trustmark pursuant to Section 8.1(c) without the Requisite Trustmark Vote having been obtained (and all other conditions set forth in Section 7.1 and Section 7.3 were satisfied or were capable of being satisfied prior to such termination), or (B) thereafter this Agreement is terminated by Hancock pursuant to Section 8.1(d) as a result of a Willful Breach, and (C) prior to the date that is 12 months after the date of such termination, Trustmark enters into a definitive agreement or consummates a transaction with respect to a Trustmark Acquisition Proposal (whether or not the same Trustmark Acquisition Proposal as that referred to above), then Trustmark shall, on the earlier of the date it enters into such definitive agreement and the date of consummation of such transaction, pay Hancock, by wire transfer of same day funds, a fee equal to $110,000,000 (the “Termination Fee”); provided that for purposes of this Section 8.2(b)(i), all references in the definition of Trustmark Acquisition Proposal to “25%” shall instead refer to “50%”.

 

-70-


(ii) In the event that this Agreement is terminated by Hancock pursuant to Section 8.1(f), then Trustmark shall pay Hancock, by wire transfer of same day funds, the Termination Fee as promptly as reasonably practicable after the date of termination (and in any event, within three business days thereafter).

(c) In no event shall Trustmark be required to pay the Termination Fee on more than one occasion.

(d) (i) In the event that after the date of this Agreement and prior to the termination of this Agreement, a bona fide Hancock Acquisition Proposal shall have been communicated to or otherwise made known to the Board of Directors or senior management of Hancock or shall have been made directly to its shareholders generally or any person shall have publicly announced (and not withdrawn at least two business days prior to the Hancock Meeting) a Hancock Acquisition Proposal with respect to Hancock and (A) thereafter this Agreement is terminated by either Hancock or Trustmark pursuant to Section 8.1(c) without the Requisite Hancock Vote having been obtained (and all other conditions set forth in Sections 7.1 and 7.2 were satisfied or were capable of being satisfied prior to such termination), or (B) thereafter this Agreement is terminated by Trustmark pursuant to Section 8.1(d) as a result of a Willful Breach, and (C) prior to the date that is 12 months after the date of such termination, Hancock enters into a definitive agreement or consummates a transaction with respect to a Hancock Acquisition Proposal (whether or not the same Hancock Acquisition Proposal as that referred to above), then Hancock shall, on the earlier of the date it enters into such definitive agreement and the date of consummation of such transaction, pay Trustmark, by wire transfer of same day funds, the Termination Fee; provided that for purposes of this Section 8.2(d)(i), all references in the definition of Hancock Acquisition Proposal to “25%” shall instead refer to “50%”.

(ii) In the event that this Agreement is terminated by Trustmark pursuant to Section 8.1(e), then Hancock shall pay Trustmark, by wire transfer of same day funds, the Termination Fee as promptly as reasonably practicable after the date of termination (and in any event, within three business days thereafter).

(e) In no event shall Hancock be required to pay the Termination Fee on more than one occasion.

(f) Each of Hancock and Trustmark acknowledges that the agreements contained in this Section 8.2 are an integral part of the transactions contemplated by this Agreement, and that, without these agreements, the other party would not enter into this Agreement; accordingly, if either party fails promptly to pay the amount due pursuant to this Section 8.2, and, in order to obtain such payment, the other party commences a suit which results in a judgment against the non-paying party for the Termination Fee or any portion thereof, such non-paying party shall pay the costs and expenses of the other party (including reasonable attorneys’ fees and expenses) in connection with such suit. In addition, if either party fails to pay the amounts payable pursuant to this Section 8.2, then such party shall pay interest on such

 

-71-


overdue amounts (for the period commencing as of the date that such overdue amount was originally required to be paid and ending on the date that such overdue amount is actually paid in full) at a rate per annum equal to the “prime rate” (as announced by JPMorgan Chase & Co. or any successor thereto) in effect on the date on which such payment was required to be made for the period commencing as of the date that such overdue amount was originally required to be paid. The amounts payable by (i) Trustmark pursuant to Section 8.2(b) and this Section 8.2(f) and (ii) Hancock pursuant to Section 8.2(d) and this Section 8.2(f), constitute liquidated damages and not a penalty, and, except in the case of Willful Breach by the other party of any provision herein occurring prior to termination, shall be the sole monetary remedy of a party in the event of a termination of this Agreement.

ARTICLE IX

GENERAL PROVISIONS

9.1 Nonsurvival of Representations, Warranties and Agreements. None of the representations, warranties, covenants and agreements in this Agreement or in any instrument delivered pursuant to this Agreement (other than the Confidentiality Agreement, which shall survive in accordance with its terms) shall survive the Effective Time, except for Section 6.7, Section 6.9, and for those other covenants and agreements contained herein and therein which by their terms apply or are to be performed in whole or in part after the Effective Time.

9.2 Amendment. Subject to compliance with applicable law, this Agreement may be amended by the parties hereto at any time before or after the receipt of the Requisite Trustmark Vote or the Requisite Hancock Vote; provided, however, that after the receipt of the Requisite Trustmark Vote or the Requisite Hancock Vote there may not be, without further approval of such shareholders of Trustmark or Hancock, as applicable, any amendment of this Agreement that requires such further approval under applicable law. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing signed on behalf of each of the parties.

9.3 Extension; Waiver. At any time prior to the Effective Time, the parties hereto may, to the extent legally allowed, extend the time for the performance of any of the obligations or other acts of the other party hereto, waive any inaccuracies in the representations and warranties of the other party contained herein or in any document delivered by the other party pursuant hereto, and waive compliance with any of the agreements or satisfaction of any conditions for its benefit contained herein; provided, however, that after the receipt of the Requisite Trustmark Vote or the Requisite Hancock Vote there may not be, without further approval of such shareholders of Trustmark or Hancock, as applicable, any extension or waiver of this Agreement or any portion thereof that requires such further approval under applicable law. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party, but such extension or waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure.

 

-72-


9.4 Expenses. Except as otherwise expressly provided in this Agreement, including in Section 8.2, all fees and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such fees or expenses, whether or not the Merger is consummated.

9.5 Notices. All notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall be (a) delivered by hand (with written confirmation of receipt), (b) sent by a nationally recognized overnight courier (with confirmed delivery receipt), (c) sent certified or registered mail, return receipt requested, postage prepaid, or (d) sent by e-mail if sent during normal business hours of the recipient, and deemed to have been given on the next business day if sent after normal business hours of the recipient, provided that (i) no “error” message or other notification of non-delivery is generated and (ii) such notice, request, claim, demand or other communication has also been delivered or sent, as applicable, in one of the manners set forth in (a) through (c) of this Section 9.5. Notices are effective upon receipt. Such communications must be sent to the respective parties at the following addresses (or at such other address for a party as shall be specified by like notice):

if to Trustmark, to:

Trustmark Corporation

248 East Capitol Street

Jackson, Mississippi 39201

Attention: Duane A. Dewey, President and Chief Executive Officer;

   Granville Tate, Jr., Secretary

Email: DDewey@trustmark.com; GTate@trustmark.com

With a copy (which shall not constitute notice) to:

Covington & Burling LLP

One International Place, Suite 1020

Boston, MA 02110-2600

Attention: Bruce Bennett; Samantha Kirby; Charlotte May

Email: BBennett@cov.com; SKirby@cov.com; CMay@cov.com

And

if to Hancock, to:

Hancock Whitney Corporation

Hancock Whitney Plaza

2510 14th Street

Gulfport, Mississippi, 39501

Attention: Juanita P. Kuhner, Esq., General Counsel and Corporate Secretary

Email: Juanita.Kuhner@hancockwhitney.com

 

-73-


With a copy (which shall not constitute notice) to:

Wachtell, Lipton, Rosen & Katz

51 West 52nd Street

New York, New York 10019

Attention: Nicholas G. Demmo

Email: NGDemmo@wlrk.com

9.6 Interpretation. The parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement. When a reference is made in this Agreement to Articles, Sections, Exhibits or Schedules, such reference shall be to an Article or Section of or Exhibit or Schedule to this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” The word “or” shall not be exclusive. References to “the date hereof” shall mean the date of this Agreement. As used in this Agreement, the “knowledge” of Trustmark means the actual knowledge of any of the officers of Trustmark listed on Section 9.6 of the Trustmark Disclosure Schedule, and the “knowledge” of Hancock means the actual knowledge of any of the officers of Hancock listed on Section 9.6 of the Hancock Disclosure Schedule. As used herein, (a) “business day” means any day other than a Saturday, a Sunday or a day on which banks in New York, New York, Gulfport, Mississippi or Jackson, Mississippi are authorized by law or executive order to be closed, (b) the term “person” means any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Entity or other entity of any kind or nature, (c) an “affiliate” of a specified person is any person that directly or indirectly controls, is controlled by, or is under common control with, such specified person, and (d) the term “made available” means any document or other information that was (i) provided by one party or its representatives to the other party and its representatives prior to the date hereof, (ii) included in the virtual data room of a party prior to the date hereof, or (iii) filed by a party with the SEC and publicly available on EDGAR prior to the date hereof. The Trustmark Disclosure Schedule and the Hancock Disclosure Schedule, as well as all other schedules and all exhibits hereto, shall be deemed part of this Agreement and included in any reference to this Agreement. All references to “dollars” or “$” in this Agreement are to United States dollars. This Agreement shall not be interpreted or construed to require any person to take any action, or fail to take any action, if to do so would violate any applicable law.

9.7 Confidential Supervisory Information. No disclosure, representation or warranty shall be made (or any other action taken) pursuant to this Agreement that would involve the disclosure of confidential supervisory information (including confidential supervisory information as defined in 12 C.F.R. § 261.2(b) and as identified in 12 C.F.R. § 4.32(b)) of a Governmental Entity by any party hereto to the extent prohibited by applicable law, and, to the extent legally permissible, appropriate substitute disclosures or actions shall be made or taken under circumstances in which the limitations of this sentence apply.

 

-74-


9.8 Counterparts. This Agreement may be executed in counterparts (including by electronic means), all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart.

9.9 Entire Agreement. This Agreement (including the documents and the instruments referred to herein) together with the Confidentiality Agreement constitutes the entire agreement among the parties and supersedes all prior agreements and understandings, both written and oral, among the parties with respect to the subject matter hereof.

9.10 Governing Law; Jurisdiction.

(a) This Agreement shall be governed by and construed in accordance with the laws of the State of Mississippi, without regard to any applicable conflicts of law principles.

(b) Each party agrees that it will bring any action or proceeding in respect of any claim arising out of or related to this Agreement or the transactions contemplated hereby exclusively in the state courts of the State of Mississippi or any federal court of competent jurisdiction located in the State of Mississippi (the “Chosen Courts”), and, solely in connection with claims arising under this Agreement or the transactions that are the subject of this Agreement, (i) irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (ii) waives any objection to laying venue in any such action or proceeding in the Chosen Courts, (iii) waives any objection that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any party and (iv) agrees that service of process upon such party in any such action or proceeding will be effective if notice is given in accordance with Section 9.5.

9.11 Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY SUIT, ACTION OR OTHER PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT: (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY SUIT, ACTION OR OTHER PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.11.

 

-75-


9.12 Assignment; Third-Party Beneficiaries. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other party. Any purported assignment in contravention hereof shall be null and void. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns. Except as otherwise specifically provided in Section 6.9, which is intended to benefit each Trustmark Indemnified Party and his or her heirs and representatives, this Agreement (including the documents and instruments referred to herein) is not intended to and does not confer upon any person other than the parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein. The representations and warranties in this Agreement are the product of negotiations among the parties hereto and are for the sole benefit of the parties. Any inaccuracies in such representations and warranties are subject to waiver by the parties hereto in accordance herewith without notice or liability to any other person. In some instances, the representations and warranties in this Agreement may represent an allocation among the parties hereto of risks associated with particular matters regardless of the knowledge of any of the parties hereto. Consequently, persons other than the parties may not rely upon the representations and warranties in this Agreement as characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date. Except as provided in Section 6.9, notwithstanding any other provision in this Agreement to the contrary, no consent, approval or agreement of any third-party beneficiary will be required to amend, modify or waive any provision of this Agreement.

9.13 Specific Performance. The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with its specific terms or were otherwise breached. Accordingly, the parties shall be entitled to specific performance of the terms of this Agreement, including an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof (including the parties’ obligation to consummate the Merger), in addition to any other remedy to which they are entitled at law or in equity. Each of the parties hereby further waives (a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any law to post security or a bond as a prerequisite to obtaining equitable relief.

9.14 Severability. Whenever possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction such that the invalid, illegal or unenforceable provision or portion thereof shall be interpreted to be only so broad as is enforceable.

 

-76-


9.15 Delivery by Electronic Transmission. This Agreement and any signed agreement or instrument entered into in connection with this Agreement, and any amendments or waivers hereto or thereto, to the extent signed and delivered by e-mail delivery of a “.pdf” format data file, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto or to any such agreement or instrument shall raise the use of e-mail delivery of a “.pdf” format data file to deliver a signature to this Agreement or any amendment hereto or the fact that any signature or agreement or instrument was transmitted or communicated through e-mail delivery of a “.pdf” format data file as a defense to the formation of a contract and each party hereto forever waives any such defense.

[Signature Page Follows]

 

-77-


IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their respective officers thereunto duly authorized as of the date first above written.

 

HANCOCK WHITNEY CORPORATION
By:  

/s/ John M. Hairston

  Name: John M. Hairston
  Title:  President & Chief Executive Officer

[Signature Page to Agreement and Plan of Merger]


TRUSTMARK CORPORATION
By:  

/s/ Duane A. Dewey

  Name: Duane A. Dewey
  Title: President & Chief Executive Officer

[Signature Page to Agreement and Plan of Merger]


EXHIBIT A

FORM OF BANK MERGER AGREEMENT

 

Exh. A

Keep reading